Refine
Has Fulltext
- yes (419)
Is part of the Bibliography
- yes (419)
Year of publication
Document Type
- Journal article (289)
- Doctoral Thesis (123)
- Book article / Book chapter (2)
- Conference Proceeding (2)
- Review (2)
- Preprint (1)
Keywords
- Infektionsbiologie (57)
- Escherichia coli (41)
- Candida albicans (25)
- Staphylococcus aureus (15)
- Virulenzfaktor (12)
- Legionella pneumophila (11)
- escherichia coli (11)
- gene expression (11)
- Biofilm (10)
- Genexpression (10)
- virulence (10)
- Immunologie (9)
- RNA-seq (9)
- Virulenz (9)
- expression (8)
- infection (8)
- Biologie (7)
- Malaria (7)
- gene regulation (7)
- identification (7)
- Genregulation (6)
- Molekularbiologie (6)
- Plasmodium falciparum (6)
- antibiotics (6)
- biofilm (6)
- epithelial cells (6)
- resistance (6)
- sRNA (6)
- transcriptome (6)
- Bakterien (5)
- Dendritische Zelle (5)
- Infektion (5)
- Leishmania major (5)
- MRSA (5)
- Molekulargenetik (5)
- Neisseria meningitidis (5)
- Proteasen (5)
- RNA (5)
- Regulation (5)
- Resistenz (5)
- Salmonella (5)
- activation (5)
- antimicrobial resistance (5)
- bacteria (5)
- messenger RNA (5)
- plasmodium falciparum (5)
- regulation (5)
- Adhäsion (4)
- Aspergillus fumigatus (4)
- Biofilmbildung (4)
- Enterobacteriaceae (4)
- Genanalyse (4)
- Hfq (4)
- Immunsystem (4)
- Legionella (4)
- Leishmania (4)
- Pathogenität (4)
- Signaltransduktion (4)
- Staphylococcus epidermis (4)
- Streptococcus pneumoniae (4)
- antibodies (4)
- antisense RNA (4)
- biofilms (4)
- inhibition (4)
- invasion (4)
- macrophages (4)
- pathogens (4)
- signal transduction (4)
- small RNA (4)
- staphylococcus aureus (4)
- synthesis (4)
- vancomycin (4)
- Antibiotikum (3)
- Bakterielle Infektion (3)
- Campylobacter jejuni (3)
- Dictyostelium (3)
- Dictyostelium discoideum (3)
- Evolution (3)
- Expression (3)
- Grad-seq (3)
- IS256 (3)
- Immunreaktion (3)
- Integrine (3)
- Invasion (3)
- Neisseria gonorrhoeae (3)
- Pathogenitätsinseln (3)
- Phasenvariation (3)
- Probiotikum (3)
- RNA sequencing (3)
- RNA-binding proteins (3)
- RNS (3)
- STEC (3)
- Salmonella Typhimurium (3)
- Salmonella enterica (3)
- Salmonella typhimurium (3)
- Schwamm (3)
- Schwämme (3)
- Small RNA (3)
- Staphylococcus (3)
- Staphylococcus epidermidis (3)
- Stickstoff (3)
- Symbiose (3)
- UPEC (3)
- adaptation (3)
- adhesion (3)
- antibacterial activity (3)
- apoptosis (3)
- autophagy (3)
- bacillus subtilis (3)
- bacteriophage (3)
- biology (3)
- cancer (3)
- candida albicans (3)
- dendritic cells (3)
- fluorescence microscopy (3)
- genes (3)
- genome sequence (3)
- leishmania major (3)
- leishmaniasis (3)
- malaria (3)
- mechanisms (3)
- medicine (3)
- mouse models (3)
- pathogenicity islands (3)
- phase variation (3)
- protein kinase (3)
- regulator genes (3)
- regulatory RNA (3)
- riboswitch (3)
- sequence (3)
- signaling pathway (3)
- stem cells (3)
- substituent (3)
- transcription (3)
- transcription factors (3)
- transcriptomics (3)
- translation (3)
- transmission (3)
- urinary tract infection (3)
- virulence factors (3)
- 16S rRNA (2)
- 3D tissue model (2)
- Adhärenz (2)
- Agent (2)
- Antibiotika (2)
- Antisense RNA (2)
- Aplysina aerophoba (2)
- Autotransporterprotein (2)
- BNIP3 (2)
- Bacteria (2)
- Bakteriophagen (2)
- Breast-tumors (2)
- COVID-19 (2)
- Cancer (2)
- Candida (2)
- Candida auris (2)
- Cysteinproteasen (2)
- DNA transcription (2)
- Deletion (2)
- E. coli Nissle 1917 (2)
- E. coli serotype 06 (2)
- Enterococcus faecium (2)
- F8 fimbriae (2)
- Fitness (2)
- Flagelle (2)
- Fluconazol (2)
- Fluconazole (2)
- Geißel <Biologie> (2)
- Gen (2)
- Gene regulation (2)
- Genomik (2)
- Genomvariabilität (2)
- Glykosylierung (2)
- Growth (2)
- HFQ (2)
- Haemophilus influenzae (2)
- Harnwegsinfektion (2)
- Harnwegsinfektionen (2)
- HeLa cells (2)
- Helicobacter pylori (2)
- Hospitalismus <Hygiene> (2)
- Immuntherapie (2)
- Impfung (2)
- In-vivo (2)
- Infection (2)
- Insertionselement (2)
- Kinase (2)
- Leishmaniose (2)
- Lung cancer (2)
- MATQ-seq (2)
- Medizin (2)
- Meeresschwämme (2)
- Metagenomik (2)
- Microarray (2)
- Mip (2)
- Nude-mice (2)
- Pathogenitätsinsel (2)
- Pathogens (2)
- Phagozytose (2)
- Pneumokokken (2)
- Poribacteria (2)
- Proteom (2)
- RNA synthesis (2)
- Resistance (2)
- Rhodobacter sphaeroides (2)
- SARS-CoV-2 (2)
- SEQ (2)
- Salmonellosis (2)
- Shigella (2)
- Staphylokokken (2)
- Streptomyces (2)
- T cells (2)
- Therapy (2)
- Toxoplasma gondii (2)
- TraDIS (2)
- Transkriptom (2)
- Transkriptomanalyse (2)
- Transposon (2)
- UTI (2)
- Vibrio cholerae (2)
- adherence (2)
- allelic replacement (2)
- antibiotic resistance (2)
- antifungals (2)
- antigen (2)
- antisense RNAs (2)
- archaea (2)
- bacterial genetics (2)
- biofilm formation (2)
- biofilmformation (2)
- bioluminescence imaging (2)
- biosynthesis (2)
- cell wall (2)
- chaperone (2)
- comparative genomics (2)
- cytokines (2)
- cytotoxicity (2)
- dRNA-Seq (2)
- enterica serovar typhimurium (2)
- epidemiology (2)
- evolution (2)
- flagellum (2)
- gametocyte (2)
- gastric cancer (2)
- gastrointestinal tract (2)
- gene (2)
- gene cloning (2)
- gene expression profiling (2)
- genome (2)
- genome annotation (2)
- glycopeptide antibiotics (2)
- hemolysin (2)
- host cells (2)
- immune response (2)
- in vitro (2)
- in vivo imaging (2)
- in-vitro (2)
- in-vivo (2)
- inflammation (2)
- inhibitor (2)
- inhibitors (2)
- leishmania (2)
- liraglutide (2)
- magnetic resonance imaging (2)
- marine sponges (2)
- mechanism (2)
- messenger-RNA (2)
- metabolism (2)
- metagenomics (2)
- metastasis (2)
- methionine (2)
- monoclonal antibodies (2)
- monoklonale Antikörper (2)
- mutation (2)
- ncRNA (2)
- neutrophils (2)
- noncoding RNA (2)
- obesity (2)
- oligopeptides (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- parasite (2)
- parasitic diseases (2)
- pathogenicity (2)
- phage (2)
- phylogeny (2)
- plants (2)
- pneumococci (2)
- polycationic peptides (2)
- proteasome (2)
- protein kinases (2)
- proteins (2)
- recombination (2)
- red fluorescent protein (2)
- regulator (2)
- reporter genes (2)
- response regulator (2)
- responses (2)
- ribonucleases (2)
- secretion (2)
- secretion systems (2)
- single-cell RNA-seq (2)
- small RNAs (2)
- small nucleolar RNAs (2)
- strains (2)
- structure-activity (2)
- subunit (2)
- therapy (2)
- transcriptome analysis (2)
- transmission electron microscopy (2)
- tumors (2)
- type VII secretion system (2)
- vaccinia virus (2)
- virulence factor (2)
- (+)-limonene (1)
- (Nucleotide sequence (1)
- 0 antigen (1)
- 18SrRNA (1)
- 19F MR (1)
- 2-component system (1)
- 3D Gewebemodelle (1)
- 3D cell culture (1)
- 3′ UTR (1)
- 5-bromodeoxyuridine (1)
- 5`-Nukleotidase (1)
- 5`-nucleotidase (1)
- 6S RNA (1)
- AAV vector (1)
- ABC-Transporter (1)
- AMP-activated kinases (1)
- APEC (1)
- ATG (1)
- ATG8 (1)
- AcrAB-TolC efflux pump (1)
- Adaptorproteine (1)
- Adenylatkinase (1)
- Adherence (1)
- Adhesion (1)
- Adhäsine (1)
- Adhäsion <Pathologie> (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Ammoniakstoffwechsel (1)
- Amoebapor-Proteine (1)
- Amoebapores (1)
- Angeborene Immunität (1)
- Anopheles stephensi (1)
- Antibiotic (1)
- Antibiotics (1)
- Antigenpräsentation (1)
- Antikörper (1)
- Antikörper-Antwort (1)
- Antimicrobial activity (1)
- Antimykotikum (1)
- Apicomplexan (1)
- Apoptose (1)
- Apoptosis (1)
- Archaea (1)
- Array (1)
- Arzneimitteldesign (1)
- Arzneimittelresistenz (1)
- Aspartatprotease (1)
- Asthma (1)
- Asymptomatic Bacteriuria (1)
- Attenuierung (1)
- Autophagie (1)
- Autophagiescore (1)
- Autotransporter (1)
- Avirulent Salmonella (1)
- B1 Mapping (1)
- BCG (1)
- BT_1884 (1)
- Bacillus subtilis (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial pathogens (1)
- Bacteriaophage AR9 (1)
- Bakterielle Konjugation (1)
- Bakteriophage (1)
- Bakteriophage K139 (1)
- Bestimmung (1)
- Biofilm formation (1)
- Bioinformatics (1)
- Biology (1)
- Biosynthese der aromatischen Aminosäuren (1)
- Bloch Siegert (1)
- Blood-brain barrier (1)
- Blutgefäß (1)
- Bordeiella pertussis (1)
- Bovine Mastitis (1)
- Bovis (1)
- Bradyrhizobium (1)
- Bronchialasthma (1)
- C-6-H (1)
- C-Terminus (1)
- CDR1-Effluxpumpe (1)
- CEACAM (1)
- CEACAM3 (1)
- CEACAMs (1)
- COX-2 (1)
- CRISPR-Cas system (1)
- CRISPRs (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- Calcineurin (1)
- Calcium (1)
- Carbonyl-Reductase <NADPH> (1)
- Carbonylreduktase (1)
- Carcino-embryonales Antigen (1)
- Carcinoma (1)
- Cas9 (1)
- Caspasen (1)
- Cathepsin E (1)
- Cell binding (1)
- Characterization (1)
- Chemical modification (1)
- Chemokine (1)
- Chemotherapy (1)
- Chlamydia (1)
- Chlamydia pneumoniae (1)
- Chlamydien (1)
- Chlamydophila pneumoniae (1)
- Citrobacter freundii (1)
- Clp <Protease> (1)
- ClpP (1)
- ClpX (1)
- Colibactin (1)
- Combination therapy (1)
- Complexome (1)
- Conjugation (1)
- CpG (1)
- Crohns-disease (1)
- CsrA (1)
- Cutaneous leishmaniasis (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- Cyclophosphamide (1)
- Cystic-fibriosis (1)
- DASH (1)
- DNA (1)
- DNA glycosation (1)
- DNA lang range mapping (1)
- DNA methylation (1)
- DNA methylferase homolog (1)
- DNA-Array (1)
- DNA-array (1)
- Darm (1)
- Darmflora (1)
- Defensine (1)
- Deletionsmutante (1)
- Deletionsrate (1)
- Demospongiae (1)
- Denaturierende Gradienten-Gelelektrophorese (1)
- Denaturing Gradient Gel Electrophoresis (1)
- Dendritic cell (1)
- Dendritic cells (1)
- Dendrtitischer Zellen (1)
- Dextran sulphate (1)
- Dezentralisierung (1)
- Diarrhea (1)
- Dimerisierung (1)
- Disease gene prioritization (1)
- Division (1)
- Drosophila (1)
- Drug resistance (1)
- Dual 3'seq (1)
- Dual RNA-seq (1)
- E. coli (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- E.coli (1)
- E.coli Nissle 1917 (1)
- ECM (1)
- EGFP (1)
- EHEC (1)
- ELISA (1)
- ER (1)
- ESAT‐6‐like secretion system (1)
- ESS (1)
- EZM (1)
- Efflux pump (1)
- Effluxpumpen (1)
- Eingeweidewürmer (1)
- Einzelzell-Genomik (1)
- Eisen (1)
- Eisenmangel (1)
- Elektronenmikroskopie (1)
- Elektronisches Publizieren (1)
- Elektroporation (1)
- Entamoeba histolytica (1)
- Enterhämorrhagische Escherichia coli (1)
- Enterica serovar typhimurium (1)
- Enteritis (1)
- Enterococcus faecalis (1)
- Enterohaemorrhagic Escherichia coli (1)
- Environmental isolate (1)
- Epstein-Barr virus (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escherichia coli strains (1)
- Escherichia coli-Hfq (1)
- Escherichia coli-Stämme (1)
- Escherichia-coli K-12 (1)
- Ethiopia (1)
- Evasionsmechanismen (1)
- ExPEC (1)
- Excision (1)
- Expressionsgenbank (1)
- Extracellular matrix (1)
- Extrazelluläre Matrix (1)
- F-19 MRI (1)
- F1 (1)
- FACS-Analyse (1)
- FACS-analysis (1)
- FAK (1)
- Factor H (1)
- Family (1)
- Fibronectin (1)
- Fibronektin (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- Fischerella sp. (1)
- Fitneßfaktor (1)
- Flavomycin (1)
- Flavophospholipol (1)
- Fluoreszenz-in-situ-Hybridisierung (1)
- Fluoreszenzmikroskopie (1)
- Foc protein (1)
- Freilebende Amöben (1)
- Ftsz (1)
- Fusobacterium nucleatum (1)
- GFP (1)
- GFP-Reportergen (1)
- GFP-reportersystem (1)
- GI-101A tumor xenografts (1)
- GLP-1 (1)
- GLV-1 h153 (1)
- GLV-1H68 (1)
- GO1 (1)
- Gametogenese (1)
- Gametozyt (1)
- Gene (1)
- Gene cloning (1)
- Gene expression (1)
- Gene mapping (1)
- Gene-expression (1)
- Gene-transfer (1)
- Genetik (1)
- Genome analysis (1)
- Genome re-annotation (1)
- Genomic profile (1)
- Genomorganisation (1)
- Genomplastizität (1)
- Genomvaribilität (1)
- Gentransfer (1)
- Germany (1)
- Gesundheitssektorreform (1)
- GibS (1)
- Gifsy-1 (1)
- Glatte Muskulatur (1)
- Glykosyltransferase (1)
- Gram-positive bacteria (1)
- Grundsubstanz (1)
- Grün fluoreszierendes Protein (1)
- H-NS (1)
- HBD2 (1)
- HD5 (1)
- HGT (1)
- HIV (1)
- Haemolysin (1)
- Haloferax volcanii (1)
- Halogenase (1)
- Harnwegsinfekt (1)
- Harnwegskrankheit (1)
- Helicobacterpylori (1)
- Helminthen (1)
- Helminths (1)
- Hemolysin excretion (1)
- Herzmuskel (1)
- Hidden-Markov-Modell (1)
- Hirnhautentzündung (1)
- Histatin 5 (1)
- Histon-ähnliche Proteine (1)
- Histone-like proteins (1)
- Homology (1)
- Horizontaler Gentransfer (1)
- Hospital water system (1)
- Host adaptation (1)
- Host cells (1)
- Human-pathogenic (1)
- Hämolysin (1)
- IL-12 production (1)
- IL-4 (1)
- IL-4 Rezeptor alpha (1)
- IL-4 receptor alpha chain (1)
- IS100 (1)
- ITAM (1)
- IcaR (1)
- Ileal Crohns-disease (1)
- Images (1)
- Immunantwort (1)
- Immunbiologie (1)
- Immunisierung (1)
- Immunohistochemistry; Immunogold-silver staining; FITC- anti-FITC system; Leucocyte subpopulations; Two-color staining (1)
- Immunotherapy (1)
- Impfstoff (1)
- Impfungen (1)
- In Vivo Expressionstechnologie (1)
- In vivo (1)
- In-vitro (1)
- Inactivation (1)
- Infection models (1)
- Infektionsbildgebung (1)
- Inflammation (1)
- Inhibitor (1)
- Inhibitoren (1)
- Insertionssequenzen (1)
- Integrin (1)
- Interferon <gamma-> (1)
- Interleukin 12 (1)
- Internal transcription start site (1)
- Invasion genes (1)
- Ire1 (1)
- Iron-oxide (1)
- Iron-uptake (1)
- IsaA (1)
- IsaB (1)
- Isolation and Characterization (1)
- IsrK (1)
- K279a (1)
- Kapsel (1)
- Katheter (1)
- Kernspintomografie (1)
- KhpB protein (1)
- Kinasen (1)
- Klebsiella pneumoniae (1)
- Kleine Proteine (1)
- Klonierungsvektoren (1)
- Koevolution (1)
- Kohlenhydrate (1)
- Kollagen (1)
- Komplement <Immunologie> (1)
- Kontrastmittel (1)
- Krankheitsübertragung (1)
- Krebs <Medizin> (1)
- Kultivierung (1)
- LPS (1)
- Laminin (1)
- Langerhans cell (1)
- Leaderless transcript (1)
- Legiolysin (1)
- Legionella ssp. (1)
- Legionellae (1)
- Legionellen (1)
- Legionnaires' disease (1)
- Legionärskrankheit (1)
- Leishmanien (1)
- Lepra (1)
- Lesions (1)
- Level (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Lichtschutz (1)
- Listeria monocytogenes (1)
- Lungenkrebs (1)
- Lysis (medicine) (1)
- Lysophospholipase (1)
- MACE (1)
- MDR1 (1)
- MET-T-box riboswitch (1)
- MI-2/NURD complex (1)
- MIP (1)
- MITE (1)
- MRI reporter (1)
- MRR1 (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MT02 (1)
- MTOR (1)
- MVT (1)
- Macrophage (1)
- Maintenance (1)
- Makrophage (1)
- Makrophagen (1)
- Malaria tropica (1)
- Malariamücke (1)
- Malignant effusion (1)
- Mastitis (1)
- Mat Fimbrien (1)
- Mat fimbriae (1)
- Mcl-1 (1)
- Medicine (1)
- Medizinische Mikrobiologie (1)
- Membraninteraktionen (1)
- Metalloprotease (1)
- Methanosarcina mazei (1)
- Methioninbiosynthese (1)
- MgrB (1)
- MicF (1)
- Mice (1)
- MicroRNAs (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mig1 (1)
- Mikroarray (1)
- Mikroorganismus (1)
- Mikroskopie (1)
- Minor subunits (1)
- Mitteldarm (1)
- Modell (1)
- Molekulare Infektionsbiologie (1)
- Moraxella catarrhalis (1)
- Mosquito (1)
- Mouse (1)
- Mrr1 (1)
- Multiadhäsionsdomänenproteine (1)
- Multidrugresistant (1)
- Multiproteinkomplex (1)
- Mutant (1)
- Mycobacterium (1)
- Mykose (1)
- Mäuse (1)
- Mücke (1)
- N-glycans (1)
- NAD (1)
- NAFLD (1)
- NAS (1)
- NASH (1)
- ND10 complex (1)
- NF-KAPPA-B (1)
- NK cells (1)
- NOTCH (1)
- NRG1 (1)
- NSG (1)
- Nachweis (1)
- Nanotubes (1)
- Naphthalinderivate (1)
- Nature-Insipired Synthesis (1)
- Nck (1)
- Neugeborenes (1)
- Nichtrezeptor-Tyrosinkinasen (1)
- Nitrifikation (1)
- Nitrogen (1)
- Nitroreduktase (1)
- Nodule (1)
- Non-coding RNA (1)
- Non-coding RNAs (1)
- Nonpathogenic Escherichia-coli (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- OLFM4 (1)
- Oberflächenproteine der Sexualstadien (1)
- Oligopeptide (1)
- Oncolytic virotherapy (1)
- One Health (1)
- Opa (1)
- Open Science (1)
- Organoids (1)
- Orthogonal field attenuation gel electrophoresis (1)
- OxyR (1)
- P-fimbriae (1)
- P. falciparum (1)
- PCR (1)
- PCR detection system (1)
- PCR-Nachweissystem (1)
- PEGylation (1)
- PETRI-seq (1)
- PFS25 (1)
- PIA/ica (1)
- PLAP (1)
- PML (1)
- PML nuclear-bodies (1)
- PPGPP (1)
- PPIasen (1)
- PPIases (1)
- PSI-blast (1)
- PYY3-36 (1)
- Paeonia (1)
- Pan1 (1)
- Parasit (1)
- Particles (1)
- Pathogene Bakterien (1)
- Pathogenicity (1)
- Pathogenicity islands (1)
- Pathogenitätsfaktoren (1)
- Pathologie (1)
- Pathology (1)
- Peptidtransport (1)
- Perfluorkarbon (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pflanzen (1)
- Pfs230 (1)
- Phage (1)
- Phageninduktion (1)
- Phagocytosis (1)
- Phagosom (1)
- Phagosomen (1)
- Phospholipase (1)
- Pigmentierung (1)
- Pilus (1)
- Pilzinfektionen (1)
- PknB (1)
- Plant extracts (1)
- Plants (1)
- Plasmid (1)
- Plasmidcharakterisierung (1)
- Plasmodium (1)
- Poly-(ADP-Ribose)Polymerase (1)
- Polyketid (1)
- Polyketid-Synthasen (1)
- Polymeric Immunoglobulin receptor (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Poribakterien (1)
- Porifera (1)
- Posttranskriptionelle Regulation (1)
- Privatisierung (1)
- ProQ (1)
- Probiotic (1)
- Promoter (1)
- Promoter prediction (1)
- Proteaseinhibitor (1)
- Proteases (1)
- Protein (1)
- Protein function prediction (1)
- Proteine (1)
- Proteins (1)
- Proteogenomics (1)
- Proteolyse (1)
- Proteolysis (1)
- Proteomanalyse (1)
- Proteomics (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pseudomonas-aeruginosa (1)
- Pyrophosphatase (1)
- Quartäre Bisnaphthalimide (1)
- Quaternary Bisnaphthalimide (1)
- Quinupristin/Dalfopristin (1)
- RFP (1)
- RNA Abbau (1)
- RNA CHAPERONE HFQ (1)
- RNA chaperone Hfq (1)
- RNA decay (1)
- RNA denaturation (1)
- RNA expression (1)
- RNA sequence analyses (1)
- RNA structure (1)
- RNA-Seq (1)
- RNA-binding protein (1)
- RNA-polymerase-I (1)
- RNA-polymerase-II (1)
- RNA-sequencing (1)
- RNAseq (1)
- RNS-Bindungsproteine (1)
- RNS-Spleißen (1)
- RNase E (1)
- RNase III (1)
- ROS (1)
- RSC Chromatin Remodeling Komplex (1)
- RSC chromatin remodeling complex (1)
- RTS,S/AS01 malaria vaccine (1)
- RYGB (1)
- Rapid evolution (1)
- Rats (1)
- Recombinant defensins (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Regression (1)
- Regulatorgene (1)
- Rekombinante DNS (1)
- RelA (1)
- Reportergene (1)
- Reproducibility challenges (1)
- Resistenzen (1)
- Resistenzmechanismen (1)
- Restenose (1)
- Rezeptor (1)
- Ribosome profiling (1)
- Roux-en-Y gastric bypass surgery (1)
- Rubritalea (1)
- S fimbrial adhesin (Sfa) (1)
- S-Fimbriae (1)
- S-fimbria (1)
- S-fimbriae (1)
- S. aureus (1)
- S. epidermidis (1)
- S.aureus (1)
- SAP2 (1)
- SCCmec (1)
- SER/THR kinase (1)
- SM-like protein (1)
- SNF1 (1)
- STP1 (1)
- SUBSP carotovora (1)
- SWI2/SNF2-like protein (1)
- Salmonella enterica Typhimurium strain SL1344 (1)
- Salmonella-enteritidis (1)
- Salmonella-typhimurium (1)
- Saposin-like proteins (1)
- Saposin-ähnliche Proteine (1)
- Schistosoma japonicum; Egg antigen; Carbohydrate epitope; Circumoval precipitin test; Immunoassay (1)
- SdsR (1)
- Secretion (1)
- Sekretom (1)
- Sekundärmetabolit (1)
- Selektionsmarker (1)
- Selektivität (1)
- Sequence Analysis (1)
- Sequence identity (1)
- Sequencing (1)
- Sequenzanalyse (1)
- Serinprotease (1)
- Serogroup (1)
- Serratia marcescens (1)
- Seuchenkontrolle (1)
- Sexualentwicklung (1)
- Sexualstadien (1)
- Sexuelle Entwicklung (1)
- Shiga toxin-producing Escherichia coli (1)
- Shiga-Toxin 2 (1)
- Shigellosis (1)
- Signalkette (1)
- Site-specific RNA labelling (1)
- Snf1 (1)
- Soft-tissue infection (1)
- Southern hybridization (1)
- Speichel (1)
- Splicing (1)
- Sponge diseases (1)
- Sponges (1)
- Src-Proteine (1)
- Staphylococcal infection (1)
- Staphylococcus aureus USA300 (1)
- Staphylococcus-aureus (1)
- Stenotrophomonas maltophilia (1)
- Stickstoff-Verwertung (1)
- Stickstoffmetabolismus (1)
- Stickstoffversorgung (1)
- Stickstoffwechsel (1)
- Stp (1)
- StpA (1)
- Strain nissle-1917 (1)
- Strains (1)
- Streptococcus faecium (1)
- Streptomyceten (1)
- Streptomycetes (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Stx2 (1)
- Stx2-Mutante (1)
- Stx2-mutant (1)
- Sugar-transport (1)
- Suicide vector (1)
- SuperSAGE (1)
- Symbionts (1)
- Synthese (1)
- Synthesis (1)
- Systematik (1)
- T cell (1)
- T helper cell (1)
- T lymphocytes (1)
- T-Zellen (1)
- T-cell (1)
- TEM (1)
- TH1/TH2 (1)
- TRNA(ASP) (1)
- Target (1)
- Taufliege (1)
- Tet-On system (1)
- Th1 immunantwort (1)
- Th1 response (1)
- Thiostrepton (1)
- Thrombospondin (1)
- Thrombospondin-1 (1)
- Tissue (1)
- Tissue Engineering (1)
- Toll-like receptors (1)
- Toxicity ; plasmids (1)
- Toxoplasmase gondii (1)
- Tracking (1)
- Transcription (1)
- Transcription profiling (1)
- Transcription start site (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transfektion (1)
- Transfer-RNA modification (1)
- Transkiptom (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Translation efficiency (1)
- Transmissionsblockierende Impfstoffe (1)
- Transmissionsblockierende Vakzine (1)
- Transporter (1)
- Transposase (1)
- Transposon insertion sequencing (1)
- Typ 1 Fimbrien (1)
- Typhimurium (1)
- UKZ (1)
- UME6 (1)
- UPECs (1)
- Urinary tract (1)
- Urogenitalsystem (1)
- Uropatbcgenie E. coli (1)
- VEGF (1)
- Vaccines (1)
- Vaccinia virus (1)
- Vakuole (1)
- Valeriana wallichii (1)
- VanA (1)
- Vancomycin (1)
- Variability (1)
- Variants (1)
- Vascular endothelial Growth Factor (1)
- Verrucomicrobia (1)
- Vertikale Weitergabe (1)
- Virologie (1)
- Virtual Research Environment (1)
- Virulence (1)
- Virulenz-assoziierte Gene (1)
- Virulenzfaktoren (1)
- Virulenzfaktors Mip (1)
- Virulenzmechanismen (1)
- Virusinfektion (1)
- WD40 (1)
- White-Opaque Switching (1)
- Wirtsspezifität (1)
- Wirtszelle (1)
- Yeast (1)
- Yersinia (1)
- Yersinia-pseudotuberculosis (1)
- YoelII-Nigeriensis (1)
- Ypk1 (1)
- Zellfilamente (1)
- Zink-Cluster-Transkriptionsfaktoren (1)
- Zink-Finger-Proteine (1)
- Zoonotisches Risiko (1)
- abscesses (1)
- acetivorans C2A (1)
- acetones (1)
- acid (1)
- acrican trypanosomes (1)
- actinomycetes (1)
- activation mechanism (1)
- acute myeloid leukemia (1)
- adaptation phase (1)
- adenylate kinase (1)
- adults (1)
- agr (1)
- agroinfiltration (1)
- albicans (1)
- alignment (1)
- alignment clustering (1)
- alpha defensins (1)
- alternative pig farming (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- ammonium (1)
- ammonium permease (1)
- angeborene Immunabwehr (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- annotation (1)
- anti-biofilm (1)
- anti-schistosomal activity (1)
- anti-sigma factor (1)
- antibacterial (1)
- antibacterial drug resistance (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic production (1)
- antifungal drug (1)
- antigenic variation (1)
- antimicrobial activity (1)
- antimicrobial peptides (1)
- antitermination (1)
- arabidopsis (1)
- aromatic amino acid biosynthesis (1)
- artifizielle Aktivierung (1)
- aspartic protease (1)
- aspergillosis (1)
- aspergillus fumigatus (1)
- atypical tetracyclines (1)
- automation (1)
- autophagy-related (1)
- autotransporter (1)
- autotransporter protein (1)
- azobenzenes (1)
- bac-genomics-scripts (1)
- bacterial (1)
- bacterial biofilms (1)
- bacterial genomes (1)
- bacterial genomics (1)
- bacterial immune evasion (1)
- bacterial infection (1)
- bacterial infection model (1)
- bacterial lipoproteins (1)
- bacterial live vector (1)
- bacterial migration (1)
- bacterial pathogen (1)
- bacterial resistance (1)
- bacterial secretion (1)
- bacterial signal molecule (1)
- bacterial transcription (1)
- bacterial uptake (1)
- bacterial virulence (1)
- bakterielle Aufnahme (1)
- bakterieller Lebendvektor (1)
- balancing selection (1)
- beta-glucuronidase (1)
- beta-lactamases (1)
- binding (1)
- binding protein HFQ (1)
- biocide polyhexamethylene biguanide (1)
- biofilm regulation (1)
- biolog (1)
- biological scaffold (1)
- bioluminescence (1)
- bioorthogonal SAM analogue ProSeDMA (1)
- biophotonic imaging (1)
- biosynthetic gene-cluster (1)
- blood (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood-stream forms (1)
- brain endothelial cells (1)
- breast-tumors (1)
- broad-spectrum antibiotics (1)
- burkholderia cenocepacia (1)
- caffeic acid bornyl ester (1)
- calcineurin (1)
- campestris PV vesicatoria (1)
- campylobacter (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- candida (1)
- capsule (1)
- carbon metabolism (1)
- carbonyl reductase (1)
- carcinoma (1)
- carcinomas (1)
- cardiac remodeling (1)
- carvacrol (1)
- caspases (1)
- casposon (1)
- catalytic (1)
- cell cultures (1)
- cell cycle (1)
- cell death (1)
- cell differentiation (1)
- cell filaments (1)
- cell fusion (1)
- cell signalling (1)
- cell vaccines (1)
- cell wall synthesis (1)
- cell-cycle arrest (1)
- cell-line (1)
- cepedia complex (1)
- chaperone HFQ (1)
- chaperone Hfq (1)
- characterization (1)
- chelocardins (1)
- chemokine (1)
- children (1)
- chlamydomonas flagella (1)
- chromosomal genes (1)
- circular intermediates (1)
- citral (1)
- citrus (1)
- clinical (1)
- clinical isolates (1)
- clonal analysis (1)
- cloning vectors (1)
- co-infection (1)
- coagulase-negative staphylococci (1)
- coevolution (1)
- cold-shock protein (1)
- coli nissel 1917 (1)
- collaboratories (1)
- colony morphotypes (1)
- colorectal (1)
- colorectal cancer (1)
- community settings (1)
- comparative sequence analysis (1)
- complete genome sequence (1)
- complex (1)
- components (1)
- conditional expressionsystem (1)
- conditional mutants (1)
- conditional promoter replacement (1)
- conservation (1)
- conserving surgery (1)
- consesus (1)
- contact lens (1)
- cost-effectiveness (1)
- crystal structure (1)
- crystal-structures (1)
- cutane leishmaniasis (1)
- cysteine preoteases (1)
- cytolethal distending toxin (1)
- dRNA-seq (1)
- dark-matter (1)
- database (1)
- decay (1)
- decentralization (1)
- deep sequencing (1)
- deepSuperSAGE (1)
- deficient mice (1)
- deletion (1)
- deletion mutagenesis (1)
- deletion rate (1)
- demospongiae (1)
- dendritische Zelle (1)
- dependent gene-expression (1)
- dependent protein-kinase (1)
- derivatives (1)
- detection (1)
- determines pathgenicity (1)
- diagnostic Microarray (1)
- diagnostischer Microarray (1)
- diarrhea (1)
- differential (1)
- dimerization (1)
- directional RNA-Seq (1)
- disease (1)
- disease control (1)
- dogs (1)
- domain (1)
- domain genes A3(2) (1)
- down regulation (1)
- drosophila (1)
- drospophila (1)
- drug (1)
- drug design (1)
- drug resistance evolution (1)
- drug-delivery systems (1)
- dual RNA-seq (1)
- dual function (1)
- dynamic programming (1)
- ecoli_VF_collection (1)
- efflux pump (1)
- eigenvector centrality (1)
- electron tomography (1)
- electrophilic stress (1)
- elements (1)
- emotional behavior (1)
- emulsions (1)
- endocytosis (1)
- endoribonuclease (1)
- energy metabolism (1)
- enteric pathogens (1)
- enterica serovar thphimurium (1)
- entero-aggregative-haemorrhagic Escherichia coli (EAHEC) (1)
- enterobacteria (1)
- enterococci (1)
- environment (1)
- environmental genomics (1)
- environmental regulation (1)
- enzyme APOBEC3G (1)
- enzyme-linked immunoassays (1)
- ephitelial cells (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- escherichia coli K-12 (1)
- essential gene (1)
- essential genes (1)
- essential oils (1)
- ethanol (1)
- eugenyl cinnamate (1)
- eukaryotes (1)
- evasion mechanisms (1)
- experimental visceral leishmaniasis (1)
- expression library (1)
- expression mutants (1)
- extracellular domain (1)
- extracellular enzymes (1)
- extraintestinal E. coli (1)
- extraintestinal isolates (1)
- extraintestinal pathogener E. coli (1)
- extrapulmonary (1)
- falciparum (1)
- family (1)
- fatty acids (1)
- fibronectin (1)
- fibronectin-binding protein (1)
- filamentous Salmonella Typhimurium (1)
- finder using symmetrical best hits (1)
- fitness (1)
- fitness factor (1)
- flagella (1)
- flagellar basal body (1)
- flavophospholipol (1)
- flexible genome (1)
- flexibler Teil des Genoms (1)
- flotillin (1)
- flow cytometry (1)
- fluconazole resistance (1)
- fluorescence imaging (1)
- fluorescence in situ hybridization (1)
- fluorescent probe (1)
- fluorescent protein (1)
- fluoreszierende in situ Hybridisierung (1)
- flux balance analysis (1)
- food industry (1)
- free-living freshwater amoebae (1)
- freilebende Süßwasseramöben (1)
- functional genomics (1)
- fungal genetics (1)
- fungal infections (1)
- fungal pathogens (1)
- fungi (1)
- fungus (1)
- gallotannins (1)
- gamete (1)
- gametes (1)
- gametocytogenesis (1)
- gametogenesis (1)
- gastric bypass (1)
- gastrointestinal disease (1)
- gastrointestinal infections (1)
- gene expression heterogeneity (1)
- gene family targeting (1)
- gene probes (1)
- gene therapy (1)
- gene variability (1)
- gene-cloning (1)
- gene-cluster (1)
- gene-expression (1)
- general stress response (1)
- genetic modification (1)
- genetic organization (1)
- genetic recombination (1)
- genetic transcription (1)
- genome organization (1)
- genome plasticity (1)
- genome variability (1)
- genome wide (1)
- genome-wide analysis (1)
- genomes (1)
- genomic deletions (1)
- genomic islands (1)
- genomic libraries (1)
- genomic library construction (1)
- genomic variability (1)
- genomics (1)
- genomische Variabilität (1)
- genomvariability (1)
- genus Aspergillus (1)
- geometry (1)
- germination (1)
- global gene expression (1)
- glv-1h68 (1)
- glycolysis (1)
- glycosome (1)
- glycosyl phosphatidyl-inostitols. (1)
- gonococci (1)
- gram-negative bacteria (1)
- green fluorescent protein (1)
- growth (1)
- growth rate control (1)
- haemoproteus-columbae (1)
- halstedii JM8 (1)
- harmonia axyridis (1)
- harmonine (1)
- health sector reform (1)
- hela cells (1)
- helicobacter (1)
- hemolytic-uremic syndrome (1)
- heterogeneity (1)
- heterologous production (1)
- heteropathogenicity (1)
- hexose transporter (1)
- hidden markov-models (1)
- high-throughput sequencing (1)
- histidine kinases (1)
- histology (1)
- homologs (1)
- homology search (1)
- horizontal gene transfer (1)
- hos tcells (1)
- host (1)
- host (organism) (1)
- host colonization (1)
- host pathogen interaction (1)
- host specificity (1)
- host-cell invasion (1)
- host-pathogen-interaction (1)
- human factor H (1)
- human herpesvirus 6 (1)
- human host cells (1)
- human macrophages (1)
- human pathogenic fungi (1)
- human pathogens (1)
- human sodium iodide symporter (hNIS) (1)
- humane Wirtszellen (1)
- humaner Faktor H (1)
- humanized mice (1)
- hybrid (1)
- hydrogen regulation (1)
- hydrogen-peroxide (1)
- hyperexpression techniques (1)
- hypersensitive response (1)
- hyperthermophile (1)
- hyphae (1)
- hypothalamic gene expression (1)
- ica (1)
- ica Operon (1)
- ica-Operon (1)
- icaADBC (1)
- immune System (1)
- immune sytem (1)
- immunity (1)
- immunization (1)
- immunodeficiency-virus type-1 (1)
- immunodominant antigens (1)
- immunodominante Antigene (1)
- immunsystem (1)
- immuntherapy (1)
- in vivo (1)
- in vivo Monitoring (1)
- in vivo expression technology (1)
- in vivo monitoring (1)
- in-vitro propagation (1)
- inactivation (1)
- infection biology (1)
- infectious disease (1)
- inflammatory bowel disease (1)
- inflammatory-bowel-disease (1)
- innate Immunity (1)
- insect immunity (1)
- insertion sequences (1)
- insights (1)
- integration (1)
- integrin (1)
- interaction surfaces (1)
- interactome (1)
- interferon-gamma (1)
- intermediate host (1)
- internalization (1)
- intervention strategies (1)
- interview (1)
- intestinal enteroids (1)
- intracellular multiplication (1)
- intracellular pathogen (1)
- intracellular pathogens (1)
- intrazelluläre Vermehrung (1)
- iron (1)
- iron limitation (1)
- island (1)
- isolation (1)
- kinase (1)
- kingdom (1)
- konditionales Expressionssystem (1)
- kutane Leishmaniose (1)
- latency (1)
- lead structure (1)
- leaves (1)
- legionella pneumophila (1)
- leishmaniose (1)
- leprosy (1)
- leuX-tRNA (1)
- libraries (1)
- library screening (1)
- life cycle (1)
- light protection (1)
- lines (1)
- linker influence (1)
- lipids (1)
- liquid chromatography-mass spectrometry (1)
- listeria monocytogenes (1)
- livestock-associated staphylococci (1)
- locus (1)
- luciferase (1)
- lux (1)
- lymph nodes (1)
- lymphadenitis (1)
- lysogen (1)
- lytic replication (1)
- mC (1)
- mCherry (1)
- macrophage infection (1)
- malaria parasite (1)
- malaria vaccine (1)
- maps (1)
- marine Schwämme (1)
- mass spectrometry (1)
- mastectomy (1)
- mastitis-associated Escherichia coli (MAEC) (1)
- maternal separation (1)
- mating (1)
- maturation (1)
- mechanism of resistance (1)
- membrane (1)
- membrane interactions (1)
- membrane proteins (1)
- membrane vesicles (1)
- membrane-protein topology (1)
- meningococcus (1)
- merozoite (1)
- messanger RNA (1)
- messenger-RNA decay (1)
- meta-analysis based orthology (1)
- metabolic adaptation (1)
- metallo protease (1)
- metastases (1)
- methanoarchaea (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- methionine biosynthesis (1)
- miRNAs (1)
- mice (1)
- microRNAs (1)
- microSPLiT (1)
- microarray (1)
- microbial diversity (1)
- microbial ecology (1)
- microbiology (1)
- microbiome (1)
- microbiota (1)
- microenvironment (1)
- microneme (1)
- microtubule motor (1)
- midgut (1)
- migration (1)
- mikrobielle Diversität (1)
- mikrobielle Ökologie (1)
- mitochondria (1)
- model (1)
- modulation of virus replication (1)
- molecular epidemiology (1)
- molecular evolution (1)
- monocyte (1)
- morphogenesis (1)
- mouse (1)
- mucosal inflammation (1)
- multidrug-resistant bacteria (1)
- multivesicular tubule (1)
- murine leishmaniasis (1)
- murines Modell der aufsteigenden Harnwegsinfektion (1)
- mycobacterium tuberculosis (1)
- mycobacterium-tuberculosis (1)
- nanotubes (1)
- natively unstructured protein (1)
- natural antisense transcripts (1)
- natural transformation (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- network biology (1)
- nitrification (1)
- nitrogen (1)
- nitrogen regulation (1)
- nitrogen utilization (1)
- nitroreductase (1)
- non-aureus staphylococci (1)
- non-coding RNA (1)
- noncoding RNAs (1)
- nondocing RNA (1)
- norovirus (1)
- northern blotting (1)
- nosocomial infections (1)
- nosocomial pathogen (1)
- nosokomiale Infektionen (1)
- nucleotide sequence (1)
- nude-mice (1)
- nutrients (1)
- olfactomedin 4 (1)
- oligopeptide transport (1)
- oncolytic viral therapy (1)
- oncolytic virus (1)
- one-health approach (1)
- organic farming (1)
- organization (1)
- organohalide respiration (1)
- organoid culture (1)
- organoids (1)
- origin (1)
- orthology (1)
- orthology network (1)
- ortsspezifische/homologe Rekombination (1)
- outbreak (1)
- outer membrane vesicles (1)
- outer-membrane proteins (1)
- oviedomycin (1)
- oxidative stress (1)
- p-Hydroxyphenylpyruvat-Dioxygenase (1)
- p-hydroxyphenylpyruvate dioxygenase (1)
- pangolin (1)
- par-seqFISH (1)
- parallel evolution (1)
- parasexual recombination (1)
- paromomycin (1)
- pathogen (1)
- pathogen-associated molecular pattern (1)
- pathogene E. coli (1)
- pathogenesis (1)
- pathogenetic organism (1)
- pathogenic E. coli (1)
- pathogenic bacteria (1)
- pathogenicity island (1)
- pathogenicity island 2 (1)
- pathotypes (1)
- peptide (1)
- peptide conjugates (1)
- peptide transport (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- peptido-glycan associated protein (1)
- permease (1)
- persistence (1)
- persister cells (1)
- phage induction (1)
- phagocytes (1)
- phagocytosis (1)
- phagosoms (1)
- pharmacokinetics (1)
- phased metamorphosis (1)
- phenotypic heterogeneity (1)
- phenotypic microarray (1)
- pheromones (1)
- phospholipase (1)
- phosphorylation (1)
- photooxidative stress (1)
- photosynthesis genes (1)
- phototrophic growth (1)
- phylogenetic analysis (1)
- phylogenetic trees (1)
- phytochemicals (1)
- pig farming methods (1)
- pigmentation (1)
- plant-made vaccines (1)
- plant-microbe interaction (1)
- plasmid characterization (1)
- plasmid-chromosome crosstalk (1)
- plasmodium (1)
- plastid targeting (1)
- point mutation (1)
- poly-(ADP-ribose)polymerase (1)
- polyadenylation sites (1)
- polycistronic transcription (1)
- polyketide (1)
- polyketide synthases (1)
- polymerase chain reaction (PCR) (1)
- poribacteria (1)
- porphyromonas gingivalis (1)
- positive selection (1)
- post-transcriptional regulation (1)
- post-transcriptionalregulation (1)
- posttranscriptional control (1)
- posttranscriptional regulation (1)
- ppl (1)
- pre-messenger RNA (1)
- privatization (1)
- promastigotes (1)
- promoters (1)
- prophage (1)
- protease (1)
- protease inhibitor (1)
- protein (1)
- protein HFQ (1)
- protein expressions (1)
- protein families database (1)
- protein kinase signaling cascade (1)
- protein synthesis (1)
- protein-RNA recognition (1)
- proteom (1)
- proteome (1)
- protozoan parasite (1)
- pseudomas aeruginosa (1)
- pulmonary (1)
- purification (1)
- pyrococcus furiosus (1)
- pyrophosphatase (1)
- quanititative proteomics (1)
- quinone (1)
- rRNA Prozessierung (1)
- rRNA depletion (1)
- rRNA processing (1)
- radiation-therapy (1)
- radioiodine therapy (1)
- ralstonia solanacearum (1)
- rat (1)
- receptor (1)
- receptors (1)
- reciprocal best hit (1)
- recombinant proteins (1)
- regionalization and organoids (1)
- regulatory small RNAs (1)
- remote sequence conservation (1)
- replication (1)
- reporter (1)
- repression (1)
- reputation (1)
- resistance mechanism (1)
- resistance-breaking properties (1)
- resistant Staphylococcus-aureus (1)
- restenosis (1)
- reveals (1)
- rhodobacter sphaeroides (1)
- ribosomal RNA (1)
- rotavirus (1)
- sRNA atlas (1)
- sRNA biogenesis (1)
- salmonella (1)
- salmonella enterica (1)
- sationary phase (1)
- scaffold protein (1)
- schistosoma (1)
- schistosomula (1)
- scholarly publishing (1)
- scientific publishing (1)
- screening (1)
- secondary structure (1)
- secreted aspartic proteases (1)
- secreted aspartic proteinase (1)
- secreted proteins (1)
- secretome (1)
- segmentation (1)
- sekretierte Proteine (1)
- sekretorische Aspartylprotease (1)
- selectionmarker (1)
- selectivity (1)
- sequence motif analysis (1)
- sequences (1)
- sequencing protocol (1)
- ser/thr kinase (1)
- serine protease (1)
- serotonin (1)
- serovar Typhimurium (1)
- serum resistance (1)
- sexual stage (1)
- sexual stage surface proteins (1)
- sexual stages (1)
- sfaA gene) (1)
- shiga toxin (1)
- shiga toxin 2 (1)
- shock sigma factor (1)
- siRNA (1)
- siRNAs (1)
- sigma factor (1)
- signal-transduction systems (1)
- signaltransduction (1)
- simultaneous (1)
- single cell genomics (1)
- singlet oxygen stress (1)
- sinorhizobium fredii NGR234 (1)
- site-specific/homologous recombination (1)
- skin fatty acid (1)
- small interfering RNAs (1)
- small non-coding RNAs (1)
- small noncoding RNAs (1)
- small proteins (1)
- small regulatory RNAs (1)
- sodium-iodide symporter (1)
- solubility (1)
- soluble-RNA (1)
- soluble-RNAs (1)
- sortase A (1)
- specificity (1)
- sponge (1)
- sponges (1)
- spores (1)
- stability (1)
- stage-i (1)
- staib agar (1)
- staphilococci (1)
- staphylocccal infection/epidemiology (1)
- staphylococci (1)
- staphylococcus (1)
- stationary phase (1)
- stomach (1)
- strain (1)
- strain Newman (1)
- streptococcus pneumoniae (1)
- stress resistance (1)
- stress response (1)
- stringency (1)
- structural elucidation (1)
- structural modification (1)
- structure activity (1)
- structure-activity relationship (1)
- structure–activity (1)
- subcellular localization (1)
- subinhibitorische Antibiotikakonzentrationen (1)
- subinhibitory antibiotikkonzentrations (1)
- subpopulation (1)
- subtilis genome (1)
- sulfates (1)
- sulfur (1)
- suppressor mutation (1)
- surgery (1)
- symbiosis (1)
- synthetase (1)
- tag based (1)
- tandem mass-spectra (1)
- target (1)
- target recognition (1)
- tetrachloroethene (1)
- thiostrepton (1)
- thymyl cinnamate (1)
- thyroid-cancer (1)
- tobacco (1)
- toll-like receptor 2 (1)
- topical treatment (1)
- toxin (1)
- trans-activation (1)
- transcription factor (1)
- transcription initiation site (1)
- transcription regulator (1)
- transcription start site (1)
- transcription start sites (1)
- transcriptional control (1)
- transcriptional landscape (1)
- transcriptional regulation (1)
- transcriptional regulator (1)
- transcriptional start site (1)
- transcriptional uni (1)
- transcriptom (1)
- transcriptomeanalysis (1)
- transfection (1)
- transfer (1)
- transfer RNA (1)
- transkiptome (1)
- translation initiation (1)
- translational initiation (1)
- translocation (1)
- transmission blocking vaccine (1)
- transmission blocking vaccines (1)
- transport (1)
- transport systems (1)
- transporter (1)
- transposable elements (1)
- transposase (1)
- transposition (1)
- transposon (1)
- tuberculosis (1)
- two-component systems (1)
- two‐component system (1)
- type 1 fimbriae (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ulcreative colitis (1)
- untranslated regions (1)
- urinary tract infection (UTI) (1)
- urinary-tract-infection (1)
- uropathogene Escherichia coli (UPEC) (1)
- uropathogener E. coli Stamm 536 (1)
- uropathogenic E. coli strain 536 (1)
- uropathogenic Escherichia coli (1)
- uropathogenic Escherichia coli (UPEC) (1)
- uropathogenicity (1)
- uropathogens (1)
- vaccine (1)
- vaccines (1)
- vacuole (1)
- vacuoles (1)
- variant surface glycoprotein (1)
- version control (1)
- vertical transmission (1)
- vibrio parahaemolyticus (1)
- viral protein-R (1)
- viral replication (1)
- virotherapy (1)
- virulence genes (1)
- virulence mechanisms (1)
- virulence modulation (1)
- virulence-associated genes (1)
- virus-infection (1)
- visceral leishmaniasis (1)
- wikis (1)
- workflow platform (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- xanthomonas maltophilia (1)
- yeast (1)
- yvcK/glmR operon (1)
- zinc cluster transcription factor (1)
- zirkuläre Intermediate (1)
- zoonotic (1)
- zoonotic risk (1)
- Ökologie (1)
- Ökosystem (1)
- Übertrag (1)
- äußere Membranvesikel (1)
Institute
- Institut für Molekulare Infektionsbiologie (419) (remove)
Sonstige beteiligte Institutionen
- Universitätsklinikum Münster (2)
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
- Zentrum für Infektionsforschung (ZINF): Nachwuchsgruppe 2 (1)
Background
The emergence of antibiotic resistant bacteria in recent decades has highlighted the importance of developing new drugs to treat infections. However, in addition to the design of new drugs, the development of accurate preclinical testing methods is essential. In vivo imaging technologies such as bioluminescence imaging (BLI) or magnetic resonance imaging (MRI) are promising approaches. In a previous study, we showed the effectiveness of \(^{19}\)F MRI using perfluorocarbon (PFC) emulsions for detecting the site of Staphylococcus aureus infection. In the present follow-up study, we investigated the use of this method for in vivo visualization of the effects of antibiotic therapy.
Methods/Principal findings
Mice were infected with S. aureus Xen29 and treated with 0.9% NaCl solution, vancomycin or linezolid. Mock treatment led to the highest bioluminescence values during infection followed by vancomycin treatment. Counting the number of colony-forming units (cfu) at 7 days post-infection (p.i.) showed the highest bacterial burden for the mock group and the lowest for the linezolid group. Administration of PFCs at day 2 p.i. led to the accumulation of \(^{19}\)F at the rim of the abscess in all mice (in the shape of a hollow sphere), and antibiotic treatment decreased the \(^{19}\)F signal intensity and volume. Linezolid showed the strongest effect. The BLI, cfu, and MRI results were comparable.
Conclusions
\(^{19}\)F-MRI with PFCs is an effective non-invasive method for assessing the effects of antibiotic therapy in vivo. This method does not depend on pathogen specific markers and can therefore be used to estimate the efficacy of antibacterial therapy against a broad range of clinically relevant pathogens, and to localize sites of infection.
Im Rahmen dieser Arbeit sollten die Möglichkeiten der MR Tomographie erkundet werden bakterielle Infektionen im Zeitverlauf darzustellen. Genauer gesagt sollte das Potential der MR Tomographie anhand eines durch eine Infektion induzierten lokalisierten Abszesses unter Verwendung dreier unterschiedlicher MRT Methoden untersucht werden: Mittels nativem \(T_2\) Kontrast; der Verwendung von superparamagnetischen Eisenoxid Partieln (USPIO) als \(T_2^*\) Kontrastmittel; und dem Einsatz von Perfluorkarbonen (PFC) als \(^{19}F\) MRT Marker (siehe Kapitel 3).
Wie erwartet führte die durch die Infektion hervorgerufene Entzündung zu veränderten \(T_2\)-Zeiten, welche auf \(T_2\)-gewichteten MR Bildern eine Lokalisierung des Abszessbereiches erlauben. Jedoch eigneten sich diese Daten aufgrund der graduellen Änderung der \(T_2\)-Zeiten nicht, um eine klare Grenze zwischen Abszess und umliegendem Gewebe zu ziehen.
Superparamagnetische Eisenoxidpartikel andererseit haben als MRT Kontrastmittel bereits in den letzten Jahren ihre Fähigkeit unter Beweis gestellt Entzündungen [53, 58, 64] darzustellen. Die Anreicherung dieser Partikel am Rande des Abszesses [53], wie sie auch in unseren MR Daten zu beobachten war, erlaubte eine relativ scharfe Abgrenzung gegenüber dem umgebenden Gewebe in der chronischen Phase der Infektion (Tag 9 p.i.). Hingegen genügte die nur sehr spärlichen Anreicherung von USPIO Partikeln in der akuten Phase der Infektion (Tag 3 p.i.) nicht für eine entsprechende Abgrenzung [58].
Aufgrund der sehr geringen biologischen Häufigkeit und den sehr kurzen Relaxationszeiten von endogenem Fluor eignen sich Perfluorkarbone als Markersubstanz in der MR Tomographie von biologischen Systemen. Insbesondere da PFC Emulsionen durch phagozytierende Zellen aufgenommen werden und im Bereich von Entzündungen akkumulieren [30, 59]. In dieser Arbeit konnte anhand der erhaltenen MRT Daten eine Akkumulation von Perfluorkarbonen nicht nur in der chronischen Phase, sondern auch in der akuten Phase nachgewiesen werden. Diese Daten erlauben somit zu allen untersuchten Zeitpunkten eine Abgrenzung zwischen Infektion und umliegenden Gewebe.
Aufgrund der besagten Vorteile wurden die Perfluorkarbone gewählt, um die Möglichkeiten der MR Tomographie zu testen, quantitative Informationen über die schwere der Infektion zu liefern. Als Referenz für die Bakterienbelastung wurden die Biolumineszenzbildgebung (BLI) [49, 50] und die Standardmethode zur Bestimmung der Bakterienbelastung cfu (koloniebildenden Einheiten) herangezogen. Eine Gegenüberstellung der zeitlichen Verläufe der durch die Biolumineszenzbildgebung und durch die cfu erhaltenen Daten liefert eine qualitative Übereinstimmung mit den durch die 19F MR Tomographie erhaltenen Daten. Dies trifft hierbei sowohl auf die über den gesamten Infektionsbereich hinweg summierten Signalamplituden, als auch auf das Volumen zu, in dem Fluor am Ort der Infektion akkumuliert wurde. Im Gegensatz zur Methode der cfu Bestimmung sind die MR Tomographie und die Biolumineszenzbildgebung nicht invasiv und erlauben die Verfolgung des Infektionsverlaufes an einem einzelnen Individuum. Hierzu benötigt, im Gegensatz zur MR Tomographie, die Methode der Biolumineszenzbildgebung jedoch einen speziellen Pathogenstamm. Darüber hinaus ist hervorzuheben, dass die MR Tomographie zudem die Möglichkeit bietet auch morphologische Informationen über den Infektionsbereich und seine Umgebung zu akquirieren.
Gerade weil jede dieser Methoden die mit der Infektion einhergehenden Prozesse aus einer leicht anderen Blickrichtung betrachtet, erscheint es sinnvoll diese etablierte Untersuchungsplattform bestehend aus MRT, BLI und cfu über die in dieser Arbeit bearbeitete Fragestellung hinaus näher zu untersuchen. Insbesondere der Aspekt inwieweit die drei Methoden sich gegenseitig ergänzen, könnte einen tieferen Einblick in die Wechselwirkung zwischen Pathogen und Wirt erlauben.
Auch wenn für die betrachtete Fragestellung bereits der hierdurchgeführte semiquanitative Ansatz zur Bestimmung der relativen Fluormengen am Ort der Infektion ausreichte, so ist doch im Allgemeinen wünschenswert probenbezogen die Sensitivität der Spule und damit die Güte der Spulenabstimmung zu bestimmen. Hierzu ist jedoch die Aufnahme von \(B_1\)-Karten unabdingbar und wird entsprechend im Kapitel 4 \(Bloch-Siegert B_1^+-Mapping\) näher addressiert. Der Schwerpunkt liegt hierbei, wie der Kapitelname bereits andeutet, auf der Bloch-Siegert Methode, die insbesondere in der präsentierten Implementierung in einer Turbo/ Multi Spin Echo Sequenz eine effiziente Nutzung der relativ langen \(T_\)2-Zeiten der Perfluorkarbone erlaubt. Da zudem die Bloch-Siegert-Methode eine rein phasenbasierte Methode ist, kann neben der aus den Daten erzeugten \(B_1\)-Karte zugleich ein unverfälschtes Magnitudenbild generiert werden, wodurch eine sehr effiziente Nutzung der vorhandenen Messzeit ermöglicht wird. Diese Eigenschaft ist insbesondere für \(^{19}F\) Bildgebung von besonderem Interesse, da hier für jede Messung, aufgrund der üblicherweise relativ geringen Konzentration an Fluoratomen, lange Messzeiten benötigt werden.
Zusammenfassend konnte anhand des untersuchten Tiermodells sowohl die Fähigkeit der MR Tomographie nachgewiesen werden Infektionen im Zeitverlauf darzustellen, als auch die Fähigkeit der MR Tomographie quantitative Informationen über den Verlauf der Infektion zu liefern. Desweiteren konnte eine Möglichkeit aufgezeigt werden, welche das Potential hat in vertretbarem Zeitrahmen auch in vivo B1+-Karten auf dem Fluorkanal zu erstellen und so einen zentralen Unsicherheitsfaktor, für Relaxometry und absolute Quantifizierung von \(^{19}F\) Daten in vivo, zu beseitigen.
A Candidate Approach Implicates the Secreted Salmonella Effector Protein SpvB in P-Body Disassembly
(2011)
P-bodies are dynamic aggregates of RNA and proteins involved in several post-transcriptional regulation processes. Pbodies have been shown to play important roles in regulating viral infection, whereas their interplay with bacterial pathogens, specifically intracellular bacteria that extensively manipulate host cell pathways, remains unknown. Here, we report that Salmonella infection induces P-body disassembly in a cell type-specific manner, and independently of previously characterized pathways such as inhibition of host cell RNA synthesis or microRNA-mediated gene silencing. We show that the Salmonella-induced P-body disassembly depends on the activation of the SPI-2 encoded type 3 secretion system, and that the secreted effector protein SpvB plays a major role in this process. P-body disruption is also induced by the related pathogen, Shigella flexneri, arguing that this might be a new mechanism by which intracellular bacterial pathogens subvert host cell function.
A remarkable feature of many small non-coding RNAs (sRNAs) of Escherichia coli and Salmonella is their accumulation in the stationary phase of bacterial growth. Several stress response regulators and sigma factors have been reported to direct the transcription of stationary phase-specific sRNAs, but a widely conserved sRNA gene that is controlled by the major stationary phase and stress sigma factor, Sigma(S) (RpoS), has remained elusive. We have studied in Salmonella the conserved SdsR sRNA, previously known as RyeB, one of the most abundant stationary phase-specific sRNAs in E. coli. Alignments of the sdsR promoter region and genetic analysis strongly suggest that this sRNA gene is selectively transcribed by Sigma(S). We show that SdsR down-regulates the synthesis of the major Salmonella porin OmpD by Hfq-dependent base pairing; SdsR thus represents the fourth sRNA to regulate this major outer membrane porin. Similar to the InvR, MicC and RybB sRNAs, SdsR recognizes the ompD mRNA in the coding sequence, suggesting that this mRNA may be primarily targeted downstream of the start codon. The SdsR-binding site in ompD was localized by 3'-RACE, an experimental approach that promises to be of use in predicting other sRNA-target interactions in bacteria.
The human pathogenic fungus Candida albicans can switch between yeast and hyphal morphologies as a function of environmental conditions and cellular physiology. The yeast-to-hyphae morphogenetic switch is activated by well-established, kinase-based signal transduction pathways that are induced by extracellular stimuli. In order to identify possible inhibitory pathways of the yeast-to-hyphae transition, we interrogated a collection of C. albicans protein kinases and phosphatases ectopically expressed under the regulation of the TETon promoter. Proportionately more phosphatases than kinases were identified that inhibited hyphal morphogenesis, consistent with the known role of protein phosphorylation in hyphal induction. Among the kinases, we identified AKL1 as a gene that significantly suppressed hyphal morphogenesis in serum. Akl1 specifically affected hyphal elongation rather than initiation: overexpression of AKL1 repressed hyphal growth, and deletion of AKL1 resulted in acceleration of the rate of hyphal elongation. Akl1 suppressed fluid-phase endocytosis, probably via Pan1, a putative clathrin-mediated endocytosis scaffolding protein. In the absence of Akl1, the Pan1 patches were delocalized from the sub-apical region, and fluid-phase endocytosis was intensified. These results underscore the requirement of an active endocytic pathway for hyphal morphogenesis. Furthermore, these results suggest that under standard conditions, endocytosis is rate-limiting for hyphal elongation.
The Gram-negative rod-shaped bacterium Pseudomonas aeruginosa is not only a major cause of nosocomial infections but also serves as a model species of bacterial RNA biology. While its transcriptome architecture and posttranscriptional regulation through the RNA-binding proteins Hfq, RsmA, and RsmN have been studied in detail, global information about stable RNA-protein complexes in this human pathogen is currently lacking. Here, we implement gradient profiling by sequencing (Grad-seq) in exponentially growing P. aeruginosa cells to comprehensively predict RNA and protein complexes, based on glycerol gradient sedimentation profiles of >73% of all transcripts and ∼40% of all proteins. As to benchmarking, our global profiles readily reported complexes of stable RNAs of P. aeruginosa, including 6S RNA with RNA polymerase and associated product RNAs (pRNAs). We observe specific clusters of noncoding RNAs, which correlate with Hfq and RsmA/N, and provide a first hint that P. aeruginosa expresses a ProQ-like FinO domain-containing RNA-binding protein. To understand how biological stress may perturb cellular RNA/protein complexes, we performed Grad-seq after infection by the bacteriophage ΦKZ. This model phage, which has a well-defined transcription profile during host takeover, displayed efficient translational utilization of phage mRNAs and tRNAs, as evident from their increased cosedimentation with ribosomal subunits. Additionally, Grad-seq experimentally determines previously overlooked phage-encoded noncoding RNAs. Taken together, the Pseudomonas protein and RNA complex data provided here will pave the way to a better understanding of RNA-protein interactions during viral predation of the bacterial cell.
IMPORTANCE Stable complexes by cellular proteins and RNA molecules lie at the heart of gene regulation and physiology in any bacterium of interest. It is therefore crucial to globally determine these complexes in order to identify and characterize new molecular players and regulation mechanisms. Pseudomonads harbor some of the largest genomes known in bacteria, encoding ∼5,500 different proteins. Here, we provide a first glimpse on which proteins and cellular transcripts form stable complexes in the human pathogen Pseudomonas aeruginosa. We additionally performed this analysis with bacteria subjected to the important and frequently encountered biological stress of a bacteriophage infection. We identified several molecules with established roles in a variety of cellular pathways, which were affected by the phage and can now be explored for their role during phage infection. Most importantly, we observed strong colocalization of phage transcripts and host ribosomes, indicating the existence of specialized translation mechanisms during phage infection. All data are publicly available in an interactive and easy to use browser.
Background: Gastric cancers have poor overall survival despite recent advancements in early detection methods, endoscopic resection techniques, and chemotherapy treatments. Vaccinia viral therapy has had promising therapeutic potential for various cancers and has a great safety profile. We investigated the therapeutic efficacy of a novel genetically-engineered vaccinia virus carrying the human sodium iodide symporter (hNIS) gene, GLV-1 h153, on gastric cancers and its potential utility for imaging with Tc-99m pertechnetate scintigraphy and I-124 positron emission tomography (PET).
Methods: GLV-1 h153 was tested against five human gastric cancer cell lines using cytotoxicity and standard viral plaque assays. In vivo, subcutaneous flank tumors were generated in nude mice with human gastric cancer cells, MKN-74. Tumors were subsequently injected with either GLV-1 h153 or PBS and followed for tumor growth. Tc-99m pertechnetate scintigraphy and I-124 microPET imaging were performed.
Results: GFP expression, a surrogate for viral infectivity, confirmed viral infection by 24 hours. At a multiplicity of infection (MOI) of 1, GLV-1 h153 achieved > 90% cytotoxicity in MNK-74, OCUM-2MD3, and AGS over 9 days, and >70% cytotoxicity in MNK-45 and TMK-1. In vivo, GLV-1 h153 was effective in treating xenografts (p < 0.001) after 2 weeks of treatment. GLV-1 h153-infected tumors were readily imaged by Tc-99m pertechnetate scintigraphy and I-124 microPET imaging 2 days after treatment.
Conclusions: GLV-1 h153 is an effective oncolytic virus expressing the hNIS protein that can efficiently regress gastric tumors and allow deep-tissue imaging. These data encourages its continued investigation in clinical settings.
Infection research largely relies on classical cell culture or mouse models. Despite having delivered invaluable insights into host-pathogen interactions, both have limitations in translating mechanistic principles to human pathologies. Alternatives can be derived from modern Tissue Engineering approaches, allowing the reconstruction of functional tissue models in vitro. Here, we combined a biological extracellular matrix with primary tissue-derived enteroids to establish an in vitro model of the human small intestinal epithelium exhibiting in vivo-like characteristics. Using the foodborne pathogen Salmonella enterica serovar Typhimurium, we demonstrated the applicability of our model to enteric infection research in the human context. Infection assays coupled to spatio-temporal readouts recapitulated the established key steps of epithelial infection by this pathogen in our model. Besides, we detected the upregulation of olfactomedin 4 in infected cells, a hitherto unrecognized aspect of the host response to Salmonella infection. Together, this primary human small intestinal tissue model fills the gap between simplistic cell culture and animal models of infection, and shall prove valuable in uncovering human-specific features of host-pathogen interplay.
Motivation:
Next generation sequencing technologies have provided us with a wealth of information on genetic variation, but predi cting the functional significance of this variation is a difficult task. While many comparative genomics studies have focused on gene flux and large scale changes, relatively little attention has been paid to quantifying the effects of single nucleotide polymorphisms and indels on protein function, particularly in bacterial genomics.
Results:
We present a hidden Markov model based approach we call delta-bitscore (DBS) for identifying orthologous proteins that have diverged at the amino acid sequence level in a way that is likely to impact biological function. We benchmark this approach with several widely used datasets and apply it to a proof-of-concept study of orthologous proteomes in an investigation of host adaptation in Salmonella enterica. We highlight the value of the method in identifying functional divergence of genes, and suggest that this tool may be a better approach than the commonly used dN/dS metric for identifying functionally significant genetic changes occurring in recently diverged organisms.
We have developed a reliable and sensitive immunohistochemical staining technique which allows the simultaneous demonstration of two different antigens expressed in or on the same cell (referred to as mixed labeling), together with the evaluation of the general histopathological appearance of the tissue. The staining procedure combines a three-step (streptavidin-biotin) immunogold-silver staining (IGSS) with a three-step immunoenzymatic labeling. For this purpose, we investigated the compatibility ofIGSS with various substrates of peroxidase or alkaline phosphatase (AP). Highly reliable and discernible mixed labeling was achieved only after iniriallabeling with IGSS followed by AP labeling using the substrates naphthol AS-MX phosphate/Fast Blue or naphthol AS-HI phosphate/New Fuchsin, respectively. To ensure utmost specificity, we applied FlTC-conjugated mouse monoclonal antibodies and rabbit anti-FlTC immunoglobulins visualized by AP-labeled immunoglobulins and the respective substrate in a final step. This novel approach provides an excellent means for demonstration of immunocompetent cells and unequivocal determination of the percentage of specific cell subsets in infiltrated tissue. The advantages of this method, as compared with double immunofluorescence or double immunoenzymatic labeling, were investigated and are discussed. (J Histochem Cytochem 38:307-313, 1990)
Post-transcriptional RNA modification methods are in high demand for site-specific RNA labelling and analysis of RNA functions. In vitro-selected ribozymes are attractive tools for RNA research and have the potential to overcome some of the limitations of chemoenzymatic approaches with repurposed methyltransferases. Here we report an alkyltransferase ribozyme that uses a synthetic, stabilized S-adenosylmethionine (SAM) analogue and catalyses the transfer of a propargyl group to a specific adenosine in the target RNA. Almost quantitative conversion was achieved within 1 h under a wide range of reaction conditions in vitro, including physiological magnesium ion concentrations. A genetically encoded version of the SAM analogue-utilizing ribozyme (SAMURI) was expressed in HEK293T cells, and intracellular propargylation of the target adenosine was confirmed by specific fluorescent labelling. SAMURI is a general tool for the site-specific installation of the smallest tag for azide-alkyne click chemistry, which can be further functionalized with fluorophores, affinity tags or other functional probes.
Many pathogenic bacteria utilize specialized secretion systems to deliver proteins called effectors into eukaryotic cells for manipulation of host pathways. The vast majority of known effector targets are host proteins, whereas a potential targeting of host nucleic acids remains little explored. There is only one family of effectors known to target DNA directly, and effectors binding host RNA are unknown. Here, we take a two-pronged approach to search for RNA-binding effectors, combining biocomputational prediction of RNA-binding domains (RBDs) in a newly assembled comprehensive dataset of bacterial secreted proteins, and experimental screening for RNA binding in mammalian cells. Only a small subset of effectors were predicted to carry an RBD, indicating that if RNA targeting was common, it would likely involve new types of RBDs. Our experimental evaluation of effectors with predicted RBDs further argues for a general paucity of RNA binding activities amongst bacterial effectors. We obtained evidence that PipB2 and Lpg2844, effector proteins of Salmonella and Legionella species, respectively, may harbor novel biochemical activities. Our study presenting the first systematic evaluation of the RNA-targeting potential of bacterial effectors offers a basis for discussion of whether or not host RNA is a prominent target of secreted bacterial proteins.
The Gram-negative Epsilonproteobacterium Campylobacter jejuni is currently the most prevalent bacterial foodborne pathogen. Like for many other human pathogens, infection studies with C. jejuni mainly employ artificial animal or cell culture models that can be limited in their ability to reflect the in-vivo environment within the human host. Here, we report the development and application of a human three-dimensional (3D) infection model based on tissue engineering to study host-pathogen interactions. Our intestinal 3D tissue model is built on a decellularized extracellular matrix scaffold, which is reseeded with human Caco-2 cells. Dynamic culture conditions enable the formation of a polarized mucosal epithelial barrier reminiscent of the 3D microarchitecture of the human small intestine. Infection with C. jejuni demonstrates that the 3D tissue model can reveal isolate-dependent colonization and barrier disruption phenotypes accompanied by perturbed localization of cell-cell junctions. Pathogenesis-related phenotypes of C. jejuni mutant strains in the 3D model deviated from those obtained with 2D-monolayers, but recapitulated phenotypes previously observed in animal models. Moreover, we demonstrate the involvement of a small regulatory RNA pair, CJnc180/190, during infections and observe different phenotypes of CJnc180/190 mutant strains in 2D vs. 3D infection models. Hereby, the CJnc190 sRNA exerts its pathogenic influence, at least in part, via repression of PtmG, which is involved in flagellin modification. Our results suggest that the Caco-2 cell-based 3D tissue model is a valuable and biologically relevant tool between in-vitro and in-vivo infection models to study virulence of C. jejuni and other gastrointestinal pathogens.
Background
During development in human erythrocytes, Plasmodium falciparum parasites display a remarkable number of adhesive proteins on their plasma membrane. In the invasive merozoites, these include members of the PfMSP1 and PfAMA1/RON complexes, which facilitate contact between merozoites and red blood cells. In gametocytes, sexual precursor cells mediating parasite transmission to the mosquito vector, plasma membrane-associated proteins primarily belong to the PfCCp and 6-cys families with roles in fertilization. This study describes a newly identified WD40-repeat protein unique to Plasmodium species that associates with adhesion protein complexes of both merozoites and gametocytes.
Methods
The WD40-repeat protein-like protein PfWLP1 was identified via co-immunoprecipitation assays followed by mass spectrometry and characterized using biochemical and immunohistochemistry methods. Reverse genetics were employed for functional analysis.
Results
PfWLP1 is expressed both in schizonts and gametocytes. In mature schizonts, the protein localizes underneath the merozoite micronemes and interacts with PfAMA1, while in gametocytes PfWLP1 primarily accumulates underneath the plasma membrane and associates with PfCCp1 and Pfs230. Reverse genetics failed to disrupt the pfwlp1 gene, while haemagglutinin-tagging was feasible, suggesting a crucial function for PfWLP1 during blood stage replication.
Conclusions
This is the first report on a plasmodial WD40-repeat protein associating with cell adhesion proteins. Since WD40 domains are known to mediate protein–protein contact by serving as a rigid scaffold for protein interactions, the presented data suggest that PfWLP1 supports the stability of adhesion protein complexes of the plasmodial blood stages.
ABSTRACT The recently emerged pathogenic yeast Candida auris is a major concern for human health, because it is easily transmissible, difficult to eradicate from hospitals, and highly drug resistant. Most C. auris isolates are resistant to the widely used antifungal drug fluconazole due to mutations in the target enzyme Erg11 and high activity of efflux pumps, such as Cdr1. In the well-studied, distantly related yeast Candida albicans, overexpression of drug efflux pumps also is a major mechanism of acquired fluconazole resistance and caused by gain-of-function mutations in the zinc cluster transcription factors Mrr1 and Tac1. In this study, we investigated a possible involvement of related transcription factors in efflux pump expression and fluconazole resistance of C. auris. The C. auris genome contains three genes encoding Mrr1 homologs and two genes encoding Tac1 homologs, and we generated deletion mutants lacking these genes in two fluconazole-resistant strains from clade III and clade IV. Deletion of TAC1b decreased the resistance to fluconazole and voriconazole in both strain backgrounds, demonstrating that the encoded transcription factor contributes to azole resistance in C. auris strains from different clades. CDR1 expression was not or only minimally affected in the mutants, indicating that Tac1b can confer increased azole resistance by a CDR1-independent mechanism.
IMPORTANCE Candida auris is a recently emerged pathogenic yeast that within a few years after its initial description has spread all over the globe. C. auris is a major concern for human health, because it can cause life-threatening systemic infections, is easily transmissible, and is difficult to eradicate from hospital environments. Furthermore, C. auris is highly drug resistant, especially against the widely used antifungal drug fluconazole. Mutations in the drug target and high activity of efflux pumps are associated with azole resistance, but it is not known how drug resistance genes are regulated in C. auris. We have investigated the potential role of several candidate transcriptional regulators in the intrinsic fluconazole resistance of C. auris and identified a transcription factor that contributes to the high resistance to fluconazole and voriconazole of two C. auris strains from different genetic clades, thereby providing insight into the molecular basis of drug resistance of this medically important yeast."
Depending on the environmental conditions, the pathogenic yeast Candida albicans can undergo different developmental programs, which are controlled by dedicated transcription factors and upstream signaling pathways. C. albicans strains that are homozygous at the mating type locus can switch from the normal yeast form (white) to an elongated cell type (opaque), which is the mating-competent form of this fungus. Both white and opaque cells use the Ste11-Hst7-Cek1/Cek2 MAP kinase signaling pathway to react to the presence of mating pheromone. However, while opaque cells employ the transcription factor Cph1 to induce the mating response, white cells recruit a different downstream transcription factor, Tec1, to promote the formation of a biofilm that facilitates mating of opaque cells in the population. The switch from the white to the opaque cell form is itself induced by environmental signals that result in the upregulation of the transcription factor Wor1, the master regulator of white-opaque switching. To get insight into the upstream signaling pathways controlling the switch, we expressed all C. albicans protein kinases from a tetracycline-inducible promoter in a switching-competent strain. Screening of this library of strains showed that a hyperactive form of Ste11 lacking its N-terminal domain (Ste11ΔN467) efficiently stimulated white cells to switch to the opaque phase, a behavior that did not occur in response to pheromone. Ste11ΔN467-induced switching specifically required the downstream MAP kinase Cek1 and its target transcription factor Cph1, but not Cek2 and Tec1, and forced expression of Cph1 also promoted white-opaque switching in a Wor1-dependent manner. Therefore, depending on the activation mechanism, components of the pheromone-responsive MAP kinase pathway can be reconnected to stimulate an alternative developmental program, switching of white cells to the mating-competent opaque phase.
A viral infection involves entry and replication of viral nucleic acid in a host organism, subsequently leading to biochemical and structural alterations in the host cell. In the case of SARS-CoV-2 viral infection, over-activation of the host immune system may lead to lung damage. Albeit the regeneration and fibrotic repair processes being the two protective host responses, prolonged injury may lead to excessive fibrosis, a pathological state that can result in lung collapse. In this review, we discuss regeneration and fibrosis processes in response to SARS-CoV-2 and provide our viewpoint on the triggering of alveolar regeneration in coronavirus disease 2019 (COVID-19) patients.
Amidochelocardin overcomes resistance mechanisms exerted on tetracyclines and natural chelocardin
(2020)
The reassessment of known but neglected natural compounds is a vital strategy for providing novel lead structures urgently needed to overcome antimicrobial resistance. Scaffolds with resistance-breaking properties represent the most promising candidates for a successful translation into future therapeutics. Our study focuses on chelocardin, a member of the atypical tetracyclines, and its bioengineered derivative amidochelocardin, both showing broad-spectrum antibacterial activity within the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) panel. Further lead development of chelocardins requires extensive biological and chemical profiling to achieve favorable pharmaceutical properties and efficacy. This study shows that both molecules possess resistance-breaking properties enabling the escape from most common tetracycline resistance mechanisms. Further, we show that these compounds are potent candidates for treatment of urinary tract infections due to their in vitro activity against a large panel of multidrug-resistant uropathogenic clinical isolates. In addition, the mechanism of resistance to natural chelocardin was identified as relying on efflux processes, both in the chelocardin producer Amycolatopsis sulphurea and in the pathogen Klebsiella pneumoniae. Resistance development in Klebsiella led primarily to mutations in ramR, causing increased expression of the acrAB-tolC efflux pump. Most importantly, amidochelocardin overcomes this resistance mechanism, revealing not only the improved activity profile but also superior resistance-breaking properties of this novel antibacterial compound.
The opportunistic fungal pathogen Candida albicans frequently produces genetically altered variants to adapt to environmental changes and new host niches in the course of its life-long association with the human host. Gain-of-function mutations in zinc cluster transcription factors, which result in the constitutive upregulation of their target genes, are a common cause of acquired resistance to the widely used antifungal drug fluconazole, especially during long-term therapy of oropharyngeal candidiasis. In this study, we investigated if C. albicans also can develop resistance to the antimicrobial peptide histatin 5, which is secreted in the saliva of humans to protect the oral mucosa from pathogenic microbes. As histatin 5 has been shown to be transported out of C. albicans cells by the Flu1 efflux pump, we screened a library of C. albicans strains that contain artificially activated forms of all zinc cluster transcription factors of this fungus for increased FLU1 expression. We found that a hyperactive Mrr1, which confers fluconazole resistance by upregulating the multidrug efflux pump MDR1 and other genes, also causes FLU1 overexpression. Similarly to the artificially activated Mrr1, naturally occurring gain-of-function mutations in this transcription factor also caused FLU1 upregulation and increased histatin 5 resistance. Surprisingly, however, Mrr1-mediated histatin 5 resistance was mainly caused by the upregulation of MDR1 instead of FLU1, revealing a previously unrecognized function of the Mdr1 efflux pump. Fluconazole-resistant clinical C. albicans isolates with different Mrr1 gain-of-function mutations were less efficiently killed by histatin 5, and this phenotype was reverted when MRR1 was deleted. Therefore, antimycotic therapy can promote the evolution of strains that, as a consequence of drug resistance mutations, simultaneously have acquired increased resistance against an innate host defense mechanism and are thereby better adapted to certain host niches.
A major obstacle in infection biology is the limited ability to recapitulate human disease trajectories in traditional cell culture and animal models, which impedes the translation of basic research into clinics. Here, we introduce a three-dimensional (3D) intestinal tissue model to study human enteric infections at a level of detail that is not achieved by conventional two-dimensional monocultures. Our model comprises epithelial and endothelial layers, a primary intestinal collagen scaffold, and immune cells. Upon Salmonella infection, the model mimics human gastroenteritis, in that it restricts the pathogen to the epithelial compartment, an advantage over existing mouse models. Application of dual transcriptome sequencing to the Salmonella-infected model revealed the communication of epithelial, endothelial, monocytic, and natural killer cells among each other and with the pathogen. Our results suggest that Salmonella uses its type III secretion systems to manipulate STAT3-dependent inflammatory responses locally in the epithelium without accompanying alterations in the endothelial compartment. Our approach promises to reveal further human-specific infection strategies employed by Salmonella and other pathogens.
IMPORTANCE Infection research routinely employs in vitro cell cultures or in vivo mouse models as surrogates of human hosts. Differences between murine and human immunity and the low level of complexity of traditional cell cultures, however, highlight the demand for alternative models that combine the in vivo-like properties of the human system with straightforward experimental perturbation. Here, we introduce a 3D tissue model comprising multiple cell types of the human intestinal barrier, a primary site of pathogen attack. During infection with the foodborne pathogen Salmonella enterica serovar Typhimurium, our model recapitulates human disease aspects, including pathogen restriction to the epithelial compartment, thereby deviating from the systemic infection in mice. Combination of our model with state-of-the-art genetics revealed Salmonella-mediated local manipulations of human immune responses, likely contributing to the establishment of the pathogen's infection niche. We propose the adoption of similar 3D tissue models to infection biology, to advance our understanding of molecular infection strategies employed by bacterial pathogens in their human host.
We report on the characterization and target analysis of the small (s) RNA\(_{162}\) in the methanoarchaeon Methanosarcina mazei. Using a combination of genetic approaches, transcriptome analysis and computational predictions, the bicistronic MM2441-MM2440 mRNA encoding the transcription factor MM2441 and a protein of unknown function was identified as a potential target of this sRNA, which due to processing accumulates as three stabile 5' fragments in late exponential growth. Mobility shift assays using various mutants verified that the non-structured single-stranded linker region of sRNA\(_{162}\) (SLR) base-pairs with the MM2440-MM2441 mRNA internally, thereby masking the predicted ribosome binding site of MM2441. This most likely leads to translational repression of the second cistron resulting in dis-coordinated operon expression. Analysis of mutant RNAs in vivo confirmed that the SLR of sRNA\(_{162}\) is crucial for target interactions. Furthermore, our results indicate that sRNA\(_{162}\)-controlled MM2441 is involved in regulating the metabolic switch between the carbon sources methanol and methylamine. Moreover, biochemical studies demonstrated that the 50 end of sRNA\(_{162}\) targets the 5'-untranslated region of the cis-encoded MM2442 mRNA. Overall, this first study of archaeal sRNA/mRNA-target interactions unraveled that sRNA\(_{162}\) acts as an antisense (as) RNA on cis- and trans-encoded mRNAs via two distinct domains, indicating that cis-encoded asRNAs can have larger target regulons than previously anticipated.
An expanded evaluation of protein function prediction methods shows an improvement in accuracy
(2016)
Background
A major bottleneck in our understanding of the molecular underpinnings of life is the assignment of function to proteins. While molecular experiments provide the most reliable annotation of proteins, their relatively low throughput and restricted purview have led to an increasing role for computational function prediction. However, assessing methods for protein function prediction and tracking progress in the field remain challenging.
Results
We conducted the second critical assessment of functional annotation (CAFA), a timed challenge to assess computational methods that automatically assign protein function. We evaluated 126 methods from 56 research groups for their ability to predict biological functions using Gene Ontology and gene-disease associations using Human Phenotype Ontology on a set of 3681 proteins from 18 species. CAFA2 featured expanded analysis compared with CAFA1, with regards to data set size, variety, and assessment metrics. To review progress in the field, the analysis compared the best methods from CAFA1 to those of CAFA2.
Conclusions
The top-performing methods in CAFA2 outperformed those from CAFA1. This increased accuracy can be attributed to a combination of the growing number of experimental annotations and improved methods for function prediction. The assessment also revealed that the definition of top-performing algorithms is ontology specific, that different performance metrics can be used to probe the nature of accurate predictions, and the relative diversity of predictions in the biological process and human phenotype ontologies. While there was methodological improvement between CAFA1 and CAFA2, the interpretation of results and usefulness of individual methods remain context-dependent.
The membrane protein EsaA is a conserved component of the type VIIb secretion system. Limited proteolysis of purified EsaA from Staphylococcus aureus USA300 identified a stable 48 kDa fragment, which was mapped by fingerprint mass spectrometry to an uncharacterized extracellular segment of EsaA. Analysis by circular dichroism spectroscopy showed that this fragment folds into a single stable domain made of mostly α‐helices with a melting point of 34.5°C. Size‐exclusion chromatography combined with multi‐angle light scattering indicated the formation of a dimer of the purified extracellular domain. Octahedral crystals were grown in 0.2 M ammonium citrate tribasic pH 7.0, 16% PEG 3350 using the hanging‐drop vapor‐diffusion method. Diffraction data were analyzed to 4.0 Å resolution, showing that the crystals belonged to the enantiomorphic tetragonal space groups P41212 or P43212, with unit‐cell parameters a = 197.5, b = 197.5, c = 368.3 Å, α = β = γ = 90°.
The heterotrimeric protein kinase SNF1 plays a key role in the metabolic adaptation of the pathogenic yeast Candida albicans. It consists of the essential catalytic α-subunit Snf1, the γ-subunit Snf4, and one of the two β-subunits Kis1 and Kis2. Snf4 is required to release the N-terminal catalytic domain of Snf1 from autoinhibition by the C-terminal regulatory domain, and snf4Δ mutants cannot grow on carbon sources other than glucose. In a screen for suppressor mutations that restore growth of a snf4Δ mutant on alternative carbon sources, we isolated a mutant in which six amino acids between the N-terminal kinase domain and the C-terminal regulatory domain of Snf1 were deleted. The deletion was caused by an intragenic recombination event between two 8-bp direct repeats flanking six intervening codons. In contrast to truncated forms of Snf1 that contain only the kinase domain, the Snf4-independent Snf1\(^{Δ311 − 316}\) was fully functional and could replace wild-type Snf1 for normal growth, because it retained the ability to interact with the Kis1 and Kis2 β-subunits via its C-terminal domain. Indeed, the Snf4-independent Snf1\(^{Δ311 − 316}\) still required the β-subunits of the SNF1 complex to perform its functions and did not rescue the growth defects of kis1Δ mutants. Our results demonstrate that a preprogrammed in-frame deletion event within the SNF1 coding region can generate a mutated form of this essential kinase which abolishes autoinhibition and thereby overcomes growth deficiencies caused by a defect in the γ-subunit Snf4.
Salmonella Typhimurium (S.Tm) is a common cause of self-limiting diarrhea. The mucosal inflammation is thought to arise from a standoff between the pathogen's virulence factors and the host's mucosal innate immune defenses, particularly the mucosal NAIP/NLRC4 inflammasome. However, it had remained unclear how this switches the gut from homeostasis to inflammation. This was studied using the streptomycin mouse model. S.Tm infections in knockout mice, cytokine inhibition and –injection experiments revealed that caspase-1 (not -11) dependent IL-18 is pivotal for inducing acute inflammation. IL-18 boosted NK cell chemoattractants and enhanced the NK cells' migratory capacity, thus promoting mucosal accumulation of mature, activated NK cells. NK cell depletion and Prf\(^{-/-}\) ablation (but not granulocyte-depletion or T-cell deficiency) delayed tissue inflammation. Our data suggest an NK cell perforin response as one limiting factor in mounting gut mucosal inflammation. Thus, IL-18-elicited NK cell perforin responses seem to be critical for coordinating mucosal inflammation during early infection, when S.Tm strongly relies on virulence factors detectable by the inflammasome. This may have broad relevance for mucosal defense against microbial pathogens.
Our body is colonized by a vast array of bacteria the sum of which forms our microbiota. The gut alone harbors >1,000 bacterial species. An understanding of their individual or synergistic contributions to human health and disease demands means to interfere with their functions on the species level. Most of the currently available antibiotics are broad‐spectrum, thus too unspecific for a selective depletion of a single species of interest from the microbiota. Programmable RNA antibiotics in the form of short antisense oligonucleotides (ASOs) promise to achieve precision manipulation of bacterial communities. These ASOs are coupled to small peptides that carry them inside the bacteria to silence mRNAs of essential genes, for example, to target antibiotic‐resistant pathogens as an alternative to standard antibiotics. There is already proof‐of‐principle with diverse bacteria, but many open questions remain with respect to true species specificity, potential off‐targeting, choice of peptides for delivery, bacterial resistance mechanisms and the host response. While there is unlikely a one‐fits‐all solution for all microbiome species, I will discuss how recent progress in bacterial RNA biology may help to accelerate the development of programmable RNA antibiotics for microbiome editing and other applications.
Der opportunistisch humanpathogene Hefepilz Candida albicans gehört bei vielen gesunden Menschen zur mikrobiellen Schleimhautflora, kann jedoch bei abwehrgeschwächten Patienten oberflächliche Infektionen sowie auch lebensbedrohliche tiefe Organmykosen verursachen. Obwohl der Immunstatus des Wirtes für eine Infektion mit diesem Erreger von entscheidender Bedeutung ist, tragen vermutlich auch eine Reihe von Virulenzfaktoren zur Pathogenität von C. albicans bei, indem sie Besiedlung, Ausbreitung und Vermehrung der Pilzzellen unter Anpassung an die verschiedensten Wirtsnischen unterstützen. Eine für die Pathogenität von C. albicans wichtige Eigenschaft ist die Bildung sekretorischer Aspartylproteasen (SAPs), die durch eine große Familie homologer Gene codiert werden. Es wird angenommen, dass die individuellen Proteasen während der Infektion verschiedene Aufgaben erfüllen bzw. optimal an unterschiedliche Wirtsnischen angepaßt sind. Jedoch ist der Beitrag der einzelnen SAP-Gene zur Pathogenese noch weitgehend unverstanden. Da die wirtsinduzierte Aktivierung dieser Virulenzgene während bestimmter Infektionsstadien Hinweise auf ihre spezifische pathogenetische Bedeutung liefern könnte, wurde in dieser Arbeit eine Methode für C. albicans entwickelt, mit der die Induktion eines Gens während der Infektion nachgewiesen werden kann. Die Methode beruht auf einer genetischen Rekombination als Reporter einer Genexpression, was bedeutet, dass nach Induktion des zu untersuchenden Gens eine site-spezifische Rekombinase spezifisch einen Mykophenolsäure-Resistenzmarker aus dem Genom der Zelle entfernt. Da diese Deletion ein irreversibles Ereignis darstellt, das auf die jeweiligen Nachkommen vererbt wird, kann selbst eine vorübergehende Genaktivierung während eines bestimmten Infektionsstadiums bzw. in einem bestimmten Organ in einzelnen Zellen nach deren Reisolierung aus infiziertem Gewebe durch Ausplattieren auf geeignetem Indikatormedium nachgewiesen werden. Durch Analyse der Expression des SAP2-Gens wurde bestätigt, dass mit diesem Reportersystem eine biologisch signifikante Genaktivierung in C. albicans nachgewiesen werden kann. SAP2 wird in C. albicans in vitro in einem Medium induziert, das Rinderserumalbumin als alleinige Stickstoffquelle enthält, ist in anderen gängigen Labormedien jedoch reprimiert. Diese in vivo-Expressionstechnologie (IVET) wurde verwendet, um die Expression von sechs verschiedenen SAP-Genen von C. albicans, SAP1-SAP6, in unterschiedlichen Tiermodellen zu studieren. Dabei konnte gezeigt werden, dass die einzelnen Proteasegene abhängig von der Art der Infektion, d.h. lokal begrenzte Schleimhautinfektion bzw. Systeminfektion, und auch vom Infektionsstadium differentiell reguliert werden. Dabei wurden sogar die äußerst homologen Gene SAP4-SAP6, die aufgrund von in vitro erzielten Ergebnissen als hyphenspezifische Gene galten, in vivo unterschiedlich reguliert. SAP5 und SAP6, aber nicht die anderen SAP-Gene, wurden in einem Maus-Ösophagus-Schleimhautmodell signifikant aktiviert, als die C. albicans-Hyphen in das Epithel invadierten. Eine stadienspezifische Expression der SAP-Gene wurde in einem Maus-Peritonitis-Modell beobachtet. Kurz nach Inokulation der C. albicans-Hefezellen in die Bauchhöhle der Tiere, zu einem Zeitpunkt, als noch keine Ausbildung von Hyphen zu beobachten war, wurde SAP5, aber nicht SAP6 oder eines der anderen analysierten SAP-Gene in einem signifikanten Anteil der infizierenden Zellen aktiviert. Demzufolge scheint SAP5 für die Gewebeinvasion während der Schleimhautinfektion und auch für die ersten Schritte während einer disseminierenden Infektion von Bedeutung zu sein. Durch die intravenöse Infektion der Maus, bei der frühe Infektionsschritte umgangen werden, wurde gezeigt, dass SAP5 und SAP6, aber auch SAP4, während der späteren Stadien einer disseminierenden Infektion weiterhin aktiviert werden. Dagegen wurde eine Induktion des SAP2-Gens vorwiegend im Spätstadium einer systemischen Infektion beobachtet, nachdem die Pilzzellen innere Organe befallen hatten. Daher fördert SAP2 vermutlich weniger die Invasion von Geweben, dafür aber die Vermehrung der Pilze nach Organbefall, möglicherweise durch die Bereitstellung von Nährstoffen. Dabei wurde gezeigt, dass die in vivo-Regulation von SAP2 durch bestimmte Repeatstrukturen innerhalb der Promotorregion dieses Gens beeinflußt wird. Während des Verlaufs einer systemischen Infektion wurden sogar die zwei SAP2-Allele des hier untersuchten C. albicans-Modellstammes CAI4, die sich in dieser Repeatregion unterscheiden, differentiell reguliert. Das SAP2-2-Allel wurde nämlich bereits deutlich früher induziert als das Allel SAP2-1. Eine Expression von SAP1 und SAP3 konnte im Gegensatz zu den anderen SAP-Genen nur in wenigen der infizierenden Zellen nachgewiesen werden, so dass diesen Genen ein Beitrag zur Pathogenität in den hier untersuchten Infektionsmodellen nicht beigemessen werden kann. Im Verlauf einer Infektion setzt C. albicans vermutlich viele verschiedene Virulenzfaktoren gleichzeitig für eine bestmögliche Anpassung an die jeweilige Wirtsnische ein. Ob in Abhängigkeit entsprechender Wirtssignale dabei unterschiedliche Eigenschaften der Pilzzelle koordiniert reguliert werden, ist kaum erforscht, erscheint jedoch für ein besseres Verständnis der Erreger-Wirts-Auseinandersetzung von besonderem Interesse. An der Kontrolle der Hyphenbildung von C. albicans sind wenigstens zwei Signaltransduktionskaskaden beteiligt, eine MAP-Kinase-Kaskade und ein cAMP-abhängiger Signalweg, die in den Transkriptionsregulatoren CPH1 bzw. EFG1 enden. Nachdem dimorphes Wachstum für die Infektion von Bedeutung ist und die Expression der Gene SAP4-SAP6 in vitro mit der Hyphenwachstumsphase verbunden ist, wurde eine mögliche Abhängigkeit hyphenassoziierter SAP-Aktivierung von diesen Regulatoren durch die Analyse der SAP5-Expression in entsprechenden Mutanten analysiert. Sowohl in cph1- als auch in efg1-Einzelmutanten wurde eine reduzierte Aktivierung des SAP5-Gens in vivo beobachtet. Dadurch konnte gezeigt werden, dass sowohl CPH1 als auch EFG1 zur SAP5-Aktivierung während der Infektion beitragen. Da cph1-Mutanten im infizierten Gewebe wie der Wildtyp-Stamm Hyphen ausbildeten, war die Hyphenbildung allein offensichtlich nicht für eine volle SAP5-Aktivierung in vivo ausreichend. Andererseits war die SAP5-Induktion in vivo nicht von der Hyphenwachstumsphase abhängig, da eine verminderte, aber dennoch signifikante SAP5-Expression auch in den efg1-Mutanten zu beobachten war, die in den infizierten Tieren nur in der Hefephase wuchsen. In Zellen, in denen beide Regulatoren fehlten, konnte eine Induktion von SAP5 kaum nachgewiesen werden. Das bedeutet, dass diese Signalwege in C. albicans für die Kontrolle verschiedener zellulärer Programme während der Infektion wichtig sind und die Expression von unterschiedlichen Virulenzgenen koordinieren. Durch die in vivo-Analyse der Virulenzgenexpression in C. albicans konnten Einblicke in regulatorische Anpassungsmechanismen dieses Mikroorganismus an verschiedene Wirtsnischen gewonnen werden. Einzelne Mitglieder einer Virulenzgenfamilie dieses Pilzes werden während der Infektion differentiell und in Abhängigkeit vom Infektionsstadium reguliert und tragen daher vermutlich sehr spezifisch zur Pathogenese bei. Unterschiedliche Virulenzmerkmale können zudem während der Infektion koordiniert reguliert werden und dadurch gemeinsam die Anpassungsfähigkeit von C. albicans an den Wirt unterstützen. Die erzielten Erkenntnisse sollten letztlich dazu beitragen, die Pathogenität dieses wichtigen opportunistisch humanpathogenen Erregers besser verstehen zu können.
Staphylococcus epidermidis ist ein wichtiger Bestandteil der gesunden Hautflora des Menschen, gleichzeitig aber auch der häufigste Erreger nosokomialer Infektionen bei immunsupprimierten Patienten. Die Forschungsarbeiten haben sich in den vergangenen Jahren besonders auf Faktoren und Mechanismen konzentriert, welche zur Etablierung der Spezies als Pathogen beigetragen haben. Eine typische Eigenschaft klinischer Isolate ist die Fähigkeit, auf künstlichen Oberflächen Biofilme zu bilden. Gegenstand der vorliegenden Arbeit war die Untersuchung der IS-vermittelten Genomflexibilität und der Vergleich der Genomstruktur nosokomialer und kommensaler Isolate von S. epidermidis. Dazu wurde eine 260 kb große spontane Deletion im Chromosom des Biofilm-bildenden Stammes S. epidermidis 307 sequenziert und annotiert, von der bekannt war, dass sie durch eine homologe Rekombination zweier IS256-Kopien ausgelöst wurde. Auf dem deletierten Fragment fanden sich neben dem ica-Operon zahlreiche potentielle Virulenz-assoziierte Gene. Das überraschende Ergebnis dieser Analyse war jedoch die Identifizierung eines neuartigen SCC-Elementes, das den rechten Rand der Deletion begrenzt. Dies ist die erste Beschreibung eines SSC-Elementes mit einer CcrC-Rekombinase, dem das Methicillin-Resistenzgen mecA fehlt. In der Nähe des Rekombinasegens fand sich S.-haemolyticus-spezifische DNA. Weitere Untersuchungen zeigten, dass das SCC-Element durch die IS256/Tn4001 -vermittelte Deletion in der Mutante verkürzt wurde. Genomvergleiche ica-positiver und ica-negativer Stämme von S. epidermidis mittels Microarrays, sowie in-silico-Analysen zweier vollständiger S.-epidermidis-Genome ergaben, dass sich kommensale und pathogene Stämme in nur wenigen Faktoren unterscheiden. Diese befinden sich jedoch fast alle in einer Region um den oriC, in dessen Nähe auch die Insertionsstelle für die SCCmec-Inseln lokalisiert ist. Das deletierte DNA-Fragment von S. epidermidis 307 konnte ebenfalls dieser Region zugeordnet werden, die offenbar eine Zone hoher genomischer Flexibilität darstellt, in der fremde DNA integriert werden kann. Im Rahmen dieser Arbeit konnte außerdem gezeigt werden, dass das ica-Operon diesen variablen Genomabschnitt begrenzt. Die exakte Grenze zwischen ica-positiven und ica-negativen Stämmen bildet eine Thr-tRNA, die in einer 1,4 kb großen intergenischen Region stromabwärts des icaR-Regulatorgens lokalisiert ist. In unmittelbarer Nachbarschaft konnte ein Transkript nachgewiesen werden, welches nur in ica-positiven S. epidermidis vorkommt. Gestützt auf bioinformatische Analysen wurden zunächst die Polarität und Länge des Transkriptes, sowie der korrespondierende Promotor experimentell bestimmt. Demnach handelt es sich um eine 487 nt lange RNA, die entgegengesetzt zur Thr-tRNA orientiert ist und mit dieser teilweise überlappt. Da die Nukelotid-Sequenz weder eine Ribosomen- Bindungsstelle noch einen größeren Leserahmen aufweist, ist es sehr wahrscheinlich, dass es sich um eine nicht-translatierte RNA handelt. Qualitative RT-PCR-Experimente zeigten, dass die IGRica-RNA kostitutiv exprimiert wird. Spontane IS256 –Insertionsmutanten in der Promotorregion der IGRica-RNA wiesen phänotypisch eine deutlich verminderte Biofilmbildung auf. Daher ist zu vermuten, dass die IGRica-RNA in die Regulation dieses wichtigen Virulenzfaktors involviert ist. In der vorliegenden Arbeit konnte weiterhin gezeigt werden, dass S. epidermidis das in vielen Spezies konservierte Hfq-Protein exprimiert, welches ein Bindungspartner und Chaperon für zahlreiche regulatorische RNAs darstellt. gel-shift-Experimente mit rekombinantem Hfq-Protein aus S. epidermidis ergaben jedoch keine nachweisbare Wechselwirkung der IGRica-RNA mit diesem Faktor in vitro. Insgesamt hat die Studie gezeigt, dass S. epidermidis eine Spezies mit einer außerordentlich hohen Genomflexibilität ist, die sich hauptsächlich in einer bestimmten Genomregion abspielt und für die IS-Elemente von besonderer Bedeutung sind. Die Identifizierung von DNA aus anderen Staphylokokken-Arten in dieser Region zeigt, dass S. epidermidis zu horizontalem Gentransfer über Speziesgrenzen hinweg in der Lage ist. Dies, sowie die Daten zur neuen SCC-Kassette, unterstreichen die Bedeutung von S. epidermidis als Reservoir für die Entwicklung neuartiger Resistenz- und Virulenzdeterminanten, die gerade im Krankenhausmilieu auf Spezies mit höherem Virulenzpotential übertragen werden können und so einen wichtigen Faktor für die anhaltende Problematik nosokomialer Infektionen mit S. aureus darstellen. Die Entdeckung einer RNA mit möglicherweise regulatorischer Funktion ist der erste Faktor dieser Art, der – abgesehen von einigen phylogenetisch hoch konservierten RNAs – bisher in S. epidermidis nachgewiesen wurde. Die funktionale Analyse der IGRica-RNA und die Suche nach weiteren regulatorischen RNAs in Staphylokokken eröffnen ein Forschungsfeld, das zum besseren Verständnis der Lebensweise dieser bedeutenden Erreger beitragen kann.
Trotz intensiver Forschung und des Global-Eradication-of-Malaria-Programms der WHO in den 1950er Jahren zählt Malaria neben AIDS und Tuberkulose auch heute immer noch zu den bedeutendsten Infektionskrankheiten weltweit. Aufgrund rasch zunehmender Resistenzentwicklung der Erreger gegen gängige Prophylaxe- sowie Therapiepräparate und dem Fehlen eines Impfstoffs sterben jährlich bis zu 3 Mio. Menschen an Malaria. Seit vor etwa 2 Jahrzehnten das wissenschaftliche Interesse an transmissionsblockierenden Vakzinen gegen den Malariaerreger erwachte, rückten sexualstadienspezifische Oberflächenproteine in den Fokus der Impfstoffforschung. Im Zuge der vollständigen Sequenzierung des P.-falciparum-Genoms wurde bei dem Screenen nach Genen, die multiple tier- oder bakterienähnliche, adhäsive, extrazelluläre Domänen kodieren, die PfCCp-Familie identifiziert. Ihre 6 Mitglieder besitzen eine bemerkenswerte Vielfalt an hoch konservierten, adhäsiven Modulen, die eine Beteiligung an Protein-Protein-, -Polysaccharid- oder -Lipid-Interaktionen vermuten lassen. Die Multiadhäsionsdomänenproteine wurden aufgrund des gemeinsamen LCCL-Moduls PfCCp1 bis PfCCp5 benannt. Dem sechsten Mitglied, PfFNPA, fehlt zwar die namensgebende Domäne, doch die ausgeprägte Ähnlichkeit zu PfCCp5 führte zur Integration des Proteins in die PfCCp-Familie. Die Charakterisierung der ersten 3 Mitglieder zeigte, dass PfCCp1, PfCCp2 und PfCCp3 sexualstadienspezifisch exprimiert werden und in der parasitophoren Vakuole reifer Gametozyten lokalisiert sind. Immunfluoreszenzstudien ließen außerdem erkennen, dass die Proteine während der Gametenbildung partiell freigesetzt werden und in einer matrix-ähnlichen Struktur Exflagellationszentren umgeben. In KO-Studien erwiesen sich PfCCp2 und PfCCp3 zusätzlich als essentielle Faktoren für die Migration reifer Sporozoiten aus den Mitteldarmoozysten in die Speicheldrüsen der Mücken. Damit erfüllen sie die 2 grundlegenden Kriterien für Komponenten transmissionsblockierender Vakzine: eine sexual-stadienspezifische Expression und essentielle Funktion während der Parasitenentwicklung in der Mücke. Aufgrund dieser viel versprechenden Daten wurde im Rahmen der vorliegenden Arbeit die Analyse der PfCCp-Familie durch funktionale Charakterisierung von PfCCp4 sowie Interaktionsstudien an den PfCCp-Proteinen fortgesetzt. Die Expressionsanalysen mittels RT-PCR, Western Blot und Immunfluoreszenzstudien ergaben für PfCCp4 ebenfalls eine sexualstadienspezifische, Plasmamembran-assoziierte Expression innerhalb der parasitophoren Vakuole reifer Gametozyten. Die Expression beginnt bereits in Gametozyten des Stadium I und erfolgt hauptsächlich in Makrogametozyten. Im Gegensatz zu PfCCp1, PfCCp2 und PfCCp3 wird PfCCp4 jedoch homogen verteilt exprimiert. Während der Gametogenese wird PfCCp4 nicht freigesetzt, sondern verbleibt an der Oberfläche von Makrogameten. Es ist zudem das einzige Mitglied der PfCCp-Familie, dessen Expression im Zuge der Ookinetenreifung wieder aufgenommen wird. KO-Studien durch Membranfütterungen von Anopheles-Mücken lassen allerdings darauf schließen, dass PfCCp4 keine essentielle Funktion bei der Parasitenentwicklung ausübt. Der Verlust von PfCCp4 beeinträchtigte weder die Fertilisation noch die Bildung, Reifung oder Migration von Ookineten, Oozysten oder Sporozoiten. PfCCp4 kann somit nicht als Kandidat transmissionsblockierender Vakzine betrachtet werden, obwohl es mit den viel versprechenden Kandidaten Pfs230 und Pfs48/45 interagiert, wie funktionelle Analysen nativer PfCCp-Proteine mittels Ko-Immunpräzipitation ergaben. Weitere Ko-Immunpräzipitationsstudien identifizierten Interaktionen innerhalb der PfCCp-Familie, wie bereits die Ko-Lokalisation und ko-abhängige Expression von PfCCp1, PfCCp2 und PfCCp3, ihre Freisetzung bei der Gametogenese und die matrixähnliche Verteilung um Exflagellationszentren vermuten ließen. In Affinitätschromatographiestudien unter Verwendung rekombinanter PfCCp-Proteine konnte gezeigt werden, dass es sich dabei um direkte Interaktionen handelt, an denen besonders die LCCL- und die SR-Domäne beteiligt zu sein scheinen. In Zelladhäsionsstudien konnte außerdem eine Bindungsaffinität ausgewählter rekombinanter PfCCp-Proteine an Makrogameten beobachtet werden. Insgesamt bestätigen diese Daten unsere Hypothese, dass PfCCp-Proteine unter Beteiligung weiterer sexualstadienspezifischer Proteine während der Gametozytenreifung und Gametogenese Proteinkomplexe ausbilden. In zukünftigen Studien gilt es einerseits, ausgewählte PfCCp-Proteine durch transmissionsblockierende Experimente in ihrem Potential als Impfstoffkomponenten zu evaluieren. Andererseits nimmt die funktionale Charakterisierung der Proteinkomplexe während der Gamogonie eine zentrale Rolle ein, um ihre Funktion in der Sexualphase von P. falciparum zu klären und die Beteiligung der PfCCp-Proteine an der Regulation dieses komplexen Lebenszyklus zu verstehen.
Analysis of a multi-component multi-stage malaria vaccine candidate—tackling the cocktail challenge
(2015)
Combining key antigens from the different stages of the P. falciparum life cycle in the context of a multi-stage-specific cocktail offers a promising approach towards the development of a malaria vaccine ideally capable of preventing initial infection, the clinical manifestation as well as the transmission of the disease. To investigate the potential of such an approach we combined proteins and domains (11 in total) from the pre-erythrocytic, blood and sexual stages of P. falciparum into a cocktail of four different components recombinantly produced in plants. After immunization of rabbits we determined the domain-specific antibody titers as well as component-specific antibody concentrations and correlated them with stage specific in vitro efficacy. Using purified rabbit immune IgG we observed strong inhibition in functional in vitro assays addressing the pre-erythrocytic (up to 80%), blood (up to 90%) and sexual parasite stages (100%). Based on the component-specific antibody concentrations we calculated the IC50 values for the pre-erythrocytic stage (17–25 μg/ml), the blood stage (40–60 μg/ml) and the sexual stage (1.75 μg/ml). While the results underline the feasibility of a multi-stage vaccine cocktail, the analysis of component-specific efficacy indicates significant differences in IC50 requirements for stage-specific antibody concentrations providing valuable insights into this complex scenario and will thereby improve future approaches towards malaria vaccine cocktail development regarding the selection of suitable antigens and the ratios of components, to fine tune overall and stage-specific efficacy.
The S flmbrial adhesln (Sfa) enables Esch richla colito attach to slalfc acld-containing receptor molecules of eukaryotJc cells. As prevlously reported, the genetlc determinant coding for the Sfa of an E. co/1 06 strain was cloned, the gene codlng for the major fimbrfal subunit was ldentlfled and sequenced and th.e S speclflc adhesin was detected. Here we present evidence that ln addltlon to the major subunit proteln SfaA three other minor subunit proteins, SfaG (17 kD), SfaS (14kD) and SfaH (31 kD) can be isolated from the S..speclfic flmbrial adhesln complex. The genes coding for these minor subunits were ldenblied, mutagenlzed separately and sequenced. Using haemagglutlnatton tests. electron-microscopy and quantitative ELISA assays with monoclonal anti-SfaA and anti-SfaS antlbodles the functlons of the minor subunlts were determined. lt was determlned that SfaS ls ldentlcal to the S-specific adhesln; whlch also plays a role ln deterrninatlon of the degree of fimbri· ation ofthe cell. The mlnor subunit SfaH also had some Jnfluence on the Ievei of fimbrlation of the cell. while StaG ls necessary for full expression of S·specific binding. lt was further shown that the amino-terminal proteln sequence of the isolated SfaS profein was identJcal to the proteln sequence calculated from the DNA sequence of the sfaS gene locus.
Analysis of host microRNA function uncovers a role for miR-29b-2-5p in Shigella capture by filopodia
(2017)
MicroRNAs play an important role in the interplay between bacterial pathogens and host cells, participating as host defense mechanisms, as well as exploited by bacteria to subvert host cellular functions. Here, we show that microRNAs modulate infection by Shigella flexneri, a major causative agent of bacillary dysentery in humans. Specifically, we characterize the dual regulatory role of miR-29b-2-5p during infection, showing that this microRNA strongly favors Shigella infection by promoting both bacterial binding to host cells and intracellular replication. Using a combination of transcriptome analysis and targeted high-content RNAi screening, we identify UNC5C as a direct target of miR-29b-2-5p and show its pivotal role in the modulation of Shigella binding to host cells. MiR-29b-2-5p, through repression of UNC5C, strongly enhances filopodia formation thus increasing Shigella capture and promoting bacterial invasion. The increase of filopodia formation mediated by miR-29b-2-5p is dependent on RhoF and Cdc42 Rho-GTPases. Interestingly, the levels of miR-29b-2-5p, but not of other mature microRNAs from the same precursor, are decreased upon Shigella replication at late times post-infection, through degradation of the mature microRNA by the exonuclease PNPT1. While the relatively high basal levels of miR-29b-2-5p at the start of infection ensure efficient Shigella capture by host cell filopodia, dampening of miR-29b-2-5p levels later during infection may constitute a bacterial strategy to favor a balanced intracellular replication to avoid premature cell death and favor dissemination to neighboring cells, or alternatively, part of the host response to counteract Shigella infection. Overall, these findings reveal a previously unappreciated role of microRNAs, and in particular miR-29b-2-5p, in the interaction of Shigella with host cells.
Over a period of 3 years, Legionella pneumophila serogroup 6 strains were isolated from warm water outlets and dental units in the Dental Faculty and from the Surgery and Internal Medicine Clinics at the University of Dresden, Dresden, Germany. In the bacteriological unit of the above-mentioned facility, L. pneumophila serogroups 3 and 12 were grown frl,)m warm water specimens. The medical facilities are located in separate buildings connected with a ring pipe warm water system. All L. pneumophila serogroup 6 strains isolated from the warm water supply reacted with a serogroup-specific monoclonal antibody, but not with two other monoclonal antibodies which are subgroup specific, reacting with other serogroup 6 strains. The NolI genomic profiles obtained by pulsed-field gel electrophoresis of 25 serogroup 6 strains isolated from the Dental Faculty over a 3-year period, 1 isolate from the Internal Medicine Clinic, and 4 strains from the Surgery Clinic were identical. Furthermore, all these strains hybridized with a 3OO-kb NolI fragment when a legiolysin (lIy)-specific DNA probe was used. The NolI pattern, however, differed from those of six serogroup 6 strains of other origins, one serogroup 12 strain from the bacteriological unit, and another six unrelated strains of serogroups other than serogroup 6. L. pneumophila serogroup 6 strains which can be divided into only two subgroups by the use of monoclonal antibodies are differentiated in at least six Noli cleavage types obtained by pulsed-field electrophoresis.
1. Summary Candida albicans is an opportunistic human fungal pathogen that causes a variety of infections, ranging from superficial mucosal to deep-seated systemic infections, especially in immunocompromised patients. Although the ability of C.albicans to cause disease largely depends on the immune status of the host, the fungus also exhibits specific characteristics that facilitate colonization, dissemination, and adaptation to different host niches and thereby turn C.albicans from a harmless commensal to an aggressive pathogen. In response to various environmental stimuli C.albicans switches from growth as a budding yeast to invasive filamentous growth, and this morphogenetic switch plays an important role in C.albicans pathogenesis. Nitrogen limitation is one of the signals that induce filamentous growth in C.albicans, and the control of the morphogenetic transition by nitrogen availability was studied in detail in the present work. Ammonium is a preferred nitrogen source for yeasts that is taken up into the cells by specific transporters. It was found in this study that C.albicans possesses two major ammonium transporters, encoded by the CaMEP1 and CaMEP2 genes, expression of which is induced by nitrogen starvation. Whereas mep1 or mep2 single mutants grew as well as the wild-type strain on limiting concentrations of ammonium, deletion of both transporters rendered C.albicans unable to grow at ammonium concentrations below 5 mM. In contrast to mep1 mutants, mep2 mutants failed to filament and grew only in the yeast form under nitrogen starvation conditions, indicating that in addition to its role as an ammonium transporter CaMep2p also has a signaling function in the induction of filamentous growth. CaMep2p was found to be a less efficient ammonium transporter than CaMep1p and to be expressed at much higher levels, a distinguishing feature important for its signaling function. By the construction and analysis of serially truncated versions of CaMep2p, the C-terminal cytoplasmic tail of the protein was shown to be essential for signaling but dispensable for ammonium transport, demonstrating that these two functions of CaMep2p are separable. In C.albicans at least two signal transduction pathways, a MAP kinase cascade and a cAMP-dependent pathway ending in the transcriptional regulators Cph1p and Efg1p, respectively, control filamentous growth, and mutants defective in either one of these pathways are defective for filamentation under nitrogen starvation conditions. A hyperactive CaMEP2 allele rescued the filamentation defect of a cph1 or a efg1 mutant, but not of a cph1 efg1 double mutant or a mutant deleted for RAS1, which acts upstream of and activates both signaling pathways. Conversely, a dominant active RAS1 allele or addition of exogenous cAMP rescued the filamentation defect of mep2 mutants. These results suggest that CaMep2p activates both the MAP kinase and the cAMP pathway in a Ras1p dependent manner to promote filamentous growth under nitrogen starvation conditions. At sufficiently high concentrations, ammonium repressed filamentous growth even when the signaling pathways were artificially activated. Therefore, C.albicans has established a regulatory circuit in which a preferred nitrogen source, ammonium, serves as an inhibitor of morphogenesis that is taken up into the cell by the same transporter that induces filamentous growth in response to nitrogen starvation. Although a detailed understanding of virulence mechanisms of C.albicans may ultimately lead to novel approaches to combat infections caused by this pathogen, the identification and characterization of essential genes as potential targets for the development of antifungal drugs is a strategy favoured by most pharmaceutical companies. Therefore, C.albicans homologs of three genes that are essential in other fungi were selected in collaboration with an industrial partner and functionally characterized in this work. RAP1 encodes the repressor/activator protein 1, a transcription factor and telomere binding protein that is essential for viability in the budding yeast Saccharomyces cerevisiae. However, deletion of the C.albicans RAP1 homolog did not affect viability or growth of the mutants, suggesting that it is not a promising target. CBF1 (centromere binding factor 1) is necessary for proper chromosome segregation and transcriptional activation of methionine biosynthesis genes in S.cerevisiae and is essential for viability in the related yeasts Kluyveromyces lactis and Candida glabrata. Deletion of CBF1 in C.albicans did not result in an increased frequency of chromosome loss, indicating that it has no role in chromosome segregation in this organism. However, the C.albicans cbf1 mutants exhibited severe growth impairment, temperature sensitivity at 42°C, and auxotrophy for sulphur amino acids, suggesting that Cbf1p is a transcription factor that is important for normal growth of C.albicans. YIL19 is an essential gene in S.cerevisiae that is involved in 18S rRNA maturation. YIL19 was found to be an essential gene also in C.albicans. Conditional mutants in which the YIL19 gene could be excised from the genome by inducible, FLP-mediated recombination were non-viable and accumulated rRNA precursors, demonstrating that YIL19 is essential for this important cellular process and for viability of C.albicans and could serve as a target for the development of antifungal drugs.
Freshly isolated human T lymphocytes were tested for their response to mycobacteria, mycobacteriallysates, 2 dimensional (2D) PAGE separated mycobacteriallysates, leishmania and defined leishmanial antigen preparations. While,o T cells proliferated vigourously in the presence of mycobacteria and mycobacteria derived lysates, a significant stimulation from 2 D gel separated lysates was not detected. In addition '10 T cells failed to respond towards leishmania or leishmanial components. In the ab T cell compartment some donors, presumably according to their state of immunity against mycobacteria, responded to mycobacteria, mycobacterial lysates and 2 D gel separated mycobacterial lysates. Neither freshly isolated '10 T cells nor ab T cells from naive donors did mount a significant immune response against leishmania.
The obligate intracellular gram-negative bacterium, Chlamydophila pneumoniae (Cpn), has a significant impact as an acute and chronic disease-causing pathogen. Its potential to undergo persistent infections has been linked to chronic diseases. Several in vitro cell culture models are used to study persistent conditions, mainly IFN_ stimulation, treatment with antibiotics and iron depletion. Little is known about changes in the Cpn transcriptome during the acute and persistent infection. Therefore, the Cpn transcriptome during its acute developmental cycle and iron depletion-mediated persistence was examined in this study. Based on expression profiles, genes with similar expression changes formed 12 clusters using the self-organizing map algorithm. While other studies define genes based on their onset of transcription, here the important feature for clustering was the expression profile. This turned out to be more appropriate for comparing the time specific relevance of a certain cluster of genes to their proposed functions in the cycle. The Cpn clusters were grouped into the 'Early', 'Mid' and 'Late' classes as described for Ctr. Additionally, a new gene expression class containing genes with steadily increasing expression at the end of the developmental cycle was defined and termed 'Tardy' class. Comparison of the Cpn clusters to published proteomics data showed that genes encoding elementary body (EB) proteins peaked in the 'Late' gene cluster. This indicated that genes of the ‘Late’ and ‘Tardy’ class have different roles in RB to EB re-differentiation. Moreover, using lexical comparison the EB mRNA profile was significantly linked to the ‘Tardy’ cluster class. This provided evidence that initial translation in the cycle might be directed from stable transcripts present in the infectious EB form. Based on these criteria the novel ‘Tardy’ class was separated from the ‘Late’ class. The gene ontologies were used to identify specific pathways and physiological functions active during the different phases of development. Additionally, the transcriptome of Cpn in the persistent stage was compared to that of the acute developmental cycle. The Cpn transcriptome was altered in the iron-depletion mediated persistence. Genes upregulated were linked to clusters at the beginning of the developmental cycle, and genes down-regulated were linked to clusters at the end of the developmental cycle. These data provided strong evidence that the Cpn transcriptome during persistence is a gene expression arrest in mid-development. In early acute infection convergently or divergently oriented gene pairs preferentially had an antagonistic expression profile, whereas tandemly oriented gene pairs showed a correlated expression profile. This suggests that the Cpn genome is organized mainly in tandemly arranged operons and in convergently or divergently oriented genes with favored antagonistic profiles. The microarray studies done with the Cpn strain CWL029 also showed expression signals for several genes annotated only for the Cpn strains AR39 and J138. BLAST comparison verified that these genes are also coded in the CWL029 genome. Several of these genes were convergently arranged with their neighboring gene and shared overlapping genome information. Among these were parB, involved in DNA segregation and rpsD, an alternative sigma factor responsible for the transcription at late stages of the developmental cycle. Both genes have been described to have major roles in the chlamydial cycle. These genes had an antagonistic expression profile at the beginning of the acute developmental cycle and in persistence, as described before to be predominant for convergently oriented genes. Real time RT-PCR analysis showed that full-length rpsD mRNA transcripts were down-regulated, whereas short-length rpsD mRNA transcripts were up-regulated during the persistent infection. This demonstrated that the rpsD promoter is activated during the persistent infection and that because of the collision of the RNA polymerases full length transcripts were down-regulated. This sigma factor-independent mechanism is known as ‘Transcriptional Interference’. This is the first description on how the alternative sigma factor rpsD might be down-regulated during persistent infections. Finally, the host cell transcriptome was analyzed in the acute and persistent infection mediated by the depletion of iron. Cpn infection triggered the upregulation of relB, involved in an alternative NF-KB signaling pathway. Several genes coding for cell cycle proteins were triggered, including cyclin G2 and cyclin D1 and inhibitors of CDK4. Taken together, this work provides insights into the modulation of the pathogen and the host transcriptome during the acute infection and the iron mediated persistent infection.
The haemolysin (hly) determinant of the plasmid pHly152 contains an IS2 element at 469 bp upstream of the hlyC gene. The sequence at the other (right-hand) end (RS) also shows multiple hybridization with the plasmid pHly152 and the chromosome of some Escherichia coli strains but the nucleotide sequence of this region does not reveal the typical properties of an IS element. Similar arrangements in the regions flanking the hly determinant are also found on various Hly plasmids from uropathogenic E. coli strains. Chromosomal hly determinants Iack both flanking sequences (IS2 and RS) in the immediate vicinity of the hly genes. The sequences immediately upstream of the hlyC gene have been determined from several chromosomal hly determinants and compared with the corresponding sequence of the hly determinant of the plasmid pHly152. We show that these sequences, which contain one promoter (left promoter, phlyL) in all hly determinants tested, vary considerably although common sequence elements can still be identified. In contrast, only relatively few nucleotide exchanges have been detected in the adjacent structural hlyC genes. The A + T content of the 200 bp sequence upstream of hlyC is very high (72 mol% A + T) but even the structural hly genes show a considerably higher A + T content (about 60 mol%) than the E. coli chromosome on average (50 mol% A+T) suggesting that the hly determinant may not have originated in E. coli.
Recently we have described the molecular cloning of the genetic determinant coding for the S-fimbrial adhesin (Sfa), a sialic acid-recognizing pilus frequently found among extraintestinal Eschenchili coli isolates. Fimbriae from the resulting Sfa + E. coli K-12 clone were isolated, and an Sfa-specific antiserum was prepared. Western blots indicate that S fimbriae isolated from different uropathogenic and meningitis-associated E. coli strains, including 083:Kl isolates, were serologically related. The Sfa-specific antibodies did not cross-react with P fimbriae, but did cross-react with FlC fimbriae. Furthermore the sja+ recombinant DNAs and some cloned s/a-flanking regions were used as probes in Southem experiments. Chromosomal DNAs isolated from 018:Kl and 083:Kl meningitis strains with and without S fimbriae and from uropathogenic 06:K + strains were hybridized against these sfa-specific probes. Only one copy of the sfa determinant was identified on the chromosome of these strains. No sfa-specific sequences were observed on the chromosome of E. coli K-12 strains and an 07:Kl isolate. With the exception of small alterations in the sfa-coding region the genetic determinants for S fimbriae were identical in uropathogenic 06:K + and meningitis 018:Kl and 083:Kl strains. The sfa determinant was also detected on the chromosome of Kl isolates with an Sfa-negative phenotype, and specific cross-hybridization signals were visible after blotting against FlC-specific DNA. In addition homology among the different strains was observed in the sfa-flanking regions.
In the last years more than one hundred microbial genomes have been sequenced, many of them from pathogenic bacteria. The availability of this huge amount of sequence data enormously increases our knowledge on the genome structure and plasticity, as well as on the microbial diversity and evolution. In parallel, these data are the basis for the scientific “revolution” in the field of industrial and environmental biotechnology and medical microbiology – diagnostics and therapy, development of new drugs and vaccines against infectious agents. Together with the genomic approach, other molecular biological methods such as PCR, DNA-chip technology, subtractive hybridization, transcriptomics and proteomics are of increasing importance for research on infectious diseases and public health. The aim of this work was to characterize the genome structure and -content of the probiotic Escherichia coli strain Nissle 1917 (O6:K5:H31) and to compare these data with publicly available data on the genomes of different pathogenic and non-pathogenic E. coli strains and other closely related species. A cosmid genomic library of strain Nissle 1917 was screened for clones containing the genetic determinants contributing to the successful survival in and colonization of the human body, as well as to mediate this strain’s probiotic effect as part of the intestinal microflora. Four genomic islands (GEI I-IVNissle 1917) were identifed and characterized. They contain many known fitness determinants (mch/mcm, foc, iuc, kps, ybt), as well as novel genes of unknown function, mobile genetic elements or newly identified putative fitness-contributing factors (Sat, Iha, ShiA-homologue, Ag43-homologues). All islands were found to be integrated next to tRNA genes (serX, pheV, argW and asnT, respectively). Their structure and chromosomal localization closely resembles those of analogous islands in the genome of uropathogenic E. coli strain CFT073 (O6:K2(?):H1), but they lack important virulence genes of uropathogenic E. coli (hly, cnf, prf/pap). Evidence for instability of GEI IINissle 1917 was given, since a deletion event in which IS2 elements play a role was detected. This event results in loss of a 30 kb DNA region, containing important fitness determinants (iuc, sat, iha), and therefore probably might influence the colonization capacity of Nissle 1917 strain. In addition, a screening of the sequence context of tRNA-encoding genes in the genome of Nissle 1917 was performed to identify genome wide potential integration sites of “foreign” DNA. As a result, similar “tRNA screening patterns” have been observed for strain Nissle 1917 and for the uropathogenic E. coli O6 strains (UPEC) 536 and CFT073. I. Summary 4 The molecular reason for the semi-rough phenotype and serum sensitivity of strain Nissle 1917 was analyzed. The O6-antigen polymerase-encoding gene wzy was identified, and it was shown that the reason for the semi-rough phenotype is a frame shift mutation in wzy, due to the presence of a premature stop codon. It was shown that the restoration of the O side-chain LPS polymerization by complementation with a functional wzy gene increased serumresistance of strain Nissle 1917. The results of this study show that despite the genome similarity of the E. coli strain Nissle 1917 with the UPEC strain CFT073, the strain Nissle 1917 exhibits a specific set of geno- and phenotypic features which contribute to its probiotic action. By comparison with the available data on the genomics of different species of Enterobacteriaceae, this study contributes to our understanding of the important processes such as horizontal gene transfer, deletions and rearrangements which contribute to genome diversity and -plasticity, and which are driving forces for the evolution of bacterial variants. At last, the fim, bcs and rfaH determinats whose expression contributes to the mutlicellular behaviour and biofilm formation of E. coli strain Nissle 1917 have been characterized.
Analysis of the mechanism and the regulation of histatin 5 resistance in \(Candida\) \(albicans\)
(2018)
Antimycotics such as fluconazole are frequently used to treat C. albicans infections of the oral mucosa. Prolonged treatment of the fungal infection with fluconazole pose a risk to resistance development. C. albicans can adapt to these stressful environmental changes by regulation of gene expression or by producing genetically altered variants that arise in the population. Adapted variants frequently carry activating mutations in zinc cluster transcription factors, which cause the upregulation of their target genes, including genes encoding efflux pumps that confer drug resistance. MDR1, regulated by the zinc cluster transcription factor Mrr1, as well as CDR1 and CDR2, regulated by the zinc cluster transcription factor Tac1, are well-known examples of genes encoding efflux pumps that extrude the antimycotic fluconazole from the fungal cell and thus contribute to the survival of the fungus.
In this study, it was investigated if C. albicans can develop resistance to the antimicrobial peptide histatin 5, which serves as the first line of defence in the oral cavity of the human host. Recently, it was shown that C. albicans transports histatin 5 outside of the Candia cell via the efflux pump Flu1. As efflux pumps are often regulated by zinc cluster transcription factors, the Flu1 efflux pump could also be regulated by a zinc cluster transcription factor which could in a hyperactive form upregulate the expression of the efflux pump, resulting in increased export of histatin 5 and consequently in histatin 5 resistance.
In order to find a zinc cluster transcription factor that upregulates FLU1 expression, a comprehensive library of C. albicans strains containing artificially activated forms of zinc cluster transcription factors was screened for suitable candidates. The screening was conducted on medium containing mycophenolic acid because mycophenolic acid is also a substrate of Flu1 and a strain expressing a hyperactive zinc cluster transcription factor that upregulates FLU1 expression should exhibit an easily recognisable mycophenolic acid-resistant phenotype. Further, FACS analysis, quantitative real-time RT-PCR analysis, broth microdilution assays as well as histatin 5 assays were conducted to analyse the mechanism and the regulation of histatin 5 resistance.
Several zinc cluster transcription factors caused mycophenolic acid resistance and upregulated FLU1 expression. Of those, only hyperactive Mrr1 was able to confer increased histatin 5 resistance. Finding Mrr1 to confer histatin 5 resistance was highly interesting as fluconazole-resistant strains with naturally occurring Mrr1 gain of function mutations exist, which were isolated from HIV-infected patients with oral candidiasis. These Mrr1 gain of function mutations as well as artificially activated Mrr1 cause fluconazole resistance by upregulation of the efflux pump MDR1 and other target genes. In the course of the study, it was found that expression of different naturally occurring MRR1 gain-of-function mutations in the SC5314 wild type background caused increased FLU1 expression and increased histatin 5 resistance. The same was true for fluconazole-resistant clinical isolates with Mrr1 gain of function mutations, which also caused the overexpression of FLU1. Those cells were less efficiently killed by histatin 5 dependent on Mrr1. Surprisingly, FLU1 contributed only little to histatin 5 resistance, rather, overexpression of MDR1 mainly contributed to the Mrr1-mediated histatin 5 resistance, but also additional Mrr1-target genes were involved. These target genes are yet to be uncovered. Moreover, if a link between the yet unknown Mrr1-target genes contributing to fluconazole resistance and increased histatin 5 resistance can be drawn remains to be discovered upon finding of the responsible target genes.
Collectively, this study contributes to the understanding of the impact of prolonged antifungal exposure on the interaction between host and fungus. Drug therapy can give rise to resistance evolution resulting in strains that have not only developed resistance to fluconazole but also to an innate host mechanism, which allows adaption to the host niche even in the absence of the drug.
The uropathogenic Escherichia coli wiJd..:type strain 536 produces S-fimbriae, P-related fimbriae and type I fimbriae. Using immuno-colony dot and ELISA techniques, variants were detected showing an increased degree of S-fimbrial production. It was demonstrated by itrtmunofluorescence microscopy that in noimal (wild-type) and hyperS- fimbriated E. coli populaiions non-fimbriated cells also · exist, and that the percentage of Sfinibrlated and non-fimbriated bacteria was roughly identica1 in either population. Hyper-Sfimbriated variants could be stably maintained. The transition from wild-type to hyper-S-fimbriation, which occurs spontaneously, is markedly higher than vice versa. Southern blot analysis of the S fimbrial adhesin (sfa) determinants of normal and hyper-fimbriated strains revealed no marked difference in the gene structure.
Legionella pneumophila, the causative agent of Legionnaires' disease is a facultative intracellular bacterium, which in the course of human infection multiplies in lung macrophages predominantly manifesting as pneumonia. The natural habitat of Legionella is found in sweet water reservoirs and man-made water systems. Virulent L. pneumophila spontaneously convert to an avirulent status at a high frequency. Genetic approaches have led to the identification of various L. pneumophila genes. The mip (macrophage infectivity potentiator) determinant remains at present the sole established virulence factor. The Mip protein exhibits activity of a peptidyl prolyl cis trans isomerase (PPiase), an enzyme which is able to bind the immunosuppressant FK506 and is involved in protein folding. The recently cloned major outer membrane protein (MOMP) could play a role in the uptake of legionellae by macrophages. Cellular models are useful in studying the intracellular replication of legionellae in eukaryotic cells. Human celllines and protozoan models are appropriate for this purpose. By using U 937 macrophage-like cells and Acanthamoeba castellanii as hosts, we could discriminate virulent and avirulent L. pneumophila variants since only the virulent strain was capable of intracellular growth at 37 oc. By using these systems we further demonstrated that a hemolytic factor cloned and characterized in our laboratory, legiolysin (lly), had no influence on the intracellular growth of L. pneumophila.
To understand the gene regulation of an organism of interest, a comprehensive genome annotation is essential. While some features, such as coding sequences, can be computationally predicted with high accuracy based purely on the genomic sequence, others, such as promoter elements or noncoding RNAs, are harder to detect. RNA sequencing (RNA-seq) has proven to be an efficient method to identify these genomic features and to improve genome annotations. However, processing and integrating RNA-seq data in order to generate high-resolution annotations is challenging, time consuming, and requires numerous steps. We have constructed a powerful and modular tool called ANNOgesic that provides the required analyses and simplifies RNA-seq-based bacterial and archaeal genome annotation. It can integrate data from conventional RNA-seq and differential RNA-seq and predicts and annotates numerous features, including small noncoding RNAs, with high precision. The software is available under an open source license (ISCL) at https://pypi.org/project/ANNOgesic/.
In Staphylococcus aureus, de novo methionine biosynthesis is regulated by a unique hierarchical pathway involving stringent-response controlled CodY repression in combination with a T-box riboswitch and RNA decay. The T-box riboswitch residing in the 5′ untranslated region (met leader RNA) of the S. aureus metICFE-mdh operon controls downstream gene transcription upon interaction with uncharged methionyl-tRNA. met leader and metICFE-mdh (m)RNAs undergo RNase-mediated degradation in a process whose molecular details are poorly understood. Here we determined the secondary structure of the met leader RNA and found the element to harbor, beyond other conserved T-box riboswitch structural features, a terminator helix which is target for RNase III endoribonucleolytic cleavage. As the terminator is a thermodynamically highly stable structure, it also forms posttranscriptionally in met leader/ metICFE-mdh read-through transcripts. Cleavage by RNase III releases the met leader from metICFE-mdh mRNA and initiates RNase J-mediated degradation of the mRNA from the 5′-end. Of note, metICFE-mdh mRNA stability varies over the length of the transcript with a longer lifespan towards the 3′-end. The obtained data suggest that coordinated RNA decay represents another checkpoint in a complex regulatory network that adjusts costly methionine biosynthesis to current metabolic requirements.
Bornyl caffeate (1) was previously isolated by us from Valeriana (V.) wallichii rhizomes and identified as an anti-leishmanial substance. Here, we screened a small compound library of synthesized derivatives 1–30 for activity against schistosomula of Schistosoma (S.) mansoni. Compound 1 did not show any anti-schistosomal activity. However, strong phenotypic changes, including the formation of vacuoles, degeneration and death were observed after in vitro treatment with compounds 23 (thymyl cinnamate) and 27 (eugenyl cinnamate). Electron microscopy analysis of the induced vacuoles in the dying parasites suggests that 23 and 27 interfere with autophagy.
Bioassay-guided fractionation of a chloroform extract of Valeriana wallichii (V. wallichii) rhizomes lead to the isolation and identification of caffeic acid bornyl ester (1) as the active component against Leishmania major (L. major) promastigotes (IC50 = 48.8 µM). To investigate the structure-activity relationship (SAR), a library of compounds based on 1 was synthesized and tested in vitro against L. major and L. donovani promastigotes, and L. major amastigotes. Cytotoxicity was determined using a murine J774.1 cell line and bone marrow derived macrophages (BMDM). Some compounds showed antileishmanial activity in the concentration range of pentamidine and miltefosine which are the standard drugs in use. In the L. major amastigote assay compounds 15, 19 and 20 showed good activity with relatively low cytotoxicity against BMDM, resulting in acceptable selectivity indices. Molecules with adjacent phenolic hydroxyl groups exhibited elevated cytotoxicity against murine cell lines J774.1 and BMDM. The Michael system seems not to be essential for antileishmanial activity. Based on the results compound 27 can be regarded as new lead structure for further structure optimization
Coagulase-negative staphylococci (CoNS) are common opportunistic pathogens, but also ubiquitous human and animal commensals. Infection-associated CoNS from healthcare environments are typically characterized by pronounced antimicrobial resistance (AMR) including both methicillin- and multidrug-resistant isolates. Less is known about AMR patterns of CoNS colonizing the general population. Here we report on AMR in commensal CoNS recovered from 117 non-hospitalized volunteers in a region of Germany with a high livestock density. Among the 69 individuals colonized with CoNS, 29 had reported contacts to either companion or farm animals. CoNS were selectively cultivated from nasal swabs, followed by species definition by 16S rDNA sequencing and routine antibiotic susceptibility testing. Isolates displaying phenotypic AMR were further tested by PCR for presence of selected AMR genes. A total of 127 CoNS were isolated and Staphylococcus epidermidis (75%) was the most common CoNS species identified. Nine isolates (7%) were methicillin-resistant (MR) and carried the mecA gene, with seven individuals (10%) being colonized with at least one MR-CoNS isolate. While resistance against gentamicin, phenicols and spectinomycin was rare, high resistance rates were found against tetracycline (39%), erythromycin (33%) and fusidic acid (24%). In the majority of isolates, phenotypic resistance could be associated with corresponding AMR gene detection. Multidrug-resistance (MDR) was observed in 23% (29/127) of the isolates, with 33% (23/69) of the individuals being colonized with MDR-CoNS. The combined data suggest that MR- and MDR-CoNS are present in the community, with previous animal contact not significantly influencing the risk of becoming colonized with such isolates.
RNA-binding proteins (RBPs) have been established as core components of several post-transcriptional gene regulation mechanisms. Experimental techniques such as cross-linking and co-immunoprecipitation have enabled the identification of RBPs, RNA-binding domains (RBDs) and their regulatory roles in the eukaryotic species such as human and yeast in large-scale. In contrast, our knowledge of the number and potential diversity of RBPs in bacteria is poorer due to the technical challenges associated with the existing global screening approaches. We introduce APRICOT, a computational pipeline for the sequence-based identification and characterization of proteins using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences using position-specific scoring matrices and Hidden Markov Models of the functional domains and statistically scores them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them by several biological properties. Here we demonstrate the application and adaptability of the pipeline on large-scale protein sets, including the bacterial proteome of Escherichia coli. APRICOT showed better performance on various datasets compared to other existing tools for the sequence-based prediction of RBPs by achieving an average sensitivity and specificity of 0.90 and 0.91 respectively. The command-line tool and its documentation are available at https://pypi.python.org/pypi/bio-apricot.
Aspergillus is an important fungal genus containing economically important species, as well as pathogenic species of animals and plants. Using eighteen fungal species of the genus Aspergillus, we conducted a comprehensive investigation of conserved genes and their evolution. This also allows us to investigate the selection pressure driving the adaptive evolution in the pathogenic species A. fumigatus. Among single-copy orthologs (SCOs) for A. fumigatus and the closely related species A. fischeri, we identified 122 versus 50 positively selected genes (PSGs), respectively. Moreover, twenty conserved genes of unknown function were established to be positively selected and thus important for adaption. A. fumigatus PSGs interacting with human host proteins show over-representation of adaptive, symbiosis-related, immunomodulatory and virulence-related pathways, such as the TGF-β pathway, insulin receptor signaling, IL1 pathway and interfering with phagosomal GTPase signaling. Additionally, among the virulence factor coding genes, secretory and membrane protein-coding genes in multi-copy gene families, 212 genes underwent positive selection and also suggest increased adaptation, such as fungal immune evasion mechanisms (aspf2), siderophore biosynthesis (sidD), fumarylalanine production (sidE), stress tolerance (atfA) and thermotolerance (sodA). These genes presumably contribute to host adaptation strategies. Genes for the biosynthesis of gliotoxin are shared among all the close relatives of A. fumigatus as an ancient defense mechanism. Positive selection plays a crucial role in the adaptive evolution of A. fumigatus. The genome-wide profile of PSGs provides valuable targets for further research on the mechanisms of immune evasion, antimycotic targeting and understanding fundamental virulence processes.
Non-coding RNAs constitute a major class of regulators involved in bacterial gene expression. A group of riboregulators of heterogeneous size and shape referred to as small regulatory RNAs (sRNAs) control trans- or cis-encoded genes through direct base-pairing with their mRNAs. Although mostly inhibiting their target mRNAs, several sRNAs also induce gene expression. An important co-factor for sRNA activity is the RNA chaperone, Hfq, which is able to rearrange intramolecular secondary structures and to promote annealing of complementary RNA sequences. In addition, Hfq protects unpaired RNA from degradation by ribonucleases and thus increases sRNA stability. Co-immunoprecipitation of RNA with the Hfq protein, and further experimental as well as bioinformatical studies performed over the last decade suggested the presence of more than 150 different sRNAs in various Enterobacteria including Escherichia coli and Salmonellae. So-called core sRNAs are considered to fulfill central cellular activities as deduced from their high degree of conservation among different species. Approximately 25 core sRNAs have been implicated in gene regulation under a variety of environmental responses. However, for the majority of sRNAs, both the riboregulators’ individual biological roles as well as modes of action remain to be elucidated. The current study aimed to define the cellular functions of the two highly conserved, Hfq-dependent sRNAs, SdsR and RydC, in the model pathogen Salmonella Typhimurium. SdsR had been known as one of the most abundant sRNAs during stationary growth phase in E. coli. Examination of the conservation patterns in the sdsR promoter region in combination with classic genetic analyses revealed SdsR as the first sRNA under direct transcriptional control of the alternative σ factor σS. In Salmonella, over-expression of SdsR down-regulates the synthesis of the major porin OmpD, and the interaction site in the ompD mRNA coding sequence was mapped by a 3'RACE-based approach. At the post-transcriptional level, expression of ompD is controlled by three additional sRNAs, but SdsR plays a specific role in porin regulation during the stringent response. Similarly, RydC, the second sRNA adressed in this study, was initially discovered in E. coli but appeared to be conserved in many related γ-proteobacteria. An interesting aspect of this Hfq-dependent sRNAs is its secondary structure involving a pseudo-knot configuration, while the 5’ end remains single stranded. A transcriptomic approach combining RydC pulse-expression and scoring of global mRNA changes on microarrays was employed to identify the targets of this sRNA. RydC specifically activated expression of the longer of two versions of the cfa mRNA encoding for the phospholipid-modifying enzyme cyclopropane fatty acid synthase. Employing its conserved single-stranded 5' end, RydC acts as a positive regulator and masks a recognition site of the endoribonuclease, RNase E, in the cfa leader.
Staphylococcus aureus is one of the most frequent causes of nosocomial and community‐acquired infections, with drug‐resistant strains being responsible for tens of thousands of deaths per year. S. aureus sortase A inhibitors are designed to interfere with virulence determinants. We have identified disulfanylbenzamides as a new class of potent inhibitors against sortase A that act by covalent modification of the active‐site cysteine. A broad series of derivatives were synthesized to derive structure‐activity relationships (SAR). In vitro and in silico methods allowed the experimentally observed binding affinities and selectivities to be rationalized. The most active compounds were found to have single‐digit micromolar Ki values and caused up to a 66 % reduction of S. aureus fibrinogen attachment at an effective inhibitor concentration of 10 μM. This new molecule class exhibited minimal cytotoxicity, low bacterial growth inhibition and impaired sortase‐mediated adherence of S. aureus cells.
Background
Autophagy participates in innate immunity by eliminating intracellular pathogens. Consequently, numerous microorganisms have developed strategies to impair the autophagic machinery in phagocytes. In the current study, interactions between Leishmania major (L. m.) and the autophagic machinery of bone marrow-derived macrophages (BMDM) were analyzed.
Methods
BMDM were generated from BALB/c mice, and the cells were infected with L. m. promastigotes. Transmission electron microscopy (TEM) and electron tomography were used to investigate the ultrastructure of BMDM and the intracellular parasites. Affymetrix® chip analyses were conducted to identify autophagy-related messenger RNAs (mRNAs) and microRNAs (miRNAs). The protein expression levels of autophagy related 5 (ATG5), BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3), cathepsin E (CTSE), mechanistic target of rapamycin (MTOR), microtubule-associated proteins 1A/1B light chain 3B (LC3B), and ubiquitin (UB) were investigated through western blot analyses. BMDM were transfected with specific small interfering RNAs (siRNAs) against autophagy-related genes and with mimics or inhibitors of autophagy-associated miRNAs. The infection rates of BMDM were determined by light microscopy after a parasite-specific staining.
Results
The experiments demonstrated autophagy induction in BMDM after in vitro infection with L. m.. The results suggested a putative MTOR phosphorylation-dependent counteracting mechanism in the early infection phase and indicated that intracellular amastigotes were cleared by autophagy in BMDM in the late infection phase. Transcriptomic analyses and specific downregulation of protein expression with siRNAs suggested there is an association between the infection-specific over expression of BNIP3, as well as CTSE, and the autophagic activity of BMDM. Transfection with mimics of mmu-miR-101c and mmu-miR-129-5p, as well as with an inhibitor of mmu-miR-210-5p, demonstrated direct effects of the respective miRNAs on parasite clearance in L. m.-infected BMDM. Furthermore, Affymetrix® chip analyses revealed a complex autophagy-related RNA network consisting of differentially expressed mRNAs and miRNAs in BMDM, which indicates high glycolytic and inflammatory activity in the host macrophages.
Conclusions
Autophagy in L. m.-infected host macrophages is a highly regulated cellular process at both the RNA level and the protein level. Autophagy has the potential to clear parasites from the host. The results obtained from experiments with murine host macrophages could be translated in the future to develop innovative and therapeutic antileishmanial strategies for human patients.
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris
(2023)
Increasing resistance against antimycotic drugs challenges anti‐infective therapies today and contributes to the mortality of infections by drug‐resistant Candida species and strains. Therefore, novel antifungal agents are needed. A promising approach in developing new drugs is using naturally occurring molecules as lead structures. In this work, 4,4'‐dihydroxyazobenzene, a compound structurally related to antifungal stilbene derivatives and present in Agaricus xanthodermus (yellow stainer), served as a starting point for the synthesis of five azobenzene derivatives. These compounds prevented the growth of both fluconazole‐susceptible and fluconazole‐resistant Candida albicans and Candida auris strains. Further in vivo studies are required to confirm the potential therapeutic value of these compounds.
Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo
(2013)
Background: The human colon harbours a plethora of bacteria known to broadly impact on mucosal metabolism and function and thought to be involved in inflammatory bowel disease pathogenesis and colon cancer development. In this report, we investigated the effect of colonic bacteria on epithelial cell differentiation factors in vitro and in vivo. As key transcription factors we focused on Hes1, known to direct towards an absorptive cell fate, Hath1 and KLF4, which govern goblet cell.
Methods: Expression of the transcription factors Hes1, Hath1 and KLF4, the mucins Muc1 and Muc2 and the defensin HBD2 were measured by real-time PCR in LS174T cells following incubation with several heat-inactivated E. coli strains, including the probiotic E. coli Nissle 1917+/- flagellin, Lactobacilli and Bifidobacteria. For protein detection Western blot experiments and chamber-slide immunostaining were performed. Finally, mRNA and protein expression of these factors was evaluated in the colon of germfree vs. specific pathogen free vs. conventionalized mice and colonic goblet cells were counted.
Results: Expression of Hes1 and Hath1, and to a minor degree also of KLF4, was reduced by E. coli K-12 and E. coli Nissle 1917. In contrast, Muc1 and HBD2 expression were significantly enhanced, independent of the Notch signalling pathway. Probiotic E. coli Nissle 1917 regulated Hes1, Hath1, Muc1 and HBD2 through flagellin. In vivo experiments confirmed the observed in vitro effects of bacteria by a diminished colonic expression of Hath1 and KLF4 in specific pathogen free and conventionalized mice as compared to germ free mice whereas the number of goblet cells was unchanged in these mice.
Conclusions: Intestinal bacteria influence the intestinal epithelial differentiation factors Hes1, Hath1 and KLF4, as well as Muc1 and HBD2, in vitro and in vivo. The induction of Muc1 and HBD2 seems to be triggered directly by bacteria and not by Notch.
We investigated the role of bacterial adherence and hemolysin production from Escherichia coli parent and genetically cloned strains as to their eft'ects on bistaJidne release from rat mast cells and leukotriene generation from human polymorphonuclear granulocytes. These mediators were involved in the induction of inftammatory disease processes and led, for example, to enhancement of vascular permeability, chemotaxis (leukotriene 84 [LTB4]), chemoaggregation, lysosomal enzyme release, and smooth muscle contraction, (LTC4, LTD4 , and LTE4). Washed bacteria (E. coli K-12 Ms+ my=; E. coli 536 Ms+ MR= my=) as weil as their culture supematants were analyzed. Washed E. coli K-12 (Hiy+), unlike Hly- strains, induced high amounts of histamine release from rat mast cells and chemotactic activity from human polymorphonuclear granulocytes. Significant leukotriene releasewas obtained with washed E. coli K-12 my+ strains and their bacterial culture supematants. Leukotriene induction was dependent on the amount of hemolysin activity present in the supematant. However, additional soluble factors should also be considered. The presence of hemolysin appeared to aceeierate and enhance the rate of phagocytosis of bacteria by neutrophUs. When E. coli 536 (MS+ MR= Hly=) strains were analyzed, the simultaneous presence of MR+ pili and hemolysin production led to an increase in histamine release as compared with MR- my+ strains. The genetically cloned MR+ my+ E. coli 536 strain induced higher amounts of IeukotrieDes as compared with the wUd-type strain. Our data soggest a potent role for adhesins and hemolysin as virulence factors in inducing the release of inftammatory mediators.
Asymptomatische Bakteriurie (ABU) stellt eine bakterielle Infektion der Harnblase über einen langen Zeitraum dar, die häufig von Escherichia coli hervorgerufen wird, ohne dass typische Symptome einer Harnwegsinfektion auftreten. Um die Charakteristika von ABU E. coli Isolaten genauer zu untersuchen, wurden die Geno- und Phänotypen von 11 ABU-Isolaten verglichen. Außerdem wurden in mehreren aufeinanderfolgenden in vivo-Reisolaten des Modell-ABU Stammes 83972 die Veränderungen im Transkriptom, Proteom und Genom während einer langfristigen Persistenz in der menschlichen Blase charakterisiert. Schließlich wurde der Effekt des menschlichen Wirtes auf die bakterielle Adaptation durch einen Vergleich von in vitro- mit in vivo-kultivierten Stämmen abgeschätzt. ABU-Isolate stellt eine heterogene Gruppe von Organismen dar. Diese können den vier phylogenetischen Hauptgruppen von E. coli sowie unterschiedlichen klonalen Gruppen zugeordnet werden. Dementsprechend unterscheiden sie sich erheblich bezüglich der Zusammensetzung des Genomes, der Genomgröße und auch der Ausstattung mit UPEC-typischen Virulenz-assoziierten Genen. Multi-Lokus-Sequenz-Typisierung legt nahe, dass bestimmte ABU Stämme sich durch Genomreduktion aus UPEC Stämmen entwickelt haben, die eine Harnwegsinfektion mit charakteristischen Symptomen auslösen konnten. Folglich erlaubt die hohe Genomplastizität von E. coli keine generalisierte Betrachtung einzelner Isolate eines Klons. Genomreduktion über Punktmutationen, Genom-Reorganisation und Deletionen resultierte in der Inaktivierung einiger Gene, die für einige UPEC Virulenz-Faktoren kodieren. Dies stützt die Vorstellung, dass eine verminderte bakterielle Aktivierung der Entzündung der Wirtsschleimhaut den Lebensstil von ABU (bei diesen E. coli-)Isolaten fördert. Genregulation und genetische Diversität sind Strategien, die es Bakterien ermöglichen unter sich fortlaufend ändernden Bedingungen zu leben bzw. zu überleben. Um die anpassungsbedingten Veränderungen bei einem langfristigen Wachstum in der Blase zu untersuchen, wurden aufeinanderfolgende Reisolate, denen eine langfristige in vivo-Kolonisierung im menschlichen Wirt beziehungsweise eine in vitro-Kultivierung vorausgegangen ist, im Hinblick auf Veränderungen Genexpression und Genomorganisation analysiert. In diesem Zusammenhang konnte gezeigt werden, dass E. coli in der Lage ist, seine metabolischen Netzwerke verschiedenen Wachstumsbedingungen anzupassen und individuelle bakterielle Kolonisierungsstrategien entwickeln kann. Transkriptom- und Proteom-Analysen zeigten verschiedene metabolische Strategien zur Nährstoffbeschaffung und Energieproduktion bei untersuchten in vivo-Reisolaten vom Stamm 83972, die es ihnen ermöglichen, den Wirt zu kolonisieren. Das Zurückgreifen auf D-Serin, Deoxy- und Ribonucleoside sowie die bidirektionale Umwandlung zwischen Pentose und Glucuronat waren hoch-regulierte Stoffwechselwege, die die in vivo-Reisolate mit zusätzlicher Energie für ein effizientes Wachstum in der Blase versorgen. Zudem wurden in dieser Studie die Netzwerke für eine Reaktion auf Abwehrmechanismen des Wirtes erforscht: Erstmals wurde hier die Rolle der Klasse-III-Alkoholdehydrogenase AdhC, bekannt durch ihre Bedeutung bei der Entgiftung von Stickstoffmonoxid, bei der Wirtsantwort während einer asymptomatischen Bakteriurie gezeigt. Aufeinanderfolgende in vivo- und in vitro-Reisolate vom Stamm 83972 wurden ebenfalls bezüglich ihrer Genomstruktur analysiert. Einige Veränderungen in der Genomstruktur der aufeinanderfolgenden Reisolate, die von einer humanen Kolonisierungsstudie stammen, implizieren die Bedeutung einer Interaktion der Bakterien mit dem Wirt bei der Mikroevolution der Bakterien. Dagegen war die Genomstruktur von Reisolaten eines langfristigen in vitro-Kultivierungsexperiments, bei dem sich der Stamm 83972 ohne Wirtskontakt vermehrt hat, nicht von Veränderungen betroffen. Das legt nahe, dass die Immunantwort eine Genomplastizität fördert und somit eine treibende Kraft für den ABU Lebensstil und die Evolution im Harnwegstrakt ist.
Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies
(2011)
Background: Oncolytic viral tumor therapy is an emerging field in the fight against cancer with rising numbers of clinical trials and the first clinically approved product (Adenovirus for the treatment of Head and Neck Cancer in China) in this field. Yet, until recently no general (bio)marker or reporter gene was described that could be used to evaluate successful tumor colonization and/or transgene expression in other biological therapies. Methods: Here, a bacterial glucuronidase (GusA) encoded by biological therapeutics (e.g. oncolytic viruses) was used as reporter system. Results: Using fluorogenic probes that were specifically activated by glucuronidase we could show 1) preferential activation in tumors, 2) rena l excretion of the activated fluorescent compounds and 3) reproducible detection of GusA in the serum of oncolytic vaccinia virus treated, tumor bearing mice in several tumor models. Time course studies revealed that reliable differentiation between tumor bearing and healthy mice can be done as early as 9 days post injection of the virus. Regarding the sensitivity of the newly developed assay system, we could show that a single infected tumor cell could be reliably detected in this assay. Conclusion: GusA therefore has the potential to be used as a general marker in the preclinical and clinical evaluation of (novel) biological therapies as well as being useful for the detection of rare cells such as circulating tumor cells
Ziel dieser Arbeit war es, eine Reihe von 17 ausgewählten Kohlehydraten auf deren Fähigkeit zu bewerten, die Adhärenz humanpathogener Enteritis-/Diärrhoe-Erreger zu reduzieren oder gänzlich zu verhindern. Gestestet wurde die Adhärenz an Kryoschnitten humaner Darmbiopsien. Hierbei wurde die bakterielle Adhäsion ohne Zusatz der Kohlehydrate bestimmt und als Vergleichswert gegenüber dem Ansatz mit Zusatz der Kohlehydrate herangezogen. Dabei kamen Stämme folgender Spezies zum Einsatz: entero-aggregative E. coli, entero-hämorrhagische E. coli, entero-pathogene E. coli, entero-toxigene E. coli, Salmonella enterica Serovar Typhimurium und Shigella flexneri. Als Positiv-Kontrolle wurde Citrobacter freundii verwendet.
Bakterielle Aufnahme, Selektivität und interne Prozessierung bei marinen Schwämmen (Porifera)
(2006)
Marine Schwämme (Porifera) gelten als die evolutionär ältesten Metazoen. Sie sind in allen Meeren verbreitet und tragen einen großen Anteil zur Invertebraten-Fauna bei. Ihrer Lebens-weise als Filtrierer entsprechend pumpen Schwämme bis zu 23.000 l Seewasser Kg-1 Schwamm Tag-1. Das enthaltene Bakterioplankton wird mit hoher Effizienz ausgefiltert und dient als Nahrung. Gleichzeitig enthalten einige Schwammspezies eine sehr hohe Anzahl phylogenetisch diverser Bakterien extrazellulär in der Mesohylmatrix, die bis zu 40% der Gesamtbiomasse ausmachen. Die als Symbionten bezeichnete Bakteriengemeinschaft weist eine hochgradig spezifische phylogenetische Zusammensetzung auf, die bei unterschiedlichen Schwammspezies, jedoch nicht im Seewasser oder Sediment, gefunden wird. Im Rahmen dieser Dissertationsarbeit wurden unterschiedliche Muster der Bakterien-haltigkeit mariner Schwämme durch Elektronenmikroskopie beschrieben. Die Gruppe der bakterienhaltigen Schwämme wies eine hohe Anzahl von Mikroben im Mesohyl auf. Aufgrund der bakteriellen Verteilung wurde zwischen stark und intermediär bakterienhaltigen Spezies unterschieden. Stark bakterienhaltige Schwämme zeigten eine gleichmäßig dichte Verteilung der Mikroben im Mesohyl, die Bakterienkonzentrationen lagen bei 109 - 1010 Zel-len g-1 Schwamm. Intermediär bakterienhaltige Schwämme enthielten lokale Anhäufungen von Mikroben, die in allen Stellen des Tieres gefunden wurden. Die Zellzahlen lagen bei 108 – 109 Bakterien g-1 Schwamm. Die Gruppe der bakterienarmen Schwämme wurde durch ein mikroskopisch bakterienfreies Mesohyl charakterisiert, die Bakterienkonzentrationen betrugen ~106 Zellen g-1 Schwamm und waren damit vergleichbar zu natürlichem Seewasser. In Korrelation zum Bakteriengehalt wurden anatomische Unterschiede des Gewebes beider Schwammgruppen beobachtet. Die bakterielle Aufnahme von Schwämmen wurde an einzelnen Individuen in Filtra-tionsexperimenten untersucht. Es wurde die Aufnahme des „Futterbakteriums“ Vibrio sp. SB177 und des schwammspezifischen Symbiontenkonsortiums gemessen. Die bakterien-haltigen Schwämme Aplysina aerophoba und Chondrosia reniformis wiesen im Vergleich zu „Futterbakterien“ eine sehr stark verminderte Aufnahme gegenüber ihren eigenen Symbionten auf, bei A. aerophoba sank die Filtrationsrate von rn = 2,76 x 106 auf 5,47 x 104 Bakterien g-1 Schwamm h-1. Die bakterienarmen Schwämme Dysidea avara und Tethya aurantium zeigten eine effiziente und undifferenzierte Aufnahme gegenüber allen Mikroben. Das nur bei bak-terienhaltigen Schwämmen gefundene Muster der stark verminderten Aufnahme von Symbi-onten ist statistisch signifikant. Untersuchungen zum Einfluss abdaubarer bakterieller Zell-wandproteine und der bakteriellen Flagelle erbrachten keine Hinweise auf eine Beteiligung dieser Faktoren am bakteriellen Filtrationsprozess der Schwämme. Zur Untersuchung einer möglichen Filtrationsselektivität gegenüber bestimmten bak-teriellen Vertretern des Seewasser- und des Symbiontenkonsortiums wurden Filtrationsexperi-mente durchgeführt. Proben des Inkubationswassers wurde während des Experiments entnom-men und die phylogenetische Zusammensetzung der Konsortien mittels Denaturierender Gradienten Gel Elektrophorese (DGGE) untersucht. Die Banden wurden anhand der Stärke über den zeitlichen Verlauf klassifiziert. Von den anfänglich 40 nachweisbaren Banden des Seewasserkonsortiums wurden nach 300 Minuten experimenteller Dauer eine als konstant, 18 als reduziert und 21 als verschwindend eingeordnet. Für das Symbiontenkonsortium wurden von den initial 65 Banden nach 300 Minuten 30 Banden als konstant, 19 als reduziert und 16 als verschwindend klassifiziert. Während für das Seewasserkonsortium eine Aufnahme fast aller bakterieller Phylotypen überwog, unterlagen nur wenige Phylotypen des Symbionten-konsortiums einer starken Aufnahme. Durch Sequenzierung und phylogenetische Zuordnung repräsentativer Banden wurde gezeigt, dass für die bakterielle Aufnahme keine Selektivität gegenüber einer bestimmten phylogenetischen Abstammungslinie besteht. So wurden z. B. Phylotypen der Chloroflexi als konstant, reduziert, als auch verschwindend beurteilt. Die interne Prozessierung und der Transport aufgenommener Partikel und Bakterien im Mesohyl wurde mikroskopisch untersucht. A. aerophoba transportierte große Aggregate aufgenommener Latex Beads in speziellen Schwammzellgruppen durch das Mesohyl. Es konnte keine Abgabe der Beads in die extrazelluläre Matrix (ECM) beobachtet werden. D. avara transportierte einzelne Beads durch das Mesohyl, nach 300 Minuten wurden zahlreiche Beads in der ECM gefunden. Die bakterielle Aufnahme wurde an dem GFP-exprimierenden „Futterbakterium“ Vibrio sp. MMW1 visualisiert. Die Bakterien wurden mit hoher Effizienz von A. aerophoba aufgenommen, konnten jedoch nicht in tieferen Mesohylbereichen nach-gewiesen werden, was auf eine zügige Lyse der Zellen hindeutete. Fluoreszenzmarkierte Symbiontenzellen wurden nicht von A. aerophoba aber, in Übereinstimung mit den Filtrationsexperimenten, von dem bakterienarmen D. avara aufgenommen. Die Ergebnisse belegen, dass bakerienhaltige Schwämme über einen komplexen Mechanismus der bakteriellen Aufnahme verfügen, durch den zwischen Futterbakterien und Symbionten unterschieden wird. Schwämme stellen deshalb ein interessantes Modellsystem zur Untersuchung von Mechanismen der generellen Phagozytose und der gleichzeitigen Tolerierung von symbiontischen Bakterienzellen im Gewebe dar.
Investigations were carried out on the adhesion of cloned S-fimbriated E. coli, labelled with fluoresceinisothiocyanate (FITC) to human buccal epithelial cells. Fluorescence microscopic analysis revealed binding of bacteria to 75-95% of epithelial cells. Inhibition experiments with fetuin, a 1-acid glycoprotein and N-acetyl neuraminic acid confirmed the specificity of bacterial binding to sialoglycoproteins. Further studies using saliva as an inhibitor resulted in a 4-5 times stronger binding inhibition by newborn saliva in comparison to adult saliva coinciding with a 4-5 times higher content of total N-acetyl neuraminic acid in samples of newborn saliva. In Western blot analysis sialoglycoprotein bands with a molecular weight >200 kD reacting with wheat germ agglutinin (WGA), were only identified in samples of newborn saliva. These bands are classified as mucins on account of molecular weight and staining. These data suggest that saliva mucins could represent a major defense mechanism against bacterial infections at a stage of ontogeny where the secretory IgAsystem is not yet developed.
Purified S fimbriae and an Escherichia coli strain carrying the recombinant plasmid pANN801-4 that encodes S fimbriae were tested for adhesion to frozen sections of human kidney. The fimbrlae and the bacteria bound to the same tissue domains, and in both cases the binding was specifically inhibited by the receptor analog of S fimbria, sialyl(a2-3)1actose. S fimbriae bound specifically to the epithelial elements in the kidneys; to the epithelial cells of proximal and distal tubules as weil as of the collecting ducts and to the visceral and parietal glomerular epithelium. In addition, they bound to the vascular endothelium of glomerull and of the renal Interstitium. No blnding to connective tissue elements was observed. The results suggest that the biological functlon of S fimbriae is to mediate the adheslon of E. coli to human epithelial and vascular endothellal ceUs.
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neontal meningitis
(1988)
Escherichia coli strains that cause sepsis and meningitis in neonatal infants carry S fimbriae that bind to sialyl galactoside units of cell surface glycoproteins. To investigate the possible role of S fimbriae in determining the tissue tropism of neonatal menlngitis, we have studied the preselice of binding sites for S fimbriae in different tissues of the neonatal rat which is susceptible to meningitis caused by S-fimbriated E. coli. Purified S fimbriae were incubated on cryostat sections of different rat oipns and their bindina was assessed by indirect immunofluorescence. In the bnin of the neonatal rat, S fimbriae specifically bound to the luminal surfaces of the vascular endothelium and of the epithelium lining the choroid plexuses and bnin ventricles. The · bindlog W.s completely inhibited by the trisaccharide NeuAca2-3Ga)ßl-4Gic, a receptor analogue of S fimbriae, and by a preceding neuraminidase treatment of the sections. A recombinant E. coli strain expressina S fimbriae adhered in large numbers to the same tissue sites in the neonatal brain sections as did the purified fimbriae, · whereas the nonfimbriated host strahi and a recombiiuuit strain expresslog P fi.mbriae did not adhere to brain tissues. The results soggest that adhesion of S-fimbriated bacteria to the binding sites observed in the neonatai bnin has a pathogenetic roJe durlog bacterial Invasion from cii'culation into the cerebrospinal fluid.
RNA-binding proteins (RBPs) have been extensively studied in eukaryotes, where they post-transcriptionally regulate many cellular events including RNA transport, translation, and stability. Experimental techniques, such as cross-linking and co-purification followed by either mass spectrometry or RNA sequencing has enabled the identification and characterization of RBPs, their conserved RNA-binding domains (RBDs), and the regulatory roles of these proteins on a genome-wide scale. These developments in quantitative, high-resolution, and high-throughput screening techniques have greatly expanded our understanding of RBPs in human and yeast cells. In contrast, our knowledge of number and potential diversity of RBPs in bacteria is comparatively poor, in part due to the technical challenges associated with existing global screening approaches developed in eukaryotes.
Genome- and proteome-wide screening approaches performed in silico may circumvent these technical issues to obtain a broad picture of the RNA interactome of bacteria and identify strong RBP candidates for more detailed experimental study. Here, I report APRICOT (“Analyzing Protein RNA Interaction by Combined Output Technique”), a computational pipeline for the sequence-based identification and characterization of candidate RNA-binding proteins encoded in the genomes of all domains of life using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences of an input proteome using position-specific scoring matrices and hidden Markov models of all conserved domains available in the databases and then statistically score them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them according to functionally relevant structural properties. APRICOT performed better than other existing tools for the sequence-based prediction on the known RBP data sets. The applications and adaptability of the software was demonstrated on several large bacterial RBP data sets including the complete proteome of Salmonella Typhimurium strain SL1344. APRICOT reported 1068 Salmonella proteins as RBP candidates, which were subsequently categorized using the RBDs that have been reported in both eukaryotic and bacterial proteins. A set of 131 strong RBP candidates was selected for experimental confirmation and characterization of RNA-binding activity using RNA co-immunoprecipitation followed by high-throughput sequencing (RIP-Seq) experiments. Based on the relative abundance of transcripts across the RIP-Seq libraries, a catalogue of enriched genes was established for each candidate, which shows the RNA-binding potential of 90% of these proteins. Furthermore, the direct targets of few of these putative RBPs were validated by means of cross-linking and co-immunoprecipitation (CLIP) experiments.
This thesis presents the computational pipeline APRICOT for the global screening of protein primary sequences for potential RBPs in bacteria using RBD information from all kingdoms of life. Furthermore, it provides the first bio-computational resource of putative RBPs in Salmonella, which could now be further studied for their biological and regulatory roles. The command line tool and its documentation are available at https://malvikasharan.github.io/APRICOT/.
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are exploited by human-specific pathogens to anchor themselves to or invade host cells. Interestingly, human granulocytes express a specific isoform, CEACAM3, that can direct efficient, opsonin-independent phagocytosis of CEACAM-binding Neisseria, Moraxella and Haemophilus species. As opsonin-independent phagocytosis of CEACAM-binding Neisseria depends on Src-family protein tyrosine kinase (PTK) phosphorylation of the CEACAM3 cytoplasmic domain, we hypothesized that an SH2-containing protein might be involved in CEACAM3-initiated, phagocytosis-promoting signals. Accordingly, we screened glutathione-S-transferase (GST) fusion proteins containing SH2 domains derived from a panel of signaling and adapter molecules for their ability to associate with CEACAM3. In vitro pull-down assays demonstrated that the SH2 domain of the adapter molecule Nck (GST-Nck SH2), but not other SH2 domains such as the Grb2 SH2 domain, interact with CEACAM3 in a phosphotyrosine-dependent manner. Either deletion of the cytoplasmic tail of CEACAM3, or point-mutation of a critical arginine residue in the SH2 domain of Nck (GST-NckSH2R308K) that disrupts phosphotyrosine binding, both abolished CEACAM3-Nck-SH2 interaction. Upon infection of human cells with CEACAM-binding Neisseria, full-length Nck comprising an SH2 and three SH3 domains co-localized with tyrosine phosphorylated CEACAM3 and associated bacteria as analyzed by immunofluorescence staining and confocal microscopy. In addition, Nck could be detected in CEACAM3 immunoprecipitates confirming the interaction in vivo. Importantly, overexpression of a GFP-fusion protein of the isolated Nck SH2 domain (GFP-Nck-SH2), but not GFP or GFP-Nck SH2 R308K reduced CEACAM3-mediated phagocytosis of CEACAM-binding Neisseria suggesting that the adaptor molecule Nck plays an important role in CEACAM3-initiated signaling leading to internalization and elimination of human-specific pathogens.
Eine Infektion durch das ausschließlich human-spezifische Pathogen Neisseria gonorrhoeae manifestiert sich bei einer symptomatischen Kolonisierung in der sog. Gonorrhö, einer venerischen Erkrankung, die durch akute Inflammation des befallenen Gewebes und durch die massive Infiltration von Granulozyten charakterisiert ist. Die Gonokokken können im Verlauf einer symptomatischen Infektion über ihre OpaCEA-Adhäsine mit CEACAM Proteinen unterschiedlicher Wirtszellen interagieren. In der vorliegenden Doktorarbeit sollten anhand verschiedener zellbiologischer, biochemischer und genetischer Methoden die molekularen Vorgänge während der OpaCEA-Gonokokken-Phagozyten-Interaktion untersucht werden. Der Kontakt von OpaCEA-Gonokokken mit primären Granulozyten induziert die Formation von Lamellipodien-ähnlichen Membranausstülpungen und führt zur CEACAM-abhängigen Phagozytose der OpaCEA Gonokokken. Schon in früheren in vitro Versuchen konnte die Reorganisation des Zytoskeletts und die Opsonin-unabhängige, CEACAM-vermittelte Aufnahme OpaCEA-exprimierender Gonokokken in differenzierte promyelomonzytären Zellen und Granulozyten mit der Stimulation von Kinasen der Src-Familie und der GTPase Rac in Verbindung gebracht werden. Erste in vitro Infektionsversuche mit CEACAM-exprimierenden 293 Zellen, in denen pharmakologische oder genetische Inhibitoren gegen Kinasen der Src-Familie eingesetzt wurden, deuteten darauf hin, dass ausschließlich die CEACAM3-vermittelte Internalisierung der Gonokokken die katalytische Aktivität von Kinasen der Src-Familie benötigt. Dies konnte auch in CEACAM3-exprimierenden, Src-Kinase defizienten Maus-Fibroblasten bestätigt werden, da nur c-Src rekonstituierte Zellen OpaCEA Gonokokken internalisieren. Die Adhäsion der OpaCEA Gonokokken an CEACAM3 induziert eine Src-abhängige Tyrosinphosphorylierung der zytoplasmatischen CEACAM3-Domäne und die Kinase selbst kann über ihre SH2-Domäne direkt an das phosphorylierte CEACAM3 binden. Auch die Stimulation der GTPase Rac verläuft über das CEACAM3 Protein, da die Expression einer dominant negativen Version der Rho GTPase ausschließlich mit der CEACAM3-, aber nicht mit der CEACAM6-abhängigen Internalisierung der OpaCEA Gonokokken interferiert. Zudem induziert nur die CEACAM3-vermittelte Aufnahme die Rekrutierung und GTP-Beladung des endogenen Rac. Eine zentrale Rolle dabei spielt die Integrität der ITAM-ähnlichen Sequenz von CEACAM3. Die Mutation beider Tyrosinreste innerhalb der ITAM-ähnlichen Sequenz oder die komplette Deletion der zytoplasmatischen Domäne inhibieren die CEACAM3-vermittelte Rac-Stimulation und blockieren die Internalisierung der OpaCEA Gonokokken. Aber nicht nur OpaCEA Gonokokken interagieren mit CEACAM3, sondern auch die CEACAM-bindenden Adhäsine von Moraxella catarrhalis und Haemophilus influenzae führen zur Rac-Stimulation und damit zur Internalisierung der Pathogene. Im letzten Teil der Arbeit konnte das molekulare Bindeglied zwischen der CEACAM3-induzierten Signalkaskade und der Stimulation der kleinen GTPase Rac identifiziert werden. Das Vav Protein fungiert dabei als GEF für die kleine GTPase Rac. Eine dominant negative Version von Vav oder eine spezifische Vav-siRNA inhibieren die CEACAM3-vermittelte Aufnahme von OpaCEA-Gonokokken bzw. die GTP-Beladung von Rac. Interessanterweise bindet das Vav Protein über seine SH2 Domäne direkt an CEACAM3 und zwar nach Phosphorylierung durch aktive Src Kinasen an den Tyrosinrest 230 der ITAM-ähnlichen Sequenz. Die distinkte CEACAM3-induzierte Signalkaskade erlaubt es, die Bedeutung von CEACAM3 für die Phagozytose CEACAM-bindender Pathogene auch in primären Granulozyten zu untersuchen. Interessanterweise inhibiert PP2 die Aufnahme der Gonokokken dosisabhängig, wohingegen die Blockade der CEACAM1- bzw. CEACAM6-vermittelten Internalisierung der Gonokokken durch Nystatin keine Auswirkungen zeigt. Auch die Proteintransduktion der dominant-negativen Version von Vav (TAT-Vav-dn) bzw. Rac (TAT-Rac-dn) in primäre Granulozyten interferierte effektiv mit der Phagozytose der OpaCEA Gonokokken. Dementsprechend verhindert ausschließlich die Blockade der CEACAM3-vermittelten Phagozytose, aber nicht der CEACAM1- bzw.CEACAM6-vermittelten Aufnahme durch monoklonale Antikörper die Internalisierung bzw. die Elimination von CEACAM-bindenden Pathogenen. Diese Arbeiten beschreiben das exklusiv auf Granulozyten exprimierte CEACAM3 Protein als einen neuen gegen CEACAM-bindende Erreger gerichteten phagozytischen Rezeptor der angeborenen Immunantwort.
A central question to biology is how pathogenic bacteria initiate acute or chronic infections. Here we describe a genetic program for cell-fate decision in the opportunistic human pathogen Staphylococcus aureus, which generates the phenotypic bifurcation of the cells into two genetically identical but different cell types during the course of an infection. Whereas one cell type promotes the formation of biofilms that contribute to chronic infections, the second type is planktonic and produces the toxins that contribute to acute bacteremia. We identified a bimodal switch in the agr quorum sensing system that antagonistically regulates the differentiation of these two physiologically distinct cell types. We found that extracellular signals affect the behavior of the agr bimodal switch and modify the size of the specialized subpopulations in specific colonization niches. For instance, magnesium-enriched colonization niches causes magnesium binding to S. aureusteichoic acids and increases bacterial cell wall rigidity. This signal triggers a genetic program that ultimately downregulates the agr bimodal switch. Colonization niches with different magnesium concentrations influence the bimodal system activity, which defines a distinct ratio between these subpopulations; this in turn leads to distinct infection outcomes in vitro and in an in vivo murine infection model. Cell differentiation generates physiological heterogeneity in clonal bacterial infections and helps to determine the distinct infection types.
Coagulase-negative staphylococci, particularly Staphylococcus epidermidis, have been recognised as an important cause of health care-associated infections due to catheterisation, and livestock-associated infections. The colonisation of indwelling medical devices is achieved by the formation of biofilms, which are large cell-clusters surrounded by an extracellular matrix. This extracellular matrix consists mainly of PIA (polysaccharide intercellular adhesin), which is encoded by the icaADBC-operon. The importance of icaADBC in clinical strains provoking severe infections initiated numerous investigations of this operon and its regulation within the last two decades. The discovery of a long transcript being located next to icaADBC, downstream of the regulator gene icaR, led to the hypothesis of a possible involvement of this transcript in the regulation of biofilm formation (Eckart, 2006). Goal of this work was to characterise this transcript, named ncRNA IcaZ, in molecular detail and to uncover its functional role in S. epidermidis.
The ~400 nt long IcaZ is specific for ica-positive S. epidermidis and is transcribed in early- and mid-exponential growth phase as primary transcript. The promotor sequence and the first nucleotides of icaZ overlap with the 3' UTR of the preceding icaR gene, whereas the terminator sequence is shared by tRNAThr-4, being located convergently to icaZ. Deletion of icaZ resulted in a macroscopic biofilm-negative phenotype with highly diminished PIA-biofilm. Biofilm composition was analysed in vitro by classical crystal violet assays and in vivo by confocal laser scanning microscopy under flow conditions to display biofilm formation in real-time. The mutant showed clear defects in initial adherence and decreased cell-cell adherence, and was therefore not able to form a proper biofilm under flow in contrast to the wildtype. Restoration of PIA upon providing icaZ complementation from plasmids revealed inconsistent results in the various mutant backgrounds.
To uncover the functional role of IcaZ, transcriptomic and proteomic analysis was carried out, providing some hints on candidate targets, but the varying biofilm phenotypes of wildtype and icaZ mutants made it difficult to identify direct IcaZ mRNA targets. Pulse expression of icaZ was then used as direct fishing method and computational target predictions were executed with candidate mRNAs from aforesaid approaches. The combined data of these analyses suggested an involvement of icaR in IcaZ-mediated biofilm control. Therefore, RNA binding assays were established for IcaZ and icaR mRNA. A positive gel shift was maintained with icaR 3' UTR and with 5'/3' icaR mRNA fusion product, whereas no gel shift was obtained with icaA mRNA. From these assays, it was assumed that IcaZ regulates icaR mRNA expression in S. epidermidis. S. aureus instead lacks ncRNA IcaZ and its icaR mRNA was shown to undergo autoregulation under so far unknown circumstances by intra- or intermolecular binding of 5' UTR and 3' UTR (Ruiz de los Mozos et al., 2013). Here, the Shine-Dalgarno sequence is blocked through 5'/3' UTR base pairing and RNase III, an endoribonuclease, degrades icaR mRNA, leading to translational blockade. In this work, icaR mRNA autoregulation was therefore analysed experimentally in S. epidermidis and results showed that this specific autoregulation does not take place in this organism. An involvement of RNase III in the degradation process could not be verified here. GFP-reporter plasmids were generated to visualise the interaction, but have to be improved for further investigations.
In conclusion, IcaZ was found to interact with icaR mRNA, thereby conceivably interfering with translation initiation of repressor IcaR, and thus to promote PIA synthesis and biofilm formation. In addition, the environmental factor ethanol was found to induce icaZ expression, while only weak or no effects were obtained with NaCl and glucose. Ethanol, actually is an ingredient of disinfectants in hospital settings and known as efficient effector for biofilm induction. As biofilm formation on medical devices is a critical factor hampering treatment of S. epidermidis infections in clinical care, the results of this thesis do not only contribute to better understanding of the complex network of biofilm regulation in staphylococci, but may also have practical relevance in the future.
We analyzed an Escherichia coli strain which harbours a chromosomal mutation that blocks the hemolysin excretion. Compartmentation studies showed that hemolysin accumulates in the cytoplasm and not in the periplasm. The mutation did not affect the SDS-PAGE protein pattern of the outer membrane, although some alterations were apparent in the periplasmic protein pattern. The mutant strain, E. coli Hsb-1 also failed to export a cloned fimbrial adhesin. The mutation maps in the min. 3.5 of the E. coli genetic map.
Characterization of a monoclonal antibody against the fimbrial F8 antigen of Escherichia coli
(1986)
A monoclonal lgG 1 antibody against F8 fimbriae was obtained with the hybridoma technique using spieen cells from C3H/f rnice immunised with a fimbrial preparation of Escherichia coli 2980 (018ac: K5: H-: FIC, F8) and Sp 2/0 Ag8 myeloma cells. The hybrid cells were cloned twice by lirniting dilution and grown in tissue culture. The monoclonal antibody was purified from culture supernatants on Protein A Sepharose. lt reacted with F8 fimbriae in colony blot, enzyme-linked immunosorbent assay (ELISA) and immunoblot after electrotransfer from sodium dodecyl sulphate-polyacrylarnide gel electrophoresis (SOS-PAGE) of fimbrial preparations. The antibody bound to and agglutinated F8-fimbriated bacteria.
E. coli stcains isolated from patients with urinary tcact infecrions (UTn very often possess mannose"sensitive (MS) and mannose-resistant (MR) adherence facmrs (fimbriae). According to their receptor specificity the mannose-resistant adhesins can be divided inm several types, P, S, M and X. We have cloned rhe determinants of rhree groups of UTI E. coli adhesins, MS, p and S, and prepared specific aorisera against the fimbriae antigens. 189 hernagglutination (HA+) -positive stcains, 96 fecal isolates and 93 strains isoJated from UTI . have been tesred with rhese specific antisera and further characterized by receptor specific : HA, HA parteras and further of rhe "common 0 serogroups" 01, 02, 04, 06, 07, 08, 018, ' 025, 075, most prevalenr in UTI, and hemolysin production. · 68 (73 %) of the UTI srrains a.nd 50 (52%) of the fecal isolates showed P-receptor specificiry; 16 (17%) of the uropathogenic bacteria and 33 (34%) of the fecal strains exhibited S, M or X-fimbriae antigens. 24% of rhe P-hemagglutinating (P+) strains reacted wirb P (F8)-specific antiserum. In contrast, more than three quaner of the s+-srrains were agglutinated by S-specific antiserum. HA-pattern VJ and 018 amigen were found to be associared with P-fimbriae strains, wbereas HA-pattern V and VII and the 0 anrigens 02 (M-type), 06 and 018 (5-type) occurred most frequently in p- -strains. A high percentage of P-fimbriated strains showed mannose-sensitive hemagglurination and hemolysin production.
H. influenzae ist ein fakultativ anaerobes, Gram-negatives Bakterium und wird in die Familie der Pasteurellacaea eingeordnet. Das Bakterium zeigt Auxotrophien für Hämin unter aeroben Bedingungen und für Nikotinamid-Adenin-Dinukleotid (NAD) bei aeroben wie anaeroben Wachstum. Es können zwei Unterarten unterschieden werden: die bekapselten Stämme, die systemische Erkrankungen hervorrufen und die unbekapselten bzw. nicht-typisierbaren Stämme, die für Oberflächeninfektionen verantwortlich sind. Da bei H. influenzae bisher nur wenig über die NAD-Aufnahme bekannt war, sollten in dieser Arbeit Proteine identifiziert und charakterisiert werden, die an der NAD-Aufnahme beteiligt sind. Das Außenmembranprotein e(P4), kodiert von dem hel-Gen, wurde als eine Komponente des Häminaufnahmesystems beschrieben. In dieser Arbeit wurde eine hel-Deletionsmutante hergestellt, anhand der nachgewiesen wurde, daß e(P4) als saure Phosphatase nicht an der Hämin-, sondern an der NAD-Aufnahme beteiligt ist. Mit Hilfe von verschiedenen Phosphatase-Assays und dem Malat-Enzym-Assay konnten NADP und Nikotinamid-Mononukleotid (NMN) als physiologisch relevante Substrate identifiziert werden. Die biologische Relevanz von e(P4) für die NAD-Aufnahme wurde durch Mutantenanalyse in Wachstumstests und Transport-Assays nachgewiesen. Es wurde gezeigt, daß die hel-Deletionsmutante mit NAD und NMN ein signifikantes Wachstumsdefizit hatte und nicht fähig war, beide Nikotinamid-Nukleotid-Quellen aufzunehmen, während die Nutzung von Nikotinamid-Ribosyl (NR) keinen Unterschied zum Wildtyp aufwies. Um die Frage zu klären, ob die Lokalisation von e(P4) als Lipoprotein an der Außenmembran wichtig für die NMN-Spaltung ist, wurden zwei Mutanten hergestellt, bei denen im hel-Gen der Lipidanker Cystein durch ein Glycin ausgetauscht wurde, um das Protein im Periplasma zu exprimieren. Die Periplasma-Extrakte dieser Cystein-Mutanten zeigten in Phosphatase-Assays keine Aktivität. Um zu untersuchen, ob die Phosphatase-Aktivität die einzige für die NAD-Aufnahme relevante Funktion von e(P4) ist, wurden Phosphatase-Mutanten hergestellt und charakterisiert. Sie exprimierten ein mutiertes e(P4)-Protein, das durch einen Aminosäureaustausch die Phosphatase-Aktivität verloren hatte. Es zeigte sich, daß die Phänotypen der Phosphatase-Mutanten in Bezug auf die Fähigkeit NMN zu spalten, NAD und NMN aufzunehmen und als Faktor V-Quelle zum Wachstum zu nutzen, exakt mit den Phänotypen der Deletionsmutante korrelierten. Es konnten daher keine weiteren Funktionen von e(P4) festgestellt werden. Das periplasmatische Protein NadN wurde als Pyrophosphatase beschrieben, die fähig ist, NAD zu NMN zu hydrolysieren. Weiter wurde eine 5´-Nukleotidase-Aktivität nachgewiesen, mit der NadN NMN zu NR dephosphorylieren kann. Die Relevanz von NadN für die NAD-Aufnahme wurde anhand einer nadN-Knockout-Mutante untersucht. In Wachstumskurven und Transport-Assays zeigte sich, daß die nadN-Mutante nicht fähig war, NAD aufzunehmen und zum Wachstum zu verwenden. Auch die Nutzung von NMN war bei der Mutante eingeschränkt, während mit NR als Faktor V-Substrat kein Unterschied zum Stamm Rd erkennbar war. Durch die Charakterisierung einer hel nadN-Doppelmutante konnte nachgewiesen werden, daß keine weiteren Enzyme außer e(P4) und NadN an der Prozessierung von NAD zu NR beteiligt sind. Es zeigte sich auch, daß nur NR über einen putativen Transporter ins Zytoplasma aufgenommen wird. Das Protein OmpP2 stellt ein Hauptporin der äußeren Membran dar. Durch eine ompP2-Deletionsmutante konnte mit Hilfe von Wachstumskurven und Transport-Assays nachgewiesen werden, daß NAD, NMN und NR durch diese Pore ins Periplasma diffundieren.
Thrombospondin-1 (TSP1) ist ein matrizelluläres, Calcium-bindendes Glykoprotein, das an der Regulation verschiedener zellulärer Prozesse beteiligt ist. TSP1 wird von unterschiedlichen Zelltypen gebildet und ist vor allem in den α-Granula der Thrombozyten zu finden, aus denen es nach deren Aktivierung sekretiert wird. Streptococcus pneumoniae (Pneumokokken) sind Gram-positive humanpathogene Bakterien. Sie besiedeln asymptomatisch den menschlichen Respirationstrakt und können schwerwiegende lokale Infektionen und lebensbedrohliche Erkrankungen, wie z.B. Sepsis, bakterielle Meningitis oder invasive Pneumonien auslösen. Die Anheftung von S. pneumoniae an Wirtsstrukturen ist ein initialer Schritt für die Kolonisierung mukosaler Epitheloberflächen. In dieser Arbeit wird die Bedeutung des humanen TSP1 für die Pathogen-Wirt Interaktion analysiert und der Effekt für die Pathogenese demonstriert. Verschiedene Bindungsstudien und durchflusszytometrische Analysen zeigten eine Assoziation von S. pneumoniae an aktivierte Thrombozyten und an lösliches und immobilisiertes TSP1. In in vitro Infektionsversuchen konnte nachgewiesen werden, dass wirtszellgebundenes TSP1 die Adhärenz an und Invasion in Epithel- bzw. Endothelzellen vermittelt. TSP1 übernimmt die Funktion als Brückenmolekül zwischen S. pneumoniae und eukaryontischen Wirtszellen. Zur Charakterisierung des bakteriellen Adhäsins für TSP1 wurden die Pneumokokken mit dem proteolytischen Enzym Pronase E bzw. mit der Zucker oxidierenden Substanz Natriumperiodat inkubiert. Eine Behandlung mit Natriumperiodat reduzierte die TSP1 vermittelte Adhärenz der Pneumokokken an humane Wirtszellen. Im Gegensatz dazu hatte die Behandlung mit Pronase E keinen Einfluss auf die TSP1 vermittelte Anheftung von S. pneumoniae an eukaryontische Zellen. Diese Ergebnisse deuten an, dass es sich bei dem bakteriellen Adhäsin für TSP1 um eine oberflächenlokalisierte Glykostruktur der Pneumokokken handelt. Die TSP1 vermittelte bakterielle Adhärenz der Pneumokokken an Wirtszellen konnte durch Pneumokokken-spezifisches Phosphorylcholin bzw. durch Lipoteichonsäuren nicht reduziert werden. Im Gegensatz dazu wurde die TSP1 vermittelte Adhärenz von S. pneumoniae an Wirtszellen durch Zugabe von löslichem Peptidoglykan signifikant inhibiert. In verschiedenen Bindungsstudien wurde das Peptidoglykan als Pneumokokken-Adhäsin für TSP1 identifiziert. Weiterhin wurde herausgestellt, dass nicht nur S. pneumoniae, sondern auch andere Gram-positive pathogene Bakterien, wie Staphylococcus aureus, Streptococcus pyogenes, Listeria monocytogenes und verschiedene apathogene Bakterien mit TSP1 interagieren, im Gegensatz zu Gram-negativen Bakterien. Es konnte gezeigt werden, dass TSP1 das Peptidoglykan aller getesteten Gram-positiven Bakterien erkennt. Diese Beobachtung weist auf einen allgemeingültigen Mechanismus der Bakterien-Wirt Interaktion hin, der wahrscheinlich von großer Bedeutung für die Pathogenese Gram-positiver Bakterien ist. Als Rezeptoren für TSP1 auf der Wirtszellseite wurden Proteoglykane auf der Oberfläche von eukaryontischen Zellen identifiziert. Weiterhin konnte herausgestellt werden, dass eine Interaktion der Gram-positiven Bakterien mit TSP1 nicht nur eine Adhärenz an Wirtszellen vermittelt, sondern die Bakterien vor einer Phagozytose durch primäre Granulozyten schützt. Zusammenfassend beweisen diese Ergebnisse eine spezifische Interaktion von Gram-positiven Bakterien mit TSP1, die zur bakteriellen Kolonisierung des Wirtsgewebes beiträgt. Das Peptidoglykan übernimmt die Funktion eines bakteriellen Adhäsins für TSP1, so dass TSP1 als molekulare Brücke die Interaktion von Gram-positiven Bakterien und Wirtszell-Proteoglykanen vermittelt. Diese Untersuchungen tragen in bedeutender Weise zu einem besseren Verständnis der Pathogenese von Infektionen durch S. pneumoniae und anderen Gram-positiven Bakterien bei.
Bislang inhibieren antibakterielle Substanzen in erster Linie die Zellwandsynthese, den DNA- und RNA-Stoffwechsel sowie die Proteinsynthese. In dieser Arbeit wurde ein erster Versuch unternommen, neue Zielstrukturen für die Antibiotika-Therapie in S. aureus zu finden. Insgesamt wurden 10 Gene untersucht, die Funktion von 7 dieser Gene war in S. aureus unbekannt. Zunächst sollte herausgefunden werden, ob diese 10 Zielgene: topB, polA, nusG, SA1857, SA1444, SA1063, SA0453, SA0241, SA0245, SA0367, für S. aureus essentiell sind. Es wurde versucht, jedes dieser Gene in S. aureus zu deletieren. Außer den Genen SA1444, SA0245 und nusG konnten alle Zielgene deletiert werden und waren daher für S. aureus nicht essentiell. Die Deletionsmutanten ΔtopB, ΔpolA, ΔSA1857, ΔSA1063, ΔSA0453, ΔSA0241, ΔSA0367 wurden außerdem in einem Sepsismodell in Mäusen untersucht und waren nicht attenuiert. Gene, die weder in vitro noch in vivo essentiell sind, sind nur von geringem Interesse für die Entwicklung neuer Antibiotika. Zur Untersuchung essentieller Gene in S. aureus wurden vier verschiedene konditionale Expressionssystem untersucht. Bei drei dieser Systeme wurde der wildtypische Promotor gegen einen regulierbaren Promotor ausgetauscht. Bei einem weiteren System handelte es sich um einen Antisense-RNA-Ansatz. Zur Überprüfung der konditionalen Expressionssysteme („proof-of-principle“) wurden die bekannten essentiellen Gene ligA und dnaE in S. aureus mutiert. Eines dieser konditionalen Expressionssysteme, das pLL30/Pspac/pMJ8426-System, konnte erfolgreich in S. aureus angewandt werden. Die konditionale Expression von ligA und von SA0245 wurde mit diesem System erzielt. Der Temperatur-sensitive Shuttle-Vektor pLL30 dieses konditionalen Expressionssystems enthält eine Insertionskassette, die das Antibiotikaresistenzgen cat (Chloramphenicol-Acetyltransferase) sowie den regulierbaren Promotor Pspac enthält. Ein wesentliches Merkmal des pLL30/Pspac/pMJ8426-Systems ist die stabile Integration des Resistenzmarkers cat und des Pspac-Promotors durch ein doppeltes Crossover Ereignis vor dem Zielgen. Der Temperatur-sensitive Shuttle-Vektor pLL30 kann anschließend durch mehrfaches Subkultivieren der Bakterien bei nicht permissiver Temperatur eliminiert werden. Der Repressor LacI wird auf einem Extra-Plasmid pMJ8426 kodiert und wird nach erfolgter Integration des Pspac-Promotors vor dem Zielgen in die Bakterien transformiert. Mehrere Kopien des Repressorplasmids ermöglichen eine gute Repression an Pspac. Durch die Zugabe des Induktors IPTG kann der Repressor LacI inaktiviert und die Gen-Expression induziert werden. Insbesondere konnte dieses konditionale Expressionssystem erfolgreich im Tiermodell angewandt werden. Ein weiterer Schwerpunkt dieser Arbeit bildete die genetische und funktionelle Charakterisierung von SA0367. Durch biochemische Untersuchungen wurde gezeigt, dass dieses Gen für eine FMN-enthaltende Oxidoreduktase codiert. Auf Grundlage der in dieser Arbeit gewonnenen Erkenntnisse zur Funktion des Proteins wurde das Gen SA0367, in Analogie zum orthologen Gen nfrA aus B. subtilis, in nfrA umbenannt. Die Oxidoreduktase NfrA oxidiert NADPH in Gegenwart von FMN. In Gegenwart von NADPH und FMN zeigt das Enzym NfrA außerdem Nitroreduktase- und eine leichte Disulfidreduktase-Aktivität. Induktionsexperimente im Wildtyp zeigten, dass nfrA durch oxidativen Stress, verursacht von Diamide oder Nitrofurantoin, und durch Ethanol induziert wird. Ethanol und oxidativer Stress führt zu Denaturierung von Proteinen. NfrA könnte an der Reparatur geschädigter Proteine beteiligt sein. Die Induktion von nfrA in S. aureus erfolgt unabhängig vom alternativen Sigmafaktor SigB. Durch Primer Extension-Experimente wurde eine putative PerR-Box vor dem nfrA-Gen identifiziert. Diese könnte für die Regulation von nfrA wichtig sein. Außerdem wird nfrA während des gesamten Wachstumszyklus von einem SigAabhängigen Promotor exprimiert. Die Deletionsmutante ΔnfrA zeigt nur in Gegenwart hoher Ethanolkonzentrationen von 6,5 % einen leichten Wachstumsnachteil im Vergleich zum Wildtyp. Außerdem weist die ΔnfrA-Mutante eine höhere Resistenz gegenüber Nitrofurantoin auf. In weiteren Untersuchungen wurde begonnen die Funktion der Ser/Thr-Kinase SA1063 durch Microarray-Experimente aufzuklären. Hierbei wurde deutlich, dass dieses Gen eine regulatorische Rolle bei der Zellwandsynthese in S. aureus spielen könnte.
Einhundertvierundvierzig STEC-Stämme von Patienten mit hämolytisch-urämischem Syndrom (68 Stämme), von Durchfallpatienten (42 Stämme) und von asymptomatischen Ausscheidern (44 Stämme) wurden im Rahmen dieser Arbeit auf ihre Antibiotika-empfindlichkeit hin untersucht. Zu den insgesamt 13 getesteten Antibiotika zählten die ß-Laktam Antibiotika Ampicillin, Piperacillin, Cefotaxim, Ceftazidim, Cefotiam und Imipenem, die Aminoglykoside Gentamicin und Streptomycin, die Gyrasehemmer Ofloxacin und Ciprofloxacin sowie Tetracyclin, Chlorampenicol und die Sulfamethoxazol/Trimethoprim-Kombination Cotrimoxazol. Alle E. coli O157 Stämme, die von Patienten mit HUS isoliert wurden, waren sensibel gegen die getesteten Antibiotika. Lediglich ein E. coli O157 Stamm, der von einem Durchfall-Patienten isoliert wurde, zeigte eine Resistenz gegen Tetracyclin. Allgemein häufiger wurden Antibiotikaresistenzen bei non-O157 Stämmen gefunden. Fünf von 22 non-O157 Stämmen, die von HUS-Patienten isolierten wurden, zeigten mindestens eine Resistenz gegen die getesteten Antibiotika. Vierzehn von fünfunddreißig non-O157 E. coli Stämmen, die sowohl von Durchfall-Patienten als auch von asymptomatischen Ausscheidern stammten, konnten sowohl Einfachresistenzen als auch Multiresistenzen aufweisen. Die Bestimmung der minimalen Hemmkonzentration (MHK) zeigte, daß alle resistente Stämme einen extrem hohen Resistenzstatus besitzen. Sowohl ß-Laktam als auch Tetracyclin Resistenzen konnten mittels Konjugation auf einen E. coli-Laborstamm übertragen werden. Dies läßt die Anwesenheit von R-Plasmiden vermuten. Die Tatsache, daß über 12 Prozent Shigatoxin produzierender E. coli Stämme aus humanen Stuhlproben Antibiotikaresistenzen aufweisen, hat klinische und epidemiologische Bedeutung. Resistente STEC-Stämme hätten einen selektiven Vorteil gegenüber anderen koliformen Bakterien in Mastbetrieben, die Antibiotika dem Futtermittel beimengen. Hieraus wiederum steigt die Gefahr einer potentiellen Übertragung resistenter Pathogene auf den Menschen. Auf der anderen Seite könnte die ansteigende Anzahl Antibiotika-resistenter Stämme zu einer rasch durchführbaren epidemiologischen Nachweismethode führen.
In Säugetieren existieren im wesentlichen zwei Abwehrsysteme gegen oxidativen Streß, in welchen die Glutathionreduktase (GR) und Thioredoxinreduktase (TrxR) Schlüsselenzyme sind. Ein einzelnes Gen der Taufliege, genannt dmtrxr-1, kodiert sowohl für die durch alternatives Splicing entstehende cytoplasmatische und mitochondriale Form der DmTrxR-1. Zum Teil innerhalb des dmtrxr-1-Gens findet sich auf dem Komplementärstrang ein weiteres Gen, welches sniffer genannt wurde. In Kooperation wurde nachgewiesen, daß dieses Gen essentiell zur Verhinderung alterungsbedingter Neurodegeneration ist. Durch biochemische Charakterisierung konnte das rekombinant hergestellte Produkt dieses Gens in der vorliegenden Arbeit als Carbonylreduktase, ein zu den Kurzketten-Dehydrogenasen (short-chain dehydrogenases) gehörendes Enzym, identifiziert werden. Sniffer weist das für Carbonylreduktasen typische Substratspektrum mit Phenanthrenequinone als bestem Substrat auf und wird von Flavonoiden wie Quercetin und Rutin sowie Hydroxymercuribenzoat gehemmt. In verschiedenen Ansätzen konnten Kristalle des rekombinanten Proteins gewonnen werden, die inzwischen in Kooperation vermessen wurden und so zu einer Kristallstruktur mit einer Auflösung von 1,7 Angström führten. Durch diese Arbeiten konnte zum ersten Mal eine Verbindung zwischen einem charakterisierten Gen (snifffer), oxidativem Streß und neurodegenerativen Effekten auf molekularer Ebene nachgewiesen werden. Parasiten haben während ihres Lebenszyklus einen hohen Bedarf an Energie und sind abhängig von einer starken Syntheseleistung. Zur Bewältigung dieses Stresses benötigen sie hohe Aktivitäten an Adenylatkinase (AK; ATP + AMP  2 ADP) und GTP-AMP-Phosphotransferase (GAK; GTP + AMP  GDP + ADP). Beide Enzyme wurden in Blutstadien des Malariaparasiten Plasmodium falciparum identifiziert und die entsprechenden Gene der PfAK und PfGAK auf den Chromosomen 10 und 4 respektive lokalisiert. Klonierung und heterologe Expression in E. coli ergab enzymatisch aktive Proteine mit einer Größe von 28,9 (PfAK), bzw. 28,0 kDa (PfGAK). Das rekombinante Protein der PfAK entspricht in seinen biochemischen Charakteristika denen der authentischen PfAK. Dies gilt auch für eine mögliche Assoziation mit einem stabilisierenden Protein mit einem Molekulargewicht von ca. 70 kDa und der hohen Substratspezifität für das Monophosphat-Nukleotid AMP. Die Spezifität für das Triphosphat-Substrat ist weniger stringent. Das beste Triphosphat-Substrat ist ATP mit einem Vmax-Wert von 75 U/mg und einem kcat von 2800 min-1. Die Sequenz der PfAK enthält eine amphiphatische Helix, welche als notwendig für die Translokation zytosolischer Adenylatkinasen in den Intermembranraum der Mitochondrien beschrieben wurde. Die PfGAK bevorzugt GTP und AMP als Substrat (100 U/mg; kcat = 2800 min-1 bei 25°C) und zeigt als Besonderheit keine messbare Aktivität mit ATP. Im Gegensatz zu ihrem Ortholog im Menschen (AK3) enthält die Sequenz der PfGAK ein Zinkfinger-Motiv und bindet Eisenionen. Erste Immunfluoreszenz-Analysen lokalisieren die PfGAK in den Mitochondrien. PfAK und PfGAK werden von den Dinukleosid-Pentaphosphat-Verbindungen AP5A beziehungsweise GP5A gehemmt. Die Ki-Werte liegen mit ca. 0.2 µM ungefähr 250-fach niedriger als die KM-Werte der entsprechenden Nukleotidsubstrate. Zur Lösung der vor allem im Rahmen einer rationalen Medikamentenentwicklung notwendigen Kristallstruktur des Zielmoleküls konnten bereits Kristalle der PfGAK erhalten werden.
Vibrio cholerae, der Erreger der Cholera, ist ein Gram-negatives, fakultativ pathogenes Bakterium. In dieser Arbeit konnte die V. cholerae Oberflächenstruktur identifiziert werden, an die der temperente V.cholerae-Phage K139 adsorbiert. Phagenbindungs-Studien mit gereinigtem Lipopolysaccharid (LPS) ergaben, daß das O-Antigen der Serogruppe O1 den Phagenrezeptor darstellt. Zusätzlich wurden phagenresistente Mutanten des transluzenten O1 El Tor Inaba Stammes P27459 nach Inkubation mit einem lytischen K139-Derivat isoliert. Analysen des LPS-Laufverhaltens in Polyacrylamid-Gelen (PAA) zeigten, daß viele der Spontanmutanten defekte LPS-Moleküle synthetisierten, die entweder im O-Antigen, im Kernoligosaccharid oder in beidem betroffen waren.Phagenresistente Mutanten mit offensichtlich unverändertem LPS bildeten entweder transluzente oder opake Kolonien. Weiterhin wurden ausgewählte spontan phagenresistente Stämme genetisch analysiert. O-Antigen Mutanten wurden in Southernblot-Analysen mit spezifischen, gegen das bereits gut charakterisierte O-Antigen-Biosynthese-Gencluster (rfb) gerichtete Sonden untersucht. Zwei der O-Antigen negativen Stämme waren durch Insertion des IS-Elementes IS1004 in das rfb-Gencluster entstanden. Spontan phagenresistente Mutanten mit verändertem Kernoligosaccharid ohne O-Antigen (R-LPS-Mutanten) sind wahrscheinlich im Kernoligosaccharid-Biosynthese-Gencluster (waa) mutiert, das in der V. cholerae Datenbank identifiziert wurde. waaF, das für die Heptosyl-II-Transferase kodiert, wurde durch genetische Manipulation inaktiviert und zeigte im PAA-Gel das gleiche Migrationsverhalten wie zwei spontan phagenresistente Mutanten. In den Spontanmutanten konnte jedoch im Gegensatz zu der konstruierten Mutante durch ein WaaF-exprimierendes Plasmid lediglich das Kernoligosaccharid, nicht aber das O-Antigen wiederhergestellt werden. Weitere genetische Analysen ergaben, daß eine der Spontanmutanten 546 bp deletiert hatte, die Teile von waaF und waaL betrafen, letzteres kodiert dabei vermutlich für die O-Antigen-Ligase. Spontanmutanten mit intaktem O-Antigen aber verändertem Kernoligosaccharid konnten als galU-Mutanten charakterisiert werden, die auch im Galaktosekatabolismus beeinträchtigt waren. Zusätzlich wurden zwei weitere gal-Gene, galE und galK, durch genetische Manipulation inaktiviert. Diese Mutanten konnten ebenfalls keine Galaktose mehr verstoffwechseln, synthetisierten aber ein intaktes LPS. In Gegenwart hoher Galaktosekonzentrationen wurde in galU- und galE- Mutanten aufgrund der Defekte im Gal-Stoffwechsel Lyse beobachtet. Zusätzlich wurde die Rolle von galU und galE in der Biofilmbildung untersucht. Da der transluzente Wildtyp (Wt) im Gegensatz zu Opakvarianten keinen Biofilm bilden konnte, wurden galE und galU auch in einer Opakvariante inaktiviert. galU- und galE-Mutationen erzeugten in der Opakvariante wieder eine transluzente Koloniemorphologie und einen biofilm-negativen Phänotyp an abiotischen Oberflächen. Diese Daten deuten an, daß die Synthese von UDP-Galaktose ausgehend von UDP-Glukose für die Synthese des Exopolysaccharides (VPS) notwendig ist. Virulenzstudien in neugeborenen Mäusen ergaben, daß O-Antigen negative Stämme sowie galU-Mutanten sehr viel schlechter und R-LPS-Mutanten nicht mehr im Dünndarm kolonisieren konnten. Da galE und galEK-Mutanten ebenso gut wie der Wt kolonisierten, konnte ausgeschlossen werden, daß toxische Galaktose-Effekte für den Kolonisierungsdefekt der galU-Mutante verantwortlich waren. Zusätzlich wurde die Überlebensfähigkeit der LPS-Mutanten in Gegenwart von verschiedenen Substanzen, die nachweislich im menschlichen Dünndarm vorkommen, unter „in vitro“ Bedingungen untersucht. R-LPS und galU-Mutanten waren im Vergleich mit dem Wt sensitiver gegenüber schwachen organischen Säuren, Defensinen, dem Komplementsystem und Gallensäuren. O-Antigen negative Stämme waren dagegen weiterhin resistent gegenüber Gallensäuren und schwachen organischen Säuren aber sensitiv gegen die Komponenten des angeborenen Immunsystems. Bisher wurde für keine der LPS-Mutanten eine größere Beeinträchtigung weiterer Virulenzfaktoren, wie z.B. Motilität, Synthese der Pili TCP oder Choleratoxin-Produktion festgestellt. Auch die Zusammensetzung der Proteine in der äußeren Membran war offensichtlich nicht beeinträchtigt, allerdings wurde beobachtet, daß aus galU Mutanten in geringem Maße und aus R-LPS Mutanten in verstärktem Maße periplasmatische Proteine in den Überstand diffundieren können. Diese Ergebnisse deuten an, daß nicht nur das O-Antigen, wie bereits bekannt, sondern auch eine spezifische Kernoligosaccharid-Struktur für eine effektive Kolonisierung von V. cholerae essentiell ist. Der Grund dafür ist höchstwahrscheinlich in der Ausbildung einer stabilen äußeren Membran zu suchen, die die Persistenz in Gegenwart bakteriozider Substanzen des Dünndarms ermöglicht.
DNA hybridization experiments demonstrated that the gene clusters encoding the F8 fimbriae (fei) as well as the type I fimbriae (pi/) exist in a single copy on the chromosome of E. coli 018:K5 strain 2980. In conjugation experiments with appropriate donors, the chromosomal site of these gene clusters was determined. The pil genes were mapped close to the gene clusters thr and Jeu controlling the biosynthesis of threonine and leucine, respectively. The fei genes were found to be located close to the galactose operon (gal) between the position 17 and 21 of the E. coli chromosomallinkage map.
Human leishmaniasis covers a broad spectrum of clinical manifestations ranging from self-healing cutaneous leishmaniasis to severe and lethal visceral leishmaniasis caused among other species by Leishmania major or Leishmania donovani, respectively. Some drug candidates are in clinical trials to substitute current therapies, which are facing emerging drug-resistance accompanied with serious side effects. Here, two cinnamic acid bornyl ester derivatives (1 and 2) were assessed for their antileishmanial activity. Good selectivity and antileishmanial activity of bornyl 3-phenylpropanoate (2) in vitro prompted the antileishmanial assessment in vivo. For this purpose, BALB/c mice were infected with Leishmania major promastigotes and treated with three doses of 50 mg/kg/day of compound 2. The treatment prevented the characteristic swelling at the site of infection and correlated with reduced parasite burden. Transmitted light microscopy and transmission electron microscopy of Leishmania major promastigotes revealed that compounds 1 and 2 induce mitochondrial swelling. Subsequent studies on Leishmania major promastigotes showed the loss of mitochondrial transmembrane potential (ΔΨm) as a putative mode of action. As the cinnamic acid bornyl ester derivatives 1 and 2 had exhibited antileishmanial activity in vitro, and compound 2 in Leishmania major-infected BALB/c mice in vivo, they can be regarded as possible lead structures for the development of new antileishmanial therapeutic approaches.
A total of 36 Escherichia coli urinary tract isolates (UTI) of serotype 06, with different combinations of capsule ( K) and flagellin ( H) antigens, were analysed according to the outer membrane pattern (OMP), serum resistance properties, mannose-resistant hemagglutination using various types of erythrocytes, and also for the genetic presence and the expression of Pfimbriae. S fimbriae/F1 C fimbriae, Type 1 fimbriae, aerobactin and hemolysin. Twenty selected strains were further analysed by pulsed field gel electrophoresis (PFGE), elaborating genomic profilas by Xba I cleavage and subsequent Southern hybridization to virulence-associated DNA probes. lt could be shown that 06 UTI isolates represent a highly heterogeneaus group of strains according to the occurrence and combination of these traits. Relatedness an the genetic and the phenotypic Ievei was found for some of the strains exhibiting the same 0: K: H: F serotype. DNA Iang-range mapping further indicated some interesting features, according to the copy number and the genomic linkage of virulence genes.
Escherichia coli isolates of serotype 06: K5 are the most common causative agents of cystitis and pyelonephritis in adults. To answer the question, as to whether strains of this particular serotype represent one special clonal group, out of a collection of 34 serotype 06: K5 isolates [Zingler et al. ( 1990) Zentralbl. Bakteriol Mikrobiol Hyg [A] 274:372-381] 15 strains were selected andanalyzed in detail. The flagellar (H) antigen and the outer membrane protein (OMP) pattern were determined. Furtherserum resistance properties and the genetic presence and expression of other virulence factors, including hemolysin, aerobactin, P fimbriae, S/F1C fimbriae and type 1 fimbriae was evaluated. In~laddition the Xbalmacrorestriction pattern of ten representative isolates was elaborated and the fimbrial (F) antigentype ofthe P fimbriae was determined, to obtain the complete 0: K: H: F pattern. These analyses could clearly show that the 06: K5 isolates do not represent one clonal group. The Xbal-macrorestriction profiles were heterogeneaus and marked differences in the hybridization patterns, using virulenceassociated gene probes in Southern hybridization of long-range-separated genomic DNA, were observed among the strains. However, some of strains showed similarities in the genomic profiles, arguing for clonal groupings among the 06: K5 isolates. lnterstingly the strains grouped tagether exhibited the same fimbrial F typethat many indicate a coincidence of this phenotypic trait with clonality.
After intraperitoneal injection of mice with Escherichia coli strains isolated from patients with urinary tract infections, the mortality due to hemolytic (Hly+) and nonhemolytic (Hiy-) isolates was 77 and 40%, respectively. Deletion of the chromosomal hemolysin (h/y) determinant in an E. co/i 06:K15:H31 urinary tract infection strain led to a significant reduction in toxicity for mice, and its reintroduction on a recombinant plasmid partially restored the original toxicity. Although introduction of the cloned plasmid pHiy152-encoded hly determinant into the Hly- E. coli 06 mutant strain increased toxicity by only a marginal degree, transformation with the cloned chromosomal hly determinants from two E. coli strains of serotypes 018ac:K5:H- and 075:K95:H? resulted in markedly greater toxicity, even exceeding that of the original Hly+ E. coli 06 wild-type strain.
The Escherichia coli blood culture isolate BK658 (07S:K1:H7) expresses F1A and F1B fimbriae as weil as a third fimbrial type which reacts with anti-S-fimbrial antiserum but fails to show S-specific binding properlies (i.e., agglutination of bovine erythrocytes). To characterize these fimbriae, we cloned the respective genetic determinant in E. coli K-12. The resulting recombinant clone HB101(pMMP658-6) expresses fimbriae of 1.2-p.m length and a diameter of approximately 7 nm. The determinant codes for the fimbrillin subunit, a protein of 17 kUodaltons in size, and for at least five other proteins of 87, 31, 23, 14.3, and 13.8 kUodaltons. By restriction analysis and by DNA-DNA hybridization, it could be shown that the cloned fimbrial determinant of strain BK658 exhibits a high degree of sequence homology to the gene clusters coding for S fimbrial adhesins (sfa) and F1C fimbriae (/oc). By using the Western blot (immunoblot) technique and a quantitative enzyme-linked immunosorbent assay, it could be further demonstrated that the cloned fimbriae of BK658, S fimbriae, and FlC fimbriae share cross-reactive epitopes as weil as antigenic determinants specific for each fimbrial type. No antigenic cross-reactivity with F1C fimbriae could be detected. The results indicate a genetical and serological relatedness of the cloned fimbriae toS fimbriae and F1C fimbriae. Therefore, this new type of fimbriae is preliminarily termed SIF1C-related fimbriae (Sfr).
The Qropathogenic Escherichia coli strain 536 (06:K15:H31) exhibits a mannose-resistant hemagglutination phenotype (Mrh) with bovine erythrocytes and delayed Mrh with human and guinea pig erythrocytes. Neuraminidase treatment of the erythrocytes abolishes mannose resistant hemagglutination, which is typical for X fimbriae. E. coli strain 536 synthesizes two different fimbriae (Fim phenotype) prQtein subunits, 16.5 and 22 kilodaltons in size. In addition the strain shows mannose-sensitive hemagglutination and common type I (Fl) fimbriae. The cosmid clone E. coli K-12(pANN801) and another nine independently isolated Mrh+ cosmid clones derived from a cosmid gene bank of strain 536 express the 16.5-kilodalton protein band, bot not the 22-kilodalton protein, indicating an association of the Mrh+ property with the "16.5-kilodalton fimbriae." All cosmid clones were fimbriated, and they reacted with antiserum produced against Mrh+ fimbriae of the E. coli strain HB101(pANN801) and lacked mannose-sensitive hemagglutination (Fl) funbriae. From the Mrh fim cosmid DNA pANN801, several subclones coding for hemagglutination and X fimbriae were constructed. Subclones that express both hemagglutination and fimbriae and subclones that only code for the hemagglutination antigen were isolated; subclones that only produce fimbriae were not detected. By transposon Tn5 mutagenesis we demonstrated that about 6.5 kilobases of DNA is required for the Mrh+ Fim+ phenotype, and the 1.5- to 2-kilobase DNA region coding for the structural proteiil of the fimbriae has been mapped adjacent to the region responsible for the Mrh+ phenotype. Two different regions can thus be distinguished in the adhesion determinant, one coding for hemagglutination and the other coding for fimbria formation. Transformation of plasmid DNA from these subclones into a Mrh- Fim- mutant of E. coli 536 and into a galE (rough) strain of Salmonella typhimurium yielded transformants that expressed both hemagglutination and fimbria production.
S fimbrial adbesins (Sfa), which are able to recognize sialic acid-containing receptors on eukaryotic cells, are produced by Escherichia coli strains causing urinary tract infections or newbom meningitis. We recently described tbe cloning and molecular cbaracterization of a determinant, termed sftJI, from the chromosome of an E. coli urinary tract infection strain. Herewe present data conceming a S fimbria-specific gene duster, designated sfall, of an E. coli newbom meningitis strain. Like tbe Sfal complex, Sfall consists of tbe major subunit protein SfaA (16 kDa) and the minor subunit proteins SfaG (17 kDa), SfaS (15 kDa), and SfaH (29 kDa). The genes encoding tbe subunit proteins of Sfall were identified and sequenced. Their protein sequences were calculated from the DNA sequences and compared with tbose of the Sfal complex subunits. Altbough the sequences ofthe two major SfaA subunits ditf'ered markedly, tbe sequences ofthe minor subunits sbowed only a few amino acid exchanges (SfaG, SfaH) or were completely identical (SfaS). The introduction of a site-specific mutation into the gene sfaSII and subsequent analysis of an SfaS-negative clone indicated that sfaSII codes for the sialic acid-specific adhesin of tbe meninigitis isolate. These data were confirmed by tbe isolation and characterization of tbe SfaSII protein and the determination of its N-terminal amino acid sequence. The identity between the sialic acid-specific adhesins of Sfal and Sfall revealed that difl'erences between the two Sfa complexes with respect to tbeir capacities to agglutinate erythrocytes must result from sequence alterations of subunit proteins other tban SfaS.
We have cloned the chromosomal hemolysin determinants from Escherichia coli strains belonging to the four O-serotypes 04, 06, 018, and 075, The hemolysin-producing clones were isolated from gene banks of these strains which were constructed by inserting partial Sau3A fragments of chromosomal DNA into the cosmid pJC74. The hemolytic cosmid clones were relatively stable. The inserts were further sub cloned either as Sail fragments in pACYC184 or as BamHI-SaLI fragments in a recombinant plasmid (pANN202) containing cistron C (hlye) of the plasmid-encoded hemolysin determinant. Detailed restriction maps of each of these determinants were constructed, and it was found that, despite sharing overall homology, the determinants exhibited minor specific differences in their structure, These appeared to be restricted to cistron A (hlyA), which is the structural gene for hemolysin. In the gene banks of two of these hemolytic strains, we could also identify clones which carried the genetic determinants for the mannose-resistant hemagglutination antigens Vb and VIc. Both of these fimbrial antigens were expressed in the E. coli K-12 clones to an extent similar to that observed in the wild-type strains. These recombinant cosmids were rather unstable, and, in the absence of selection, segregated at a high frequency.
A genomic library of Legionello pneumophihz, the causative agent of Legionnaires disease in humans, was constructed in Escherichill coli K-12, and the recombinant clones were screened by immuno-colony blots with im antiserum raised against heat-killed L. pneumophilo. Twenty-three clones coding for a LegioneUa-specific protein of 19 kDa were isolated. The 19-kDa protein, which represents an outer membrane protein, was found tobe associated with the peptidoglycan layer bothin L. pneumophilo andin the recombinant E. coli clones. This was shown by electrophoresis and Western immunoblot analysis of bacterial cell membrane fractions witb a monospecific polyclonal 19-kDa protein-specific antiserum. Tbe protein was termed peptidoglycan-associated protein of L. pneumophilo (Ppl). The corresponding genetic determinant, ppl, was subcloned on a 1.8-kb Clol fragment. DNA sequence studies revealed that two open reading frames, pplA and pplB, coding for putative proteins of 18~9 and 16.8 kDa, respectively, were located on the Clol fragment. Exonuclease 111 digestion studies confirmed tbat pplA is the gene coding for the peptidoglycan.;.associated 19-kDa protein of L. pneumophilo. The amino acid sequence of PpiA exhibits a high degree of homology to the sequences of the Pal Iipoproteins of E. coli K-12 and liaemophilus injluenvze.
Despite the internet's dynamic and collaborative nature, scientists continue to produce grant proposals, lab notebooks, data files, conclusions etc. that stay in static formats or are not published online and therefore not always easily accessible to the interested public. Because of limited adoption of tools that seamlessly integrate all aspects of a research project (conception, data generation, data evaluation, peerreviewing and publishing of conclusions), much effort is later spent on reproducing or reformatting individual entities before they can be repurposed independently or as parts of articles.
We propose that workflows - performed both individually and collaboratively - could potentially become more efficient if all steps of the research cycle were coherently represented online and the underlying data were formatted, annotated and licensed for reuse. Such a system would accelerate the process of taking projects from conception to publication stages and allow for continuous updating of the data sets and their interpretation as well as their integration into other independent projects.
A major advantage of such work ows is the increased transparency, both with respect to the scientific process as to the contribution of each participant. The latter point is important from a perspective of motivation, as it enables the allocation of reputation, which creates incentives for scientists to contribute to projects. Such work ow platforms offering possibilities to fine-tune the accessibility of their content could gradually pave the path from the current static mode of research presentation into a more coherent practice of open science.
Background
The capacity of the recombinant Vaccinia virus GLV-1h68 as a single agent to efficiently treat different human or canine cancers has been shown in several preclinical studies. Currently, its human safety and efficacy are investigated in phase I/II clinical trials. In this study we set out to evaluate the oncolytic activity of GLV-1h68 in the human lung adenocarcinoma cell line PC14PE6-RFP in cell cultures and analyzed the antitumor potency of a combined treatment strategy consisting of GLV-1h68 and cyclophosphamide (CPA) in a mouse model of PC14PE6-RFP lung adenocarcinoma.
Methods
PC14PE6-RFP cells were treated in cell culture with GLV-1h68. Viral replication and cell survival were determined by plaque assays and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. Subcutaneously implanted PC14PE6-RFP xenografts were treated by systemic injection of GLV-1h68, CPA or a combination of both. Tumor growth and viral biodistribution were monitored and immune-related antigen profiling of tumor lysates was performed.
Results
GLV-1h68 efficiently infected, replicated in and lysed human PC14PE6-RFP cells in cell cultures. PC14PE6-RFP tumors were efficiently colonized by GLV-1h68 leading to much delayed tumor growth in PC14PE6-RFP tumor-bearing nude mice. Combination treatment with GLV-1h68 and CPA significantly improved the antitumor efficacy of GLV-1h68 and led to an increased viral distribution within the tumors. Pro-inflammatory cytokines and chemokines were distinctly elevated in tumors of GLV-1h68-treated mice. Factors expressed by endothelial cells or present in the blood were decreased after combination treatment. A complete loss in the hemorrhagic phenotype of the PC14PE6-RFP tumors and a decrease in the number of blood vessels after combination treatment could be observed.
Conclusions
CPA and GLV-1h68 have synergistic antitumor effects on PC14PE6-RFP xenografts. We strongly suppose that in the PC14PE6-RFP model the enhanced tumor growth inhibition achieved by combining GLV-1h68 with CPA is due to an effect on the vasculature rather than an immunosuppressive action of CPA. These results provide evidence to support further preclinical studies of combining GLV-1h68 and CPA in other highly angiogenic tumor models. Moreover, data presented here demonstrate that CPA can be combined successfully with GLV-1h68 based oncolytic virus therapy and therefore might be promising as combination therapy in human clinical trials.
Background: Vibrio parahaemolyticus is a Gram-negative halophilic bacterium. Infections with the bacterium could become systemic and can be life-threatening to immunocompromised individuals. Genome sequences of a few clinical isolates of V. parahaemolyticus are currently available, but the genome dynamics across the species and virulence potential of environmental strains on a genome-scale have not been described before.
Results: Here we present genome sequences of four V. parahaemolyticus clinical strains from stool samples of patients and five environmental strains in Hong Kong. Phylogenomics analysis based on single nucleotide polymorphisms revealed a clear distinction between the clinical and environmental isolates. A new gene cluster belonging to the biofilm associated proteins of V. parahaemolyticus was found in clincial strains. In addition, a novel small genomic island frequently found among clinical isolates was reported. A few environmental strains were found harboring virulence genes and prophage elements, indicating their virulence potential. A unique biphenyl degradation pathway was also reported. A database for V. parahaemolyticus (http://kwanlab.bio.cuhk.edu.hk/vp webcite) was constructed here as a platform to access and analyze genome sequences and annotations of the bacterium.
Conclusions: We have performed a comparative genomics analysis of clinical and environmental strains of V. parahaemolyticus. Our analyses could facilitate understanding of the phylogenetic diversity and niche adaptation of this bacterium. "
Comparative genomics provides structural and functional insights into Bacteroides RNA biology
(2022)
Bacteria employ noncoding RNA molecules for a wide range of biological processes, including scaffolding large molecular complexes, catalyzing chemical reactions, defending against phages, and controlling gene expression. Secondary structures, binding partners, and molecular mechanisms have been determined for numerous small noncoding RNAs (sRNAs) in model aerobic bacteria. However, technical hurdles have largely prevented analogous analyses in the anaerobic gut microbiota. While experimental techniques are being developed to investigate the sRNAs of gut commensals, computational tools and comparative genomics can provide immediate functional insight. Here, using Bacteroides thetaiotaomicron as a representative microbiota member, we illustrate how comparative genomics improves our understanding of RNA biology in an understudied gut bacterium. We investigate putative RNA-binding proteins and predict a Bacteroides cold-shock protein homolog to have an RNA-related function. We apply an in silico protocol incorporating both sequence and structural analysis to determine the consensus structures and conservation of nine Bacteroides noncoding RNA families. Using structure probing, we validate and refine these predictions and deposit them in the Rfam database. Through synteny analyses, we illustrate how genomic coconservation can serve as a predictor of sRNA function. Altogether, this work showcases the power of RNA informatics for investigating the RNA biology of anaerobic microbiota members.
Background
The lytic cycle of the protozoan parasite \(Toxoplasma\) \(gondii\), which involves a brief sojourn in the extracellular space, is characterized by defined transcriptional profiles. For an obligate intracellular parasite that is shielded from the cytosolic host immune factors by a parasitophorous vacuole, the brief entry into the extracellular space is likely to exert enormous stress. Due to its role in cellular stress response, we hypothesize that translational control plays an important role in regulating gene expression in \(Toxoplasma\) during the lytic cycle. Unlike transcriptional profiles, insights into genome-wide translational profiles of \(Toxoplasma\) \(gondii\) are lacking.
Methods
We have performed genome-wide ribosome profiling, coupled with high throughput RNA sequencing, in intracellular and extracellular \(Toxoplasma\) \(gondii\) parasites to investigate translational control during the lytic cycle.
Results
Although differences in transcript abundance were mostly mirrored at the translational level, we observed significant differences in the abundance of ribosome footprints between the two parasite stages. Furthermore, our data suggest that mRNA translation in the parasite is potentially regulated by mRNA secondary structure and upstream open reading frames.
Conclusion
We show that most of the \(Toxoplasma\) genes that are dysregulated during the lytic cycle are translationally regulated.
A new mouse model for systemic infection with Escherichia coli is presented. Whereas in other models 107_108 bacteria have to be injected into an animal to induce toxic effects resulting in death within 24 hours, now, only 103_104 bacteria of an appropriate strain are required to produce a genuine infection characterized by an increase in the bacterial load over several days. The quantitative determination of bacterial counts per liver allows a more sensitive measurement than recording death rates. Furthermore, few animals are required for a definite result in contrast to the LDso determination of other models. The salient point regarding this new model is that conditioning of animals has to be achieved by incorporating the inoculum into agar which is injected subcutaneously. The resulting infection is completely dependent on the E. colicondistrain used. Whereas a hemolytic, uropathogenic strain is so virulent that an overwhelming infection develops within 48 hours after the injection of 103 bacterial cells, a non-hemolytic variant of this strain is completely avirulent, being unable to multiply in spite of the potentiating agar. The hemolytic E. coli strain ATCC 25922 is intermediate in virulence. The bacterial counts per liver increase steadily until death occurs five to seven days after the injection of 104 bacteria. This bacterial infection can be therapeutically influenced by daily treatment with various drugs. Ciprofloxacin, ceftriaxone and co-trimoxazole are able to cure the infection, whereas amoxicillin given orally is only moderately active against this ATCC strain, which is relatively resistant to amoxicillin.
DNA probes specific for different regions of the S-fimbrial adhesin (sja) determinant were constructed and hybridized with DNA sequences coding for P (F8 and F13), mannose-sensitive hemagglutinating type 1 (FlA), and FlC fimbriae. While the sfa and F1C DNA determinants exhibited homology along their entire lengths, the P-fimbrial and type 1-fimbrial determinants exhibited homology to regions of the sfa duster responsible for the control of transcription and, to a minor extent, to regions coding for proteins involved in biogenesis and/or adhesion of the fimbriae and for the N-terminal part of the fimbrillin subunit.
The S fimbrial adhesin (sfa) determinant of E. co/i comprises nine genes situated on a stretch of 7.9 kilobases (kb) DNA. Here the nucleotide sequence of the genes sfa B and sfaC situated proximal to the main structural gene sfaA is described. Sfa-LacZ fusions show that the two genes are transcribed in opposite directions. The isolation of mutants in the proximal region of the sfa gene cluster, the construction of sfa-phoA gene fusions and subsequent transcomplementation sturlies indicated that the genes sfaB and sfaC play a role in regulation of the sfa determinant. ln addition the nucleotide sequence of the genes sfa D, sfa E and sfa F situated between the genes sfaA and sfaG responsible for S subunit proteins, were determined. lt is suggested that these genes are involved in transport and assembly of fimbrial subunits. Thus the entire genetic organization of the sfa determinant is presented and compared with the gene clusters coding for P fimbriae (pap), F1 C fimbriae (foc) and type I fimbriae ( fim). The evolutionary relationship of fimbrial adhesin determinants is discussed.
The probiotic Escherichia coli strain Nissle 1917 (EcN) is one of the few probiotics licensed as a medication in several countries. Best documented is its effectiveness in keeping patients suffering from ulcerative colitis (UC) in remission. This might be due to its ability to induce the production of human beta defensin 2 (HBD2) in a flagellin-dependent way in intestinal epithelial cells. In contrast to ulcerative colitis, for Crohn´s disease (CD) convincing evidence is lacking that EcN might be clinically effective, most likely due to the genetically based inability of sufficient defensin production in CD patients. As a first step in the development of an alternative approach for the treatment of CD patients, EcN strains were constructed which were able to produce human alpha-defensin 5 (HD5) or beta-defensin 2 (HBD2). For that purpose codon-optimized defensin genes encoding either the proform with the signal sequence or the mature form of human alpha defensin 5 (HD5) or the gene encoding HBD2 with or without the signal sequence were cloned in an expression vector plasmid under the control of the T7 promoter. Synthesis of the encoded defensins was shown by Western blots after induction of expression and lysis of the recombinant EcN strains. Recombinant mature HBD2 with an N-terminal His-tag could be purified by Ni-column chromatography and showed antimicrobial activity against E. coli, Salmonella enterica serovar Typhimurium and Listeria monocytogenes. In a second approach, that part of the HBD2-gene which encodes mature HBD2 was fused with yebF gene. The resulting fusion protein YebFMHBD2 was secreted from the encoding EcN mutant strain after induction of expression. Presence of YebFMHBD2 in the medium was not the result of leakage from the bacterial cells, as demonstrated in the spent culture supernatant by Western blots specific for ß-galactosidase and maltose-binding protein. The dialyzed and concentrated culture supernatant inhibited the growth of E. coli, Salmonella enterica serovar Typhimurium and Listeria monocytogenes in radial diffusion assays as well as in liquid coculture. This demonstrates EcN to be a suitable probiotic E. coli strain for the production of certain defensins.
Escherichia coli 536 (06:K15:H31), which was isolated from a case of urinary tract infection, determines high nephropathogenicity in a rat pyelonephritis system as measured by renal bacterial counts 7 days after infection. The loss of S fimbrial adhesin formation (Sfa-) (mannose-resistant hemagglutination [Mrh-] and fimbria production [Fim-]), serum resistance (Sre-), and hemolysin production (Hly-) in the mutaßt 536-21 led to a dramatic reduction of bacterial counts from almost tOS to only 40 cells per g of kidney. The reintroduction of the cloned S fimbrial adhesin determinant (sfa) increases the virulence of the avirulent mutant strain by a factor of 20; almost the same eß'ect was observed after restoration of serum resistance by Integration of an sja+ recombinant cosmid into the chromosome. Additional reintroduction of the my+ phenotype by Iransformation of two hly determinants increased the virulence of the strains. Demolysin production determined increased renal elimination of leukocytes and erythrocytes. Thus all three determinants investigated, S fimbriae, serum resistance, and hemolysin, contribute to the multifactorial phenomenon of E. coli nephropathogenicity.